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ABSTRACT 
In vitro test models may reduce the time and resources required for pre clinical 
toxicology studies, as well as decrease the number of laboratory animals needed 
to assess toxicity of drugs.  Several models and toxicity assays have been 
evaluated at GE Healthcare, e.g. using rat liver slices, but the viability of slices 
has not been optimal and the results inconclusive.  
The aims of this study were to test a new incubator and improve the viability of 
rat liver slices; evaluate various in vitro assays for toxicity; and evaluate the 
in vitro toxicity of menadione and iron (II) sulphate on rat liver slices. 
Exsanguinous rat livers were cut in slices of 8 mm diameter and 250 µm 
thickness and incubated in William’s medium E with menadione or iron (II) 
sulphate for various time periods.  The slices were analysed for weight, 
mitochondrial viability (MTT test), enzyme leakage (ALAT, ASAT, GLDH, 
LDH), and iron and potassium content. 
Leakage of certain enzymes (ASAT, GLDH), and reduced potassium content, 
indicated less viability of liver slices treated with iron (II) sulphate than 
negative controls.  Of the assays studied here, GLDH leakage seemed to be the 
most predictive of iron (II) sulphate toxicity.  The MTT test, LDH leakage, and 
reduced potassium content indicated less viability of liver slices treated with 
menadione than negative controls. 
More practical training of personnel in using the equipment is required to 
improve the performance of the rat liver slice model.  Isolated hepatocytes may 
be easier to culture and use for toxicity screening. 
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ABBREVIATIONS 
Short form Complete form Definition, function or use 
ALAT, or ALT alanine aminotransferase cellular enzyme 
ASAT, or AST aspartate aminotransferase cellular enzyme 
ATP adenosine triphosphate energy-storing biomolecule 
DMSO dimethylsulfoxide organic solvent 
FBS fetal bovine serum additive to culture medium 
GLDH glutamate dehydrogenase cellular enzyme 
ICP-AES inductively coupled plasma  
atomic emission spectrometry 
method for quantifying single elements, 
especially metals 
LDH lactate dehydrogenase cellular enzyme 
MQ-water milli-Q water de-ionised RO-water 
MTT 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazoliumbromide 
dye used in assay for cell viability 
NADH / NAD+ nicotinamide adenine 
dinucleotide (reduced / oxidised) 
enzyme cofactor 
NBF neutral-buffered formalin, or 
normal-buffered formalin 
formaldehyde solution adjusted to 
neutral pH (≈ 7); used to fix tissues for 
histology 
PBS phosphate-buffered saline salt water adjusted to physiological pH 
(7.4) with a phosphate buffer system; 
used to transport and contain tissue 
samples during experiments 
RO-water reverse osmosis water water purified by reverse osmosis 
SD standard deviation measure of variation within a group of 
observations (sample size: n), based on 
the differences between individual data 
(x) and the sample mean (X) 
SD = √[ Σ(x–X)2 / (n-1) ] 
     = √[ (Σx2 - nX2) / (n-1) ] 
     = √[ (Σx2 - {Σx}2/n ) / (n-1) ] 
SE, or SEM standard error of the mean measure of variation between sample 
means from different groups, calculated 
as the SD using the means as individual 
data, or – if sample sizes are equal and 
the SDs are the same in all groups – 
SE = SD / √[n] 
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1. OBJECTIVES 
1.1. INTRODUCTION 
Validated and relevant in vitro models may contribute to reduce the time and resources 
required for pre-clinical toxicology studies, as well as decrease the number of laboratory 
animals needed to assess toxicity of drugs. 
Several in vitro incubation systems and assays for toxicity have been evaluated at the 
GE Healthcare site in Oslo.  For example rabbit kidney slices and rat liver slices have been 
cultured for periods of up to 24 hours, but the viability of slices has not been optimal and the 
results inconclusive.  One of the goals of this project was therefore to improve the quality 
and viability of slices in the liver slice model. 
A new incubator had been purchased recently, allowing tissue slices to be incubated in 
rolling glass vials with teflon or titanium inserts.  The intention was to evaluate different 
concentrations and types of test substances, and different exposure times, as well as various 
in vitro assays for toxicity, e.g. enzyme leakage, the MTT test, and histology. 
A known hepatotoxicant, menadione, was to be used as the test substance in early 
experiments, and as a positive control for one or more test substances in later experiments.  
A substance of interest in the later experiments was iron, which is the principal constituent of 
certain magnetic resonance imaging (MRI) contrast agents currently in development.  These 
agents contain microparticles of iron oxide, but for testing of toxicity a soluble form of iron 
was chosen for this project; iron (II) sulphate (ferrous sulphate, FeSO4). 
Rat livers, liver slices and isolated hepatocytes, and various iron compounds including iron 
(II) sulphate, have been involved in previous research on iron toxicity (e.g. Bacon et al. 
1986, Mak and Weglicki 1985, Pushpendran et al. 1998).  However, the treatment of rat liver 
slices with iron (II) sulphate seems to be a novel approach. 
Page 12 of 182 
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1.2. PRIMARY OBJECTIVES 
– test the new incubator and improve the quality and viability of slices in the liver slice 
model at GE Healthcare 
– evaluate various in vitro assays for toxicity, e.g. enzyme leakage and the MTT test, to 
identify the most sensitive endpoints 
1.3. SECONDARY OBJECTIVES 
– observe the effects of different exposure times and concentrations of test substances 





2.1.1. General aspects 
The liver is the largest internal organ in mammals and is richly supplied with blood from the 
hepatic artery and the portal vein, filtering approximately one fifth of cardiac output each 
minute.  All blood from the intestines is drained through the portal vein, and since the 
majority of xenobiotics enter the body via the gastrointestinal tract and are absorbed into the 
blood by the intestines, they must first pass the liver to reach the systemic circulation.  
Considering its size and position, in addition to its very high concentrations of a variety of 
enzymes, the liver is the major metabolic and detoxifying organ of the body.  However, its 
anatomy and blood supply also makes it vulnerable to toxic influences, and injury to the liver 
may have profound systemic repercussions. 
Most xenobiotics are oxidised or otherwise converted to harmless (or less harmful) 
substances by the liver.  It facilitates their excretion via the kidneys through increasing their 
water-solubility, or takes them out of circulation by complexing them with bile salts and 
excreting them into the bile duct and thence into the intestine.  Some compounds may be 
activated rather than inactivated by hepatic enzymes.  Others cause transformations of the 
enzymes themselves, destroying their function and reducing the liver’s metabolic capacity 
until new enzymes have been synthesised.  The liver may also fail to metabolise the 
compounds rapidly enough, allowing them to persist and cause toxicity to the liver, as well 
as to other organ systems. 
Cytotoxic mechanisms include cytoskeleton alterations, mitochondrial dysfunction and 
energy deprivation, loss of thiols and antioxidant status, and perturbation of intracellular 
calcium homeostasis with subsequent activation of degradative enzymes.  Damage to the 
plasma membrane or a block in ATP synthesis impairs energy-dependent cellular ion 
pumping mechanisms, allowing sodium and calcium to enter and potassium to escape, 
resulting in loss of plasma membrane volume control and acute cell swelling (Vickers, 1997).  
The liver can generally recover from mild acute injury by hepatocellular regeneration with 
the production of new cells, which restore liver function and normal tissue architecture, but 
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chronic or more severe acute injury may lead to fibrogenesis, scar formation, and distortion 
of the normal tissue architecture (Mehendale, 1991). 
Endpoints of chronic toxicity observed in liver include cell necrosis, apoptosis, steatosis 
(fatty liver), cholestasis (inhibition of bile flow) and jaundice, hepatitis, cirrhosis, and 
neoplasia (Hodgson, 2001; Plaa and Charbonneau, 1994).  Because cellular necrosis is 
accompanied by leakage of cellular contents, their detection in plasma or serum is commonly 
used as a non-invasive surrogate endpoint.  Some enzymes measured to monitor liver status 
are alanine aminotransferase (ALAT) and aspartate aminotransferase (ASAT) (Meyer, 2001). 
2.1.2. Menadione 
Menadione is a member of the vitamin K family (Figure 2.1-a), which is involved in the bio-
activation, or post-translational modification, of blood coagulation factors II (prothrombin), 
VII, IX, X, and certain other proteins.  In vivo, both menadione (vitamin K3) and phyllo-
quinone (vitamin K1) are converted to the bioactive metabolite menaquinone-4 (vitamin K2).  
This form of the vitamin is a coenzyme for the oxidation of glutamic acid (Glu) residues to 





a )  K  v ita m in s
C H 3
C H 3C H 3C H 3C H 3
R 1 :
C H 3







b ) W a r fa r in
 
Figure 2.1. Chemical structures of a) some K vitamins including menadione, and 
b) the vitamin K antagonist, warfarin 
R = R1  vitamin K1  phylloquinone  2-methyl-3-phytyl-1,4-napthoquinone;  
R = R2  vitamin K2  menaquinone-4  2-methyl-3-tetraprenyl-1,4-napthoquinone;  
R = H  vitamin K3  menadione  2-methyl-1,4-napthoquinone. 
Vitamin K is used therapeutically as a pro-thrombogenic drug and as an antidote for 
poisoning with coumarin derivatives.  Some examples of these are the sweet clover 
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constituent bishydroxycoumarol, which causes sporadic casualties in livestock, and warfarin 
(Figure 2.1-b), the active principle of rat poison and some anticoagulant drugs.  On the other 
hand, excessive vitamin K is itself toxic due to its oxidative properties, and because of its 
lipid solubility it may accumulate in adipose tissue.  The toxicity of menadione and other 
K vitamins involves oxidative stress caused by redox cycling and/or arylation of protein 
thiols (Stubberfield and Cohen, 1989). 
Although normally metabolised to menaquinone in vivo, menadione does not need any 
metabolic activation to exert its toxicity and is commonly used as a positive control 
substance for in vitro toxicology studies (Leeman et al., 1995; Price et al., 1996).  However, 
a certain level of oxygen (O2) is necessary to reveal the toxicity of menadione.  In isolated 
hepatocytes treated with 100-400 µM menadione, the threshold level lies below the 
atmospheric oxygen average of 21% (Utley and Mehendale, 1989).  200 µM menadione at 
21% O2 is toxic to hepatocytes but not to liver slices (Wright and Paine, 1992).  Toxic effects 
are observed in liver slices treated with 50-400 µM menadione at 40% O2 (Leeman et al., 
1995), or with 100-300 µM menadione at 95% O2 (Chan et al., 1992). 
The liver slices in the present study were supplied with 95% O2 / 5% CO2 during incubation, 
and the medium had also been gassed with 95% O2 / 5% CO2 before incubation. 
2.1.3. Iron 
Iron (Fe) is an essential element for most living organisms, and in many higher forms of life 
it comprises the central part of the oxygen-carrying haemoglobin molecules of the red blood 
cells.  It is also part of a number of electron-carriers in the respiratory chain, plus many other 
enzymes.  Iron is transported throughout the body by transferrin, a specialised iron-carrying 
protein, and is stored intracellularly bound to ferritin, mainly in the liver. 
Varying amounts of iron are lost in menstrual bleeding, haemorrhage, and red cell turnover, 
and must be replaced through the diet.  Cereals, coarse bread, liver and blood products are 
rich sources of iron.  If the diet does not replace all the iron lost or the iron is not properly 
exploited, which may be the case for fertile women, elderly people and in certain diseases, a 
supplement of iron should be taken.  However, iron is also a highly reactive element that 
promotes free radical formation, and in high concentrations it is carcinogenic (Griffiths et al., 
1999).  It can therefore be dangerous to take an iron supplement constantly without 
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monitoring the iron level, or to take large doses of iron at any one time.  Regulation of in 
vivo iron levels concerns only uptake, and the most common disorders involving 
misregulation result in hyperchromatosis, i.e. iron overload (Griffiths et al., 1999). 
The liver is a target organ for iron accumulation and toxicity in various iron-overload 
disorders, and in vitro oxidative damage by ferrous iron has been demonstrated in liver 
homogenates (Pushpendran et al., 1998), isolated hepatic lysosomes (Mak and Weglicki, 
1985), and isolated hepatic mitochondria (Bacon et al., 1986; Pushpendran et al., 1998).  
The isolated perfused rat liver, even when it is already in a state of iron overload, effectively 
takes up and clears non-transferrin-bound iron from plasma (Wright et al., 1986; Wright and 
Lake, 1990). 
Ferrous iron (Fe2+) is directly toxic, whereas the toxicity of ferric iron (Fe3+) depends on 
conversion to ferrous iron by a reducing agent such as ascorbic acid (vitamin C), or cycling 
between ferric and ferrous iron (Mak and Weglicki, 1985).  Because of its influence on the 
toxic potential of iron, the common antioxidant vitamin C may in large doses (several grams) 
prove harmful to persons affected by hyperchromatosis of various aetiologies.  Although the 
incidence of chronic iron overload is well below 1%, caution should be exhibited regarding 
high-dose vitamin C. 
2.2. IN VITRO LIVER CULTURE SYSTEMS 
To minimise the number of animals used in toxicological studies, and to improve the 
utilisation of time and other resources in such studies, an array of in vitro models have been 
developed in different laboratories.  These methods are used, among other things, for 
metabolism studies (phase I and phase II metabolism), toxicity screening (which compounds 
are toxic and which are not), comparative medicine (comparing species), and for determining 
the appropriate species for in vivo studies.  A few in vitro systems for culturing liver tissue 
will be described here; the isolated perfused liver, isolated hepatocytes, and liver slices.  
Some assays for toxicity are described in section 2.4 (page 24 ff) and section 3.3 (page 40 ff). 
As mentioned in section 2.1.1, the hepatotoxic potential of a compound is often related to its 
biotransformation.  An in vitro toxicological system should therefore reproduce the in vivo 
biotransformations of compounds in order to be predictive of hepatotoxicity.  However, the 
Background 
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in vivo metabolism and effects of many substances vary according to inter-individual 
differences in enzyme levels, health condition, alcohol or drug abuse, the legitimate use of 
drugs, and other factors not easily reproduced in vitro.  Results from in vitro experiments 
should be interpreted with these potentially confounding factors in mind.  On the other hand, 
relative homogeneous in vitro study materials available from animals of the same age, sex, 
and breed, may contribute valuable stability to routine investigations of large amounts of test 
compounds.  Other advantages and disadvantages of in vitro systems are discussed below. 
2.2.1. The isolated perfused liver 
The liver is excised together with its afferent and efferent blood vessels, then submerged in a 
suitable oxygenated, buffered and temperature-controlled nutrient medium, with the blood 
vessels connected to tubes.  By use of pumps and these tubes, the organ is provided with a 
perfusate similar to the surrounding medium, and this is collected for analyses after passage 
through the liver.  It may also be recycled through the liver continuously or a specific 
number of times.  Various substances can easily be added to the afferent perfusate and 
changes in composition, reflecting metabolic activity in the organ, can be monitored. 
Important advantages of the perfused organ model are, preservation of cellular and whole-
organ functionality, a very good in vivo – in vitro correlation, and ease of administration and 
collection of test substances.  Unfortunately the regional, cellular, and sub-cellular locations 
of particular biochemical reactions are difficult to establish, and the viability of organs can 
only be sustained for relatively short periods.  Other disadvantages include limited numbers 
of experimental units (only one liver per animal), and large laboratory space and perfusate 
volumes needed per unit (often several litres). 
2.2.2. Isolated hepatocytes 
The liver consists of parenchymal cells, or hepatocytes, and non-parenchymal cells including 
Kupffer cells, biliary epithelial cells, blood vessel endothelial cells, and several other cell 
types.  Much of the work on isolated liver cells has been focused on hepatocytes because 
they are the main metabolic unit of the liver, and they amount to 60% of the organ’s cells by 
number; 80% by volume (Plaa and Charbonneau, 1994).  To isolate hepatocytes, the liver is 
perfused with an oxygenated collagenase-containing buffer, which must be sterile and 
bubble-free.  Collagenase digests the extracellular matrix in the liver without disrupting 
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cellular membranes or Glisson’s capsule, the outer membrane of the organ.  This procedure 
can either be performed on a previously excised liver stored on wet ice in a sterile environ-
ment for up to 36 hours, or in situ during non-survival surgery (Mudra and Parkinson, 2001).  
The latter method yields a higher percentage of viable hepatocytes, but requires a highly 
skilled technician to avoid maltreatment of the test subject. 
After digestion with collagenase the hepatocytes are suspended in sterile, oxygenated, 
buffered nutrient medium, then filtered.  The suspension is centrifuged, the supernatant 
removed, and the cells resuspended in new medium several times to thoroughly rinse the 
cells and to remove dead cells which will float during centrifugation.  The number of cells 
per ml is counted after staining a sample of the suspension with trypan blue, and the rest of 
the suspension is diluted with medium to the desired concentration (e.g. 1x106 cells/ml).  
Aliquots of hepatocytes can be cryo-preserved or used directly in experiments, in which case 
they are seeded into 24- or 96-well microplates, or larger vials, with medium containing test 
substances of interest.  Incubation is done at 37°C for the desired time, and the necessary 
analyses are performed (Mudra and Parkinson, 2001). 
Among the advantages of isolated hepatocytes are the high numbers of cells obtained, their 
ability to survive cryo-preservation, and their maintenance for longer periods than whole 
organs; at least 6 hours.  However, when the extracellular matrix is disrupted and the hepato-
cytes are separated, they rapidly de-differentiate and do not retain the regional specialisation 
within the liver lobes (periportal, centrilobular, canalicular). 
An extension of the isolated hepatocyte method is the use of hepatocyte cultures permitting 
longer test periods by attaching cells to an artificial extracellular matrix placed in a 
periodically refreshed medium to keep them viable (Berry et al., 1991; Grisham, 1979).  
Factors such as the matrix used for cell attachment, culture medium, addition of hormones, 
oxygen tension, cell density, and presence of other cell types determine enzyme and gene 
expression and affect cell viability in mono-layer cultures of hepatocytes (McQueen, 1993). 
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2.2.3. Liver slices 
Earlier, tissue slices were prepared by hand using razorblades, but nowadays they are 
prepared with mechanical precision instruments (for details on procedures, see the next 
section).  Slices are generally prepared from untreated animals and exposed to the study drug 
or drugs in vitro, although a few experiments are performed with pre-treated organs. 
Several factors make the use of tissue slices attractive.  The major advantage of tissue slices 
over single-cell systems is that the slices contain all cell types of an organ in their normal in 
vivo architectural relationships with the preservation of intercellular communication and 
interactions, enabling both regional and cell-specific effects to be investigated (Bach et al., 
1996; McGuinness et al., 1993; Ruegg, 1994).  Compared to whole-organ systems slices 
require less laboratory space per experimental unit, and are not as limited in number.  
As many as 75-100 slices may be obtained from an adult rat liver, or 10000-20000 slices 
from an adult human liver (Bach et al., 1996).  Tissue slices also facilitate comparison 
between different organs and species, since the methodology for preparing and treating slices 
is similar regardless of the organ or species from which the slices are derived (Bach et al., 
1996; Gandolfi et al., 1995).  Last, but not least, incubations of tissue slices can last for 
5 days under sterile and otherwise strictly controlled conditions (Bach et al., 1996; Fisher 
et al., 1995a; Parrish et al., 1995; Smith et al., 1985). 
Compared to in vivo methods, advantages of tissue slices involve decreased costs, time, and 
numbers of animals necessary to complete a study. 
2.3. PRECISION-CUT TISSUE SLICES 
2.3.1. Preparation of slices – the Krumdieck tissue slicer 
When tissue slice techniques were first introduced, the cutting of slices by hand led to very 
heterogeneous sets of slices.  In addition, the manual process rendered slices too thick to 
allow sufficient oxygen and nutrient supply for the inner cell layers, resulting in necrosis 
(Smith et al., 1985).  Later, mechanical tissue slicers have been developed, capable of 
producing thin tissue slices of consistent thickness from a range of organs and species.  
One of these, the Krumdieck tissue slicer, is described here. 
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In 1980, Krumdieck et al. had developed a mechanical tissue slicer that allowed a relatively 
inexperienced operator to rapidly produce slices of nearly identical thickness, of very similar 
shape, with minimal tissue damage, and in a controlled environment.  The Krumdieck tissue 
slicer (Figure 2.2) contains a motorised, horizontally oscillating razorblade submerged in a 
reservoir filled with a viscous, oxygenated buffer.  The buffer circulates through channels in 
the reservoir, driven by the centrifugal force of the blade’s power shaft.  Cylindrical tissue 
cores resting on a horizontal base are held in place by a cutting arm with weights, and moved 
back and forth across the oscillating blade by the movement of the arm, which is also 
motorised.  A tissue slice is produced on each passage of the core against the razorblade.  
Slice thickness is controlled with a micrometer screw regulating the vertical distance 
between the blade and the base upon which the cores rest, and the achieved thickness 
corresponds well to the setting of the instrument (Krumdieck et al., 1980).  Optimal 
dimensions of slices vary with regard to organs and species, but for rat liver slices the 
optimal thickness is 200-250 µm (Smith et al., 1985) and diameter 8 mm (Fisher et al., 
1995b). 
 
Slices are produced by a mechanically driven, straight razorblade 
(A), which oscillates in a plane perpendicular to the diagram. The 
tissue core rests in the cutting arm (B) and is swept across the 
blade by a piston pivot mount. Slice thickness is a function of 
tissue type, the weight over the tissue core (C), and the setting of 
the micrometer screw (D). Slices are trapped on a strainer placed 
in the slice collection vessel (E) and are retrieved through a valve 
during breaks in motor operation (F). Slicing buffer is returned to 
the reservoir (G) after passing through the collection vessel.  
Diagram modified with permission from Parrish et al. (1995). 
Figure 2.2. Schematic view of the Krumdieck tissue slicer (Alabama R&D) 
 
One problem with early mechanical slicers was that the process of removing ready-cut slices 
was slow and very dependent on the experience of the operator.  This is not a problem with 
the Krumdieck tissue slicer because slices are carried away by the circulating buffer and 
trapped on a strainer from which they can be removed at intervals and stored on ice.  Thus, 
the operator’s task is simplified and the instrument’s function is speeded up, and one can 
easily obtain more than 10 slices per minute.  Another major advantage of the Krumdieck 
tissue slicer is that the tissue is constantly bathed in oxygenated, buffered medium, which 
may also be cooled during the operation by adding a recirculating refrigeration unit, 
improving the viability of slices.  A study performed on the variation of liver slices produced 
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by the Krumdieck tissue slicer demonstrated a consistency among slices with regard to 
thickness and surface area, allowing them to be used as individual experimental units (Smith 
et al., 1985). 
2.3.2. Incubation of slices 
2.3.2.1. Time span 
The incubation of slices can roughly be divided into three categories (Bach et al., 1996): 
(a) Short-term incubation; slices are incubated with various compounds for 8 hours or less 
in simple tissue culture media.  These conditions are often suitable for investigating 
the metabolism of compounds. 
(b) Intermediate-term incubation; slices are incubated for up to 24 hours in nutrient-
enriched tissue culture media for studies on toxicity and metabolism.  Slices can also 
be exposed to chemicals for a short time and then maintained for up to 24 hours to 
assess the effects of acute exposure. 
(c) Long-term incubation; slices are kept viable for more than 24 hours in specially 
enhanced tissue culture media and under strict control of physico-chemical and micro-
biological environment.  This makes it possible to investigate the effects of longer 
exposure to chemicals and to study induction of enzymes. 
In the present study, liver slices are incubated on short and intermediate term. 
2.3.2.2. Incubation systems 
A variety of incubation systems have been developed for slices, generally based on two 
principles; the continuously submerged incubation and the dynamic organ culture incubation.  
Both principles have their unique attributes, but their common feature is the delivery of 
nutrients and oxygenated culture medium to both surfaces of the slices. 
During continuously submerged incubation, slices are in the medium all the time and air or 
other gas supply is bubbled through or passed over the medium.  Some examples are the 
submersion bubble system (Ruegg et al., 1987), the stirred well system (Dogterom, 1993), 
and the shaken flask system (de Kanter and Koster, 1995).  Using continuously submerged 
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incubation, viability of liver slices has been maintained for 1 to 3 days, and some of these 
systems are suitable for long-term incubation (Bach et al., 1996). 
In dynamic organ culture incubation, slices are placed on small-meshed nets and inter-
mittently exposed to medium and air (gas), improving the oxygen transfer into slices.  
Examples are the dynamic roller system (Smith et al., 1985) and the rocker platform system 
(Leeman et al., 1995).  Incubations preserving viability for up to 5 days have been performed 
using this principle, and it is believed to be the optimal one for long-term incubation of liver 
slices (Bach et al., 1996; Fisher et al., 1995a; Parrish et al., 1995). 
The present study uses dynamic organ culture incubation with rolling vials (see Figure 3.4, 
page 34). 
2.3.2.3. Culture media 
A number of nutrient-enriched culture media have been tested to find the optimal media for 
incubating tissue slices from different organs, and various synthetic or semi-synthetic media 
have been developed especially for liver slices.  One research group found that all the culture 
media they tested – DMEM, DMEM/F12, MEM, H-Y, McCoy’s, RPMI, Waymouth, and 
Williams’ E – maintained cellular concentrations of potassium (K) above 80 µmol per gram 
wet weight for 72 hours and were suitable for long-term incubation of rat liver slices (Fisher 
et al., 1995b).  All the tested media were without phenol red and were supplemented with 
sodium bicarbonate, 10% fetal calf serum, 85 µg/ml gentamicin sulphate, and 1% FungiBact. 
The present study uses Williams’ medium E with phenol red, sodium bicarbonate, 5% fetal 
bovine serum and 1% Antibiotic-Antimycotic, in addition to L-glutamine, glucose, and 
insulin (for more details on medium composition see section 3.2, page 32 ff). 
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2.4. MARKERS OF TOXICITY 
2.4.1. Lipid peroxidation and antioxidant status 
The integrity of cellular membranes (plasma membrane, mitochondrial membranes, nuclear 
envelope, etc.) depends heavily on the chemical stability of their lipid constituents, mainly 
cholesterol, triglycerides, and phospholipids.  Reactive oxygen species and other free 
radicals involved in toxicity may create an oxidative stress disturbing cellular antioxidant 
status, particularly by oxidation or arylation of thiols such as glutathione, so that the lipids 
and other bio-molecules protected by the thiols become vulnerable to oxidation. 
The extent of lipid peroxidation is assessed by the production of malondialdehyde (MDA) 
using the thiobarbituric acid (TBA) test.  Samples are treated with a solution of TBA, and 
MDA is then determined spectrophotometrically at 535 nm (Burge and Aust, 1978).  Anti-
oxidant status can be established by measuring both reduced (GSH) and oxidised (GSSG) 
forms of glutathione using Hissin and Hilf’s method (1976) or a modification thereof 
(Obatomi et al., 1998a).  The assay involves fluorescence spectrometry with excitation at 
350 nm and emission at 420 nm. 
2.4.2. Alterations in protein synthesis 
Toxic substances affect protein functionality in a number of ways, ranging from the early 
steps of gene transcription (DNA template; RNA synthesis) via gene translation (RNA 
template; protein synthesis) to protein performance and in some cases the excretion of 
proteins from a cell.  Through chemical bonding and chemical reactions the toxins may 
inhibit the function or cause the destruction of DNA, RNA, the proteins themselves, or the 
enzymatic machinery associated with them. 
The method of Downs and Wilfinger (1983) or later modifications can be used to measure 
cellular content of intact DNA.  Samples are dissolved in a buffered mixture of surfactants 
and chelators, and DNA content is determined fluorometrically with excitation at 350 nm and 
emission at 460 nm (Miller et al., 1993). 
Protein synthesis and excretion can be measured after incubation with a radioactively 
labelled amino acid, e.g. 0.3 µCi/ml of L-[3H]leucine.  The incorporation of radioactivity into 
acid-precipitable protein is assessed by liquid scintillation counting and expressed as 
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dpm/mg protein (dpm; number of radioactive degradations per minute) (Fisher et al., 1995b; 
Sipes et al., 1987; Smith et al., 1986).  For the protein synthesis assay the whole sample is 
dissolved before precipitation of protein, whereas only culture-medium proteins are 
precipitated for the excretion assay.  Total protein is routinely determined according to 
Lowry et al. (1951). 
Excretion or leakage of certain enzymes, which are proteins, was measured in the present 
study using photometric methods (see the next section). 
2.4.3. Enzyme leakage 
Cytotoxic mechanisms include cytoskeleton alterations and lipid peroxidation, compromising 
the integrity of the plasma membrane.  This may induce cellular swelling or necrosis and is 
accompanied by leakage of cellular contents into the extracellular space.  In the earlier stages 
of tissue damage, cytoplasmic enzymes may leak from cells where plasma membrane 
permeability has altered.  As the severity of tissue damage progresses, enzymes normally 
present in subcellular organelles will be released (Evans GO, 1996).  If the leakage adds 
significantly to the extracellular levels of particular substances, which is often the case with 
cellular enzymes, it can be detected in blood plasma in vivo, or in culture medium in vitro, 
and is a marker of toxicity. 
Several tissue- or organ-specific enzymes have been identified making distinctions feasible 
between various illnesses or injuries with only blood samples instead of biopsies.  In vitro 
toxicological studies on kidney or liver almost invariably include measurements of lactate 
dehydrogenase (LDH), although this enzyme is not particularly organ-specific.  Other, more 
specific candidates are alkaline phosphatase (ALP) for kidney studies and alanine amino-
transferase (ALAT) or aspartate aminotransferase (ASAT) for liver studies (Obatomi et al., 
1998b).  However, the organ specificity of an enzyme may differ between species, or even 
individuals, which must be considered in the choice of enzymes and analytical methods in 
comparative medicine. 
An array of commercial reagent kits exist for measuring concentrations of various enzymes 
in different matrices, mainly serum or plasma.  The methods of quantification are often based 
on the rate of oxidation of NADH to NAD+ (two forms of the coenzyme, nicotinamide 
adenine dinucleotide) being linearly correlated with enzyme concentration, and the dis-
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appearance of NADH detectable by UV-absorption photometry.  The contents and 
procedures of the reagent kits are generally recommended by the International Federation of 
Clinical Chemistry (IFCC), the French Society of Clinical Biology (Société Française de 
Biologie Clinique, SFBC), the German Society of Clinical Chemistry (Deutsche Gesellschaft 
für Klinische Chemie, DKGC), or other major national associations. 
In the present study, the activities of four enzymes are measured in the incubation media 
after incubation of rat liver slices for 3, 6, or 24 hours: 
– alanine aminotransferase (ALAT), liver-specific in rats, mainly cytosolic;  
– aspartate aminotransferase (ASAT), less liver-specific, cytosolic/mitochondrial;  
– glutamate dehydrogenase (GLDH), liver-specific in rats, mainly mitochondrial; and  
– lactate dehydrogenase (LDH), low organ-specificity, mainly cytosolic. 
ALAT (also known as glutamic pyruvic transaminase, GPT) (Enzyme Commission no. EC 
2.6.1.2) is mainly a hepatic enzyme in many species, e.g. rat and dog, and plasma levels of 
the enzyme can be measured as a marker of liver status or hepatic injury.  It is generally 
considered a cytosolic enzyme, but is also present in the mitochondria of some species, 
including the rat (Evans GO, 1996). 
ASAT (also known as glutamic oxaloacetate transaminase, GOT) (Enzyme Commission no. 
EC 2.6.1.1) is less liver-specific than ALAT, but is often measured together with ALAT to 
identify the site and extent of injury.  It exists in both mitochondria and cytosol; the 
proportion of mitochondrial versus cytosolic forms being greater with ASAT than with 
ALAT (Evans GO, 1996). 
GLDH (Enzyme Commission no. EC 1.4.1.3) is an essentially mitochondrial enzyme present 
in liver, kidney and muscle tissues, with the highest concentrations in liver (Evans GO, 
1996). 
LDH (Enzyme Commission no. EC 1.1.1.27) is a cytosolic enzyme widely distributed in 
different tissues, the distribution patterns varying from species to species.  In rats the enzyme 
is not specific to the liver, but may indicate general tissue damage (Evans GO, 1996). 
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2.4.4. Reduced mitochondrial viability – the MTT test 
As mentioned above, mitochondrial membranes are vulnerable to oxidative stress and lipid 
peroxidation.  The components of the electron transport chain (ETC) of cellular respiration 
are located in these membranes and are also vulnerable to oxidation, and injury to either the 
membranes or the ETC may result in mitochondrial dysfunction.  Examples of ETC 
components are ubiquinone (coenzyme Q10), ferredoxin, cytochromes a, b, c, and various 
dehydrogenase enzymes. 
The water-soluble yellow dye, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium-
bromide, or C18H16N5SBr, so-called thiazolyl blue), is absorbed by cells and reduced to the 
water-insoluble blue dye, formazan (C18H17N5S), by dehydrogenase activity in functional 
mitochondria (Figure 2.3).  For a given cell type, the quantity of formazan produced is 
proportional to the number of living cells and the concentration of MTT.  The formazan is 
extracted with an organic solvent such as DMSO or isopropanol, and the optical density 
(OD) of the resulting solution is measured photometrically at a wavelength of 505, 550, or 
570 nm.  If required, reference values may be obtained from untreated cells.  All values 
should be normalised against protein content or tissue weight (Berridge and Tan, 1993; 
Borenfreund et al., 1988; Leeman et al., 1995; Mosmann, 1983; Obatomi et al., 1998c). 
MTT (yellow) Formazan (blue)
 
Figure 2.3. Reaction scheme for the reduction of MTT to formazan 
This reaction is catalysed by dehydrogenase in functional mitochondria.  Two ground-state hydrogen atoms 
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2.4.5. Potassium leakage and reduced ATP levels 
Entry and exit of potassium (K) to and from cells is central to many physiological processes, 
e.g. stomach acid production, hormone secretion, neurological action potentials, and 
muscular contraction.  Cellular K levels are normally maintained by the energy-dependent 
Na/K-ATPase, and lowered by voltage- or substrate-controlled ion channels or other ion 
exchange mechanisms.  Damage to the plasma membrane or a block in ATP synthesis 
impairs these mechanisms, allows sodium and calcium to enter and potassium to escape, and 
causes acute cell swelling (Vickers, 1997).  Production of ATP takes place in the 
mitochondria and may be inhibited by processes mentioned in the previous section, or by an 
insufficient supply of nutrients.  The ATP level in a cell thus reflects both cellular integrity 
and the metabolic state of the cell. 
Potassium leakage from cells or tissues is not easily measured.  However, the retained intra-
cellular content of the element can be determined by flame photometry, or atomic 
absorption- or emission-spectrophotometry (AAS or AES).  Samples are washed in 
0.9% (w/v) NaCl, homogenised e.g. by sonication, and dissolved in strong acid, before 
measuring the concentration of K in the resulting solution (Dogterom, 1993; Price et al., 
1998; Smith et al., 1986). 
ATP can be quantified by the ATP-dependent, bioluminescent luciferin-luciferase reaction.  
The tissue is homogenised and centrifuged, and the supernatant treated with a luciferin-
luciferase solution.  Bioluminescence is measured in a luminescence photometer, and the 
result is given as amount of ATP per milligram of protein (DeLuca and McElroy, 1978; 
Kimmick et al., 1975; Lundin et al., 1986; Lundin, 2000).  Alternatively, ATP and the other 
adenosine nucleotides (ADP, AMP) can be quantified by high-performance liquid chromato-
graphy, HPLC (Dogterom, 1993; Jones, 1981; Olinga et al., 1997). 
 
3. MATERIALS AND METHODS 
The origin of a material is generally specified in parentheses after the first appearance of the 
material in a new context.  The specifications always include name of brand or supplier, 
which may or may not be abbreviated, and in most cases an article/catalogue number or other 
unique type designation is also given.  (See appendix A–1 for a more detailed list of 
manufacturers and suppliers.) 
3.1. PREPARATION OF RAT LIVER SLICES 
3.1.1. Animals 
Livers from 6-8 weeks old, male Sprague-Dawley rats (type BKL from B&K) were used.  
(See appendix A–2 for a summary of animal characteristics.)  The animals were acclimatised 
for at least 5 days at a temperature of 21±2°C, relative air humidity 55±10%, ventilation 
changing the air 20 times per hour, and periods of 12h light / 12h dark in phase with natural 
daylight.  Standard food (811002 / RM1(E) SQC from SDS) and quality-controlled tap water 
were supplied ad lib until 8 or 9 p.m. on the last night, at which time food was withdrawn.  
Water was not withdrawn, but rats usually do not drink much when not eating.  
The experiments started between 8 and 9 a.m. 
In each experiment one animal was used, except from one occasion when two animals of the 
same litter were used in order to have more liver material (experiment denoted EGN-05-01 in 
appendix A–2).  To simplify matters, however, methods will principally be described and 
results presented so that each experiment can be interpreted as involving one animal. 
Most of the rats were decapitated by means of a guillotine (AH-55-0012 from Harvard), to 
which the animals had been trained during acclimatisation.  In the first few experiments 
involving menadione alone (section 3.2.2) the animals were not decapitated, but had their 
neck arteries cut during isoflurane anaesthesia (Isoflurane from Baxter). 
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3.1.2. Preparation of liver cores 
In each experiment the liver was excised, weighed, and transported to the laboratory in ice-
cold PBS (phosphate-buffered saline)* which had been gassed with 95% oxygen / 
5% carbon dioxide (5 mole-% carbon dioxide in oxygen, from AGA) for 10 minutes 
immediately before use.  Liver weights were between 7.4 and 9.8 grams (see appendix A–2).  
The wet liver was placed on 3-4 layers of wet filter paper (331511 / 520B from Schleicher) 
on top of a plastic support.  Using a coring tool composed of a sharpened, 8 mm diameter, 
stainless steel tube (MP-0144 from Alabama) and an electric drill (6470H2 from Skil) 
mounted vertically in a levered rack, 8 mm tissue cores were prepared from all liver lobes 
that were sufficiently wide (Figure 3.1-a).  The steel cylinder, filter papers, and liver were 
moistened with PBS at intervals during the process. 
Preparation of cores started 5-10 minutes after excising the liver and was finished within an 
additional 15-25 minutes.  The cores were collected in ice-cold PBS which had been gassed 
with 95% O2 / 5% CO2.  Suitable cores were approximately cylindrical; that is, circular and 
not too wedge-shaped, and having nearly parallel cutting edges (Figure 3.1-b).  To spread 
lobe variations, cores from different lobes were mixed to some degree before the liver slices 
were prepared. 
 
* PBS: Dissolve 5 PBS tablets (P-4417 from Sigma) in 1 litre of sterile water (82479-E from Braun) to obtain 
≈9.5 mM phosphate buffer (8.10 mM Na2HPO4 and 1.47 mM KH2PO4), 2.68 mM KCl and 137 mM NaCl; 
pH 7.4.  Keep at 4°C for up to 1 week. 
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a)  b) 
Figure 3.1. a) Rat liver and coring tool. b) Examples of liver cores (scale: cm, mm) 
 
3.1.3. Preparation of liver slices 
Slices were prepared from the liver cores using a Krumdieck tissue slicer (MD-1100-A2 
from Alabama) (Figure 3.2-a; see also Figure 2.2, page 21) set to a nominal slice thickness of 
240 µm and a cycle speed of 60 per minute (i.e. the frequency of movements across the 
razorblade).  The microtome and reservoir of the slicer had been cleaned, assembled and 
refrigerated to 4°C before use, disinfected by spraying with 70% ethanol (from Arcus), run 
through with two portions of ice-cold, sterile water (82479-E from Braun), and was water-
cooled during the slicing process.  The reservoir was filled with ice-cold slicing buffer 
consisting of PBS with 0.08% to 0.1% (w/v) agarose† (Obatomi et al., 1998a, c), which was 
gassed with 95% O2 / 5% CO2 for 10 minutes immediately before use. 
a)  b) 
Figure 3.2. a) Front view of tissue slicer. b) Examples of liver slices (scale: cm, mm) 
 
                                                 
† Slicing buffer: Add 0.80 or 1.00 g of low-gelling-temperature agarose (A-0701 from Sigma) to 1 litre of PBS, 
and dissolve by autoclaving for 1 hour at 125°C and 20 psi (1.4 bar).  Rapidly cool to 4°C to prevent clotting. 
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Preparation of liver slices started when three to five cores were ready, and was finished 
within 10-15 minutes after the last core had been prepared.  The first slice from each core 
was discarded.  Subsequent slices were collected in slicing buffer (Figure 3.2-b) and kept on 
ice until further processing.  Cores and slices were kept separated from each other. 
3.2. TREATMENT OF SLICES 
3.2.1. Pre-incubation for 1 hour 
Slices were pre-incubated for 1 hour to remove tissue debris, enzymes and other cellular 
contents released during slice preparation.  Some analyses were performed after pre-
incubation (treatment group A), but most analyses were carried out only after subsequent 
treatment (treatment groups B, C, etc). 
3.2.1.1. Medium 
A synthetic liver culture medium, Williams’ medium E (Williams et al., 1971), was used 
with the addition of certain nutrients and growth factors and an antibiotic/antimycotic 
solution, according to Table 3.1.  Fresh medium was prepared for each experiment and was 
used for both pre-incubation and, with further additives, for the treatment that followed (for 
description of treatment see sections 3.2.2 through 3.2.6).  The medium was kept 
refrigerated, and was gassed with 95% O2 / 5% CO2 for 10 minutes immediately before use.  
In order to reduce foaming, the serum was added after the medium had been gassed. 
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Table 3.1. Composition of fresh medium for pre-incubation 
Component Supplier Article no. Qty. Final concentration 
Williams’ medium E (with phenol red 
and NaHCO3, without L-glutamine) 
Sigma W-4128 500 ml  
D-(+)-Glucose monohydrate Merck 1.04074 550 mg 5.2 mM 
1 mM insulin (bovine)‡ Sigma I-5500 0.5 ml ≈ 1 µM 
200 mM  L-glutamine LifeTech 25030-024 5 ml ≈ 2 mM 
Antibiotic-Antimycotic (penicillin G, 
streptomycin sulphate,  
amphotericin B) 
LifeTech 15240-096 5 ml ≈ 100 U/ml, 
100 µg/ml, 
0.25 µg/ml 
FBS (fetal bovine serum) BioWhit 14-701-F 25 ml ≈ 5% (v/v) 
 
3.2.1.2. Pre-incubation 
Each slice was placed on the grid of a titanium roller insert (Roller Insert Type C from 
Vitron, or type MA-0034 from Alabama) and put in a 20 ml glass scintillation vial (6000348 
from Packard) containing 1.70 ml of fresh medium (Figure 3.3).  Each vial had a cap 
(6000239 from Packard) with a 2 mm hole for gas exchange.  Vials, inserts, and medium 
were kept at room temperature. 
The process of placing the slices on rollers started when three to five cores had been sliced, 
and was finished within 10-15 minutes after the last core had been sliced.  The slices were 
placed in the incubator in groups of 10 to 15 (see the following paragraphs).  Total time from 
start of coring until the slices were placed in the incubator ranged from 20-30 minutes to 
45-60 minutes in different experiments. 
                                                 
‡ 1 mM insulin: Reconstitute 143.5 mg of anhydrous insulin from bovine pancreas (insulin I-5500 from Sigma) 
with 25.0 ml of MQ-water.  Add some drops of 4 M  HCl  till a clear solution is achieved.  Sterilise through a 
0.2 µM filter in portions of 0.5 ml.  Keep at ÷20°C for up to 5 years. 
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a)  b) 
Figure 3.3. a) Placing a slice on its roller insert. b) The insert and slice inside a vial 
 
Slices were pre-incubated for 1 hour at 37°C, continuously supplied with 95% O2 / 5% CO2 
at a flow rate of 0.5 litres/min.  The incubator used was a Dynamic Organ Culture Incubator 
(from Vitron) with an internal chamber rotating at 2 rpm (Figure 3.4).  Vials rotated with the 
chamber at 2 rpm, while inserts rolled inside the vials at approximately 3 rpm providing 
slices alternately with medium and gas.  The chamber could hold at most 96 vials in two 
depths, but was never used with more than 40. 
     
Figure 3.4. Front view of Dynamic Organ Culture Incubator (Vitron) 
The incubator chamber rotates by means of a motor placed in the cabinet behind it. The cabinet also contains a 
transformer/thermostat unit that heats the chamber. Plastic gas pipes connect the incubator with an external 
gas source. The rate of gas supply is given by the flow meter attached to the left of the cabinet. 
 
After pre-incubation, some slices were taken as zero-hour controls and analysed (group A).  
Enzyme leakage was not measured at this stage, because considerable amounts of enzymes 
had presumably been released in the slicing process and washed out during pre-incubation. 
Inserts with remaining slices (treatment groups B and C) were moved to new vials containing 
1.70 ml of fresh medium with added solvent (group B) and/or test substance (group C).  
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The media had been gassed with 95% O2 / 5% CO2 for 10 minutes, and vials and media were 
pre-heated to 37°C.  Slices were incubated for 3, 6, or 24 hours in the same incubator and the 
same conditions as pre-incubation; that is, a temperature of 37°C, gas supply 95% O2 / 
5% CO2 at 0.5 litres/min, and 2-3 rpm rotation. 
3.2.2. Treatment with menadione 200 µM for 3, 6, or 24 hours 
Untreated slices were prepared as described in section 3.2.1 (group A). 
A stock solution of 20.0 mM menadione§ or dimethylsulfoxide (DMSO) was mixed with 
fresh medium to obtain the test medium (group C) and control medium (group B), according 
to Table 3.2.  Each medium contained 1% (v/v) DMSO, a concentration that is not 
considered to affect the analyses (Leeman et al., 1995). 
Table 3.2. Composition of media; menadione 200 µM for 3, 6, or 24h 
In this table, volumes are given per liver slice, but the media were prepared in larger batches.  
For the composition of fresh medium see Table 3.1, page 33. 
Slice numbers (treatment group) fresh medium 20.0 mM menadione DMSO 
A1-A2 (immediately after slicing) - - - 
A3-A7 (only pre-incubated) 1.700 ml - - 
B1-B15 (negative control) 1.683 ml - 17.0 µl 
C1-C15 (menadione 200 µM) 1.683 ml 17.0 µl - 
 
Subgroups of slices from groups B and C were incubated for 3, 6, or 24 hours according to 
Table 3.3.  After incubation, slices were taken out of their vials and subjected to various 
analyses (see Table 3.3; analyses are described in section 3.3, page 40 ff).  Due to time 
constraints, the MTT test was not performed in the 0h and 6h groups.  Incubation media were 
put on ice and used for the determination of enzyme leakage (section 3.3.2). 
                                                 
§ 20.0 mM menadione: Dissolve 34.4 mg of menadione (M-5625 from Sigma) in 10.0 ml of DMSO (D-8779 
from Sigma).  Keep at room temperature and protected from light, for up to 1 week. 
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(section 
3.3.6) 
A1-A2 –1h - - - - 2 
A3-A7 0h all  5 - 3 - 2 
B1-B5 3h all  5 all  5 1 2 2 
B6-B10 6h all  5 all  5 3 - 2 
B11-B15 24h all  5 all  5 1 2 2 
C1-C5 3h all  5 all  5 1 2 2 
C6-C10 6h all  5 all  5 3 - 2 
C11-C15 24h all  5 all  5 1 2 2 
 
3.2.3. Treatment with ferrous sulphate 100 µM for 3, 6, or 24 hours 
Untreated slices were prepared as described in section 3.2.1 (group A). 
A stock solution of 10.0 mM ferrous sulphate (FeSO4)** or water was mixed with fresh 
medium to obtain the test medium (group C) and control medium (group B), according to 
Table 3.4.  Each medium contained 1% (v/v) sterile water. 
Table 3.4. Composition of media; FeSO4 100 µM for 3, 6, or 24h 
In this table, volumes are given per liver slice, but the media were prepared in larger batches. 
For the composition of fresh medium see Table 3.1, page 33. 






A1 (immediately after slicing) - - - 
A2-A5 (only pre-incubated) 1.700 ml - - 
B1-B16 (negative control) 1.683 ml - 17.0 µl 
C1-C19 (FeSO4 100 µM) 1.683 ml 17.0 µl - 
 
                                                 
** 10.0 mM ferrous sulphate (FeSO4): Dissolve 55.6 mg of ferrous sulphate heptahydrate (FeSO4·7H2O) 
(F-2387 from Sigma) in 20.0 ml of sterile water (82479-E from Braun).  Keep cold and protected from light, for 
up to 1 day. 
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Slices were incubated for 3, 6, or 24 hours according to Table 3.5 and analysed according to 
Table 3.5 below and section 3.3, page 40 ff.  Incubation media were put on ice and used for 
the determination of enzyme leakage (section 3.3.2). 
















      
(section 
3.3.3) 





      
(section 
3.3.6) 
A1 –1h - - - - - 1 
A2-A5 0h all  4 - 1 - 2 1 
B1-B6 3h all  6 all  6 1 2 2 1 
B7-B10 6h all  4 all  4 1 - 2 1 
B11-B16 24h all  6 all  6 1 2 2 1 
C1-C7 3h all  7 all  7 1 2 2 2 
C8-C12 6h all  5 all  5 1 - 2 2 
C13-C19 24h all  7 all  7 1 2 2 2 
 
3.2.4. Treatment with 3 concentrations of ferrous sulphate; 
general aspects 
In each of the following experiments, three concentrations of ferrous sulphate were tested; 
100-200-400 µM, or 200-1000-5000 µM.  (The unit µM is used here to have a common scale 
for all the FeSO4 culture media.) 
Untreated slices were prepared as described in section 3.2.1 (group A).  Fresh medium with 
DMSO was used for negative controls (group B).  Menadione 200 µM was used for positive 
toxic controls (group C). 
Stock solutions of 40.0 or 500 mM ferrous sulphate††, or 20.0 mM menadione (described 
earlier), together with sterile water and/or DMSO, were mixed with fresh medium to obtain 
                                                 
†† 40.0 or 500 mM ferrous sulphate: Dissolve 0.1112 g or 1.390 g, respectively, of FeSO4·7H2O (F-2387 from 
Sigma), in 10.0 ml of cold, sterile water (82479-E from Braun).  Keep cold and protected from light.  Use 
immediately. 
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the control media (groups B, C) and test media (groups D, E, F), according to Table 3.7 and 
Table 3.8.  Each medium contained 1% (v/v) DMSO. 
After pre-incubation, inserts with remaining slices (groups B through F) were moved to new 
vials containing 1.70 ml of control medium or test medium.  The media had been gassed with 
95% O2 / 5% CO2 for 10 minutes, and vials and media were pre-heated to 37°C.  All slices 
were incubated for 24 hours in the same incubator and the same conditions as pre-incubation; 
that is, a temperature of 37°C, gas supply 95% O2 / 5% CO2 at 0.5 litres/min, and 2-3 rpm 
rotation.  After treatment, slices were analysed according to Table 3.6 below and section 3.3, 
page 40 ff.  Incubation media were put on ice and used to determine enzyme leakage (section 
3.3.2). 
Table 3.6. Number of replicates analysed; three concentrations of FeSO4 for 24h 
















      
(section 
3.3.3) 





      
(section 
3.3.6) 
A1 –1h - - - - - 1 
A2-A7 0h all  6 - 1 2 2 1 
B2-B7 24h all  6 all  6 1 2 2 1 
C2-C7 24h all  6 all  6 1 2 2 1 
D1-D7 24h all  7 all  7 1 2 2 2 
E1-E7 24h all  7 all  7 1 2 2 2 
F1-F7 24h all  7 all  7 1 2 2 2 
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3.2.5. Treatment with ferrous sulphate 100, 200, or 400 µM for 24 hours 
The various slices were treated with culture media according to Table 3.7 and incubated and 
analysed as described in section 3.2.4 above. 
Table 3.7. Composition of media; FeSO4 100, 200, or 400 µM for 24h 
In this table, volumes are given per liver slice, but the media were prepared in larger batches. 












A1 (after slicing) - - - - - 
A2-A7 (pre-incubated) 1.700 ml - - - - 
B2-B7 (negative control) 1.666 ml - - 17.0 µl 17.0 µl 
C2-C7 (positive control) 1.666 ml - 17.0 µl 17.0 µl - 
D1-D7 (FeSO4 100 µM) 1.666 ml 4.3 µl - 12.7 µl 17.0 µl 
E1-E7 (FeSO4 200 µM) 1.666 ml 8.5 µl - 8.5 µl 17.0 µl 
F1-F7 (FeSO4 400 µM) 1.666 ml 17.0 µl - - 17.0 µl 
 
3.2.6. Treatment with ferrous sulphate 200, 1000, or 5000 µM for 24 hours 
The various slices were treated with culture media according to Table 3.8 and incubated and 
analysed as described in section 3.2.4 above. 
Table 3.8. Composition of media; FeSO4 200, 1000, or 5000 µM for 24h 
In this table, volumes are given per liver slice, but the media were prepared in larger batches. 












A1 (after slicing) - - - - - 
A2-A7 (pre-incubated) 1.700 ml - - - - 
B2-B7 (negative control) 1.666 ml - - 17.0 µl 17.0 µl 
C2-C7 (positive control) 1.666 ml - 17.0 µl 17.0 µl - 
D1-D7 (FeSO4 200 µM) 1.666 ml 0.68 µl - 16.3 µl 17.0 µl 
E1-E7 (FeSO4 1000 µM) 1.666 ml 3.4 µl - 13.6 µl 17.0 µl 
F1-F7 (FeSO4 5000 µM) 1.666 ml 17.0 µl - - 17.0 µl 
 
Materials and methods 
 
Page 40 of 182 
3.3. ANALYSES 
3.3.1. Measuring slice weights 
The weights of all slices, except those taken for histology immediately after slicing, were 
recorded to be able to adjust certain other results according to slice weights. 
Using a pair of tweezers, each slice was dried gently on filter paper (331511 / 520B from 
Schleicher) that had been moistened with a few drops of the slice’s own incubation medium 
(Figure 3.5-a), and then weighed on an analytical balance (AT261 DeltaRange from Mettler).  
The weighing was performed directly in the vial containing the appropriate reagent or 
solution for further analyses, such as 1% triton for determination of remaining enzymes 
(section 3.3.2.5) or 10% formalin for histology (section 3.3.6).  The tweezers were rinsed in 
cold PBS between handling every slice. 
Williams’ medium E contains only trace amounts of iron (0.000025 µM, or 0.0001 mg/l, 
Fe(NO3)3.9H2O; Williams et al., 1971), but varying amounts of ferrous sulphate had been 
added before treatment.  To minimise the influence of Fe in medium on the following iron 
assay (section 3.3.4), slices assigned for this analysis were rinsed in cold PBS (Figure 3.5-b) 
prior to drying and weighing, and the filter paper was moistened with PBS instead of 
incubation medium. 
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a)  b) 
Figure 3.5. a) Drying a slice on filter paper (scale: cm, mm). b) Rinsing a slice in PBS 
 
3.3.2. Enzyme leakage 
Incubation media (Figure 3.6-a) were kept on ice and then centrifuged at ≈2400  xg 
(5000 rpm; radius 85 mm) for 6 minutes at 4°C.  Supernatants (Figure 3.6-b) were diluted 5-
fold with fresh medium (100 µl supernatant + 400 µl medium) to bring enzymes within 
ranges of measurement.  The dilution was performed in 1 ml vials (73.910.004 / Cobas 
sample cups from Sarstedt) designed to fit the analytic instrument.  Vials were stored at 
÷70°C awaiting analyses, which were performed within one week after treatment.  
(Preliminary experiments had indicated that enzyme activities were satisfactorily preserved 
by ultra-freezing for the period of interest; data not shown).  Enzyme activities were 
measured on a Cobas Fara II automatic analyser (from Roche), using reagent kits specific to 
the individual enzymes. 
a) b) 
Figure 3.6. a) Incubation media after removal of slices. b) Centrifuged media 
Note the pellets of cellular debris at the centrifuge tube bottoms. 
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3.3.2.1. Alanine aminotransferase (ALAT) 
In this study ALAT activity was measured using a UV-kinetic reagent kit (07 3638 4 / 
Unimate 3 ALAT from Roche), based on recommendations by the SFBC (1982a) and IFCC 
(1986a).  The kit contained i.a. L-alanine, α-ketoglutarate, NADH, and LDH. 
ALAT catalyses the physiological reaction: 
               ALAT 
L-alanine + α-ketoglutarate                           L-glutamate + pyruvate 
This reaction forms the principle for the quantitative analysis of the enzyme.  Biological 
samples containing ALAT are mixed with reagent kits holding reagents for both the above 
reaction and a second one in which NADH is oxidised to NAD+, catalysed by the enzyme 
lactate dehydrogenase (LDH): 
              LDH 
pyruvate + NADH + H+                           L-lactate + NAD+
NADH and NAD+ are the reduced and oxidised forms, respectively, of the enzyme cofactor, 
nicotinamide adenine dinucleotide.  The rate of NADH oxidation, or disappearance, is 
directly related to the ALAT activity from the first reaction.  NADH levels are measured 
photometrically at 340 nm by the Cobas Fara II analyser (from Roche). 
3.3.2.2. Aspartate aminotransferase (ASAT) 
In this study ASAT activity was measured using a UV-kinetic reagent kit (07 3641 4 / 
Unimate 3 ASAT from Roche), based on recommendations by the SFBC (1982b) and IFCC 
(1986b).  The kit contained i.a. L-aspartate, α-ketoglutarate, NADH, and MDH. 
ASAT catalyses the physiological reaction: 
              ASAT 
L-aspartate + α-ketoglutarate                           L-glutamate + oxaloacetate 
Oxaloacetate is involved in a second reaction where NADH is oxidised, catalysed by the 
enzyme malate dehydrogenase (MDH): 
               MDH 
oxaloacetate + NADH + H+                           L-lactate + NAD+
NADH levels, indicating ASAT activity, are measured photometrically at 340 nm. 
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3.3.2.3. Glutamate dehydrogenase (GLDH) 
In this study GLDH activity was measured using a UV-kinetic reagent kit (1929992 from 
Roche), based on recommendations by the DGKC (1972).  The kit contained i.a. α-keto-
glutarate, NADH, and NH4+ (ammonium). 
GLDH catalyses the physiological reaction: 
                  GLDH 
α-ketoglutarate + NADH + NH4+                           L-glutamate + NAD+
Here, NADH is oxidised directly in the GLDH dependent reaction.  NADH levels are 
measured photometrically at 340 nm. 
3.3.2.4. Lactate dehydrogenase (LDH) 
In this study LDH activity was measured using a UV-kinetic reagent kit (07 3657 0 / 
Unimate 3 LDH SFBC from Roche), based on recommendations by the SFBC (1982c).  
The kit contained i.a. pyruvate and NADH. 
LDH catalyses the physiological reaction: 
              LDH 
pyruvate + NADH + H+                           L-lactate + NAD+
This is identical with the second reaction of the ALAT assay (see above).  NADH levels, 
indicating LDH activity, are measured photometrically at 340 nm. 
3.3.2.5. Remaining enzymes in slices 
To calculate the relative amounts of enzymes that had leaked out during treatment, the 
remaining enzymes in slices were estimated.  This was accomplished by lysing slices with a 
surfactant, triton, and measuring the activities of the four enzymes (ALAT, ASAT, GLDH, 
and LDH) in the resulting lysate. 
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One or three slices per treatment group were treated individually in polypropylene tubes 
(368632 / CryoTubes from Nunc) with 1.50 ml of a 1% triton solution‡‡ at room temperature 
overnight on a rocking table (SM1 from Desaga).  The lysate was centrifuged at ≈2000  xg 
(3000 rpm; radius 205 mm) for 10 minutes at room temperature.  Supernatants were diluted 
20-fold with fresh medium (25.0 µl supernatant + 475 µl medium) in Cobas vials.  The vials 
were stored at ÷70°C for up to one week awaiting analyses.  Enzyme activities were 
measured using a Cobas Fara II automatic analyser and reagent kits as described above for 
incubation media. 
3.3.3. MTT test 
The amount of formazan (blue) produced by cells when incubated with MTT (yellow) is an 
indication of mitochondrial function and cell viability (section 2.4.4, page 27). 
Two slices per group (except from the 0h and 6h groups in the 3/6/24 hour experiments) 
were incubated individually in polypropylene tubes with 1.50 ml of a 1.21 mM MTT 
solution§§ at 37°C in the dark for 40 minutes on a rocking table (SM1 from Desaga).  
The slices were rinsed in cold PBS, and formazan was extracted from the slices in poly-
propylene tubes with 1.50 ml of isopropanol (article 1004858 from Arcus) at room 
temperature in the dark overnight on a rocking table.  Slices were then removed from the 
extracts, which were kept refrigerated for 2-4 days before they were analysed. 
200 µl of extract was pipetted in two parallels per slice onto a flat-bottomed 96-well micro-
plate (439454 / MaxiSorp F96 from Nunc).  The absorbency, or optical density, at 570 nm 
(OD570) was measured using an automatic plate reader (MRX from Dynatech) with the 
appropriate software (BioLinx from Dynatech).  Pure isopropanol was used as background. 
 
‡‡ 1% triton: Dilute 1.00 ml of triton X-100 (article T-6878 from Sigma) with 99 ml of sterile water (82479-E 
from Braun).  Keep at room temperature for up to 6 months. 
§§ 1.21 mM (0.50 mg/ml) MTT: Dissolve 50 mg of MTT (M-2128 from Sigma) in 100 ml of PBS (for the 
composition of PBS see footnote in section 3.1, page 30).  Keep at room temperature and protected from light, 
for up to 1 day.  Filter through filter paper (10331514 / 520B½ from Schleicher) immediately before each use. 
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3.3.4. Analysis of iron content 
Effects of treatment could be related not only to iron concentrations in media, but to the 
degree of passive and/or active iron uptake during treatment and consequently to iron 
contents in tissue.  Therefore, in the experiments involving iron, two slices from each 
treatment group (including controls) were analysed for iron content using inductively 
coupled plasma atomic emission spectrometry (ICP-AES).  The same slices were also 
analysed for potassium content. 
3.3.4.1. Sample preparation 
To minimise the influence of Fe in medium on the following iron assay, slices assigned for 
this analysis were rinsed in cold PBS (Figure 3.5-b, page 41) prior to drying and weighing, 
and the filter paper was moistened with PBS instead of incubation medium. 
Each slice was put in a 1 ml polypropylene tube (366656 / CryoTubes from Nunc) containing 
500 µl of sterile water (82479-E from Braun).  Slice weights were recorded (for details on 
the weighing procedure see section 3.3.1).  The slices were kept at ÷70°C until further 
processing and analyses. 
After thawing, each slice was transferred to an acid-washed, 15 ml polypropylene tube 
(62.554 from Sarstedt) together with its 0.5 ml of water.  1 ml of concentrated nitric acid 
(65% HNO3 from ChemScan) was used to rinse the smaller tube and was then transferred to 
the larger tube to dissolve organic components.  0.5 ml of concentrated hydrochloric acid 
(30% HCl from ChemScan) was added to solubilise the iron.  The resulting mixture was 
incubated at 70°C overnight.  Using an electronic auto-dispenser (130100 / Microlab1000 
from Hamilton), 500 µl of a 10 ppm scandium (Sc) solution*** was added as internal 
standard.  Before assaying, the sample was diluted to approximately 5 ml with MQ-water, so 
the matrix was ≈20% nitric acid, ≈10% hydrochloric acid, and ≈1 ppm Sc.  Since 90-95% of 
the slices used for iron analyses weighed less than 30 mg (data not shown), cellular material 
generally comprised less than 0.6% of the 5 ml solution. 
 
*** 10 ppm Sc: Use only acid-washed glassware.  Pipette 5.00 ml of 1000±3 ppm Sc (Spectrascan 8055 from 
Teknolab) into a 500 ml flask.  Fill with MQ-water. 
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Reference samples were prepared from aliquots of approximately 50 mg dried, pulverised 
bovine liver (SRM 1577b from NIST) with specified contents of iron (Fe), potassium (K), 
and certain other elements.  Each aliquot was suspended in 500 µl of MQ-water.  To imitate 
treatment of slices during experiments, every third reference sample was spiked with 250 µl 
of a 20 mM ferrous sulphate solution††† corresponding to 112 ppm Fe.  Another third was 
spiked with 250 µl of a 100 ppm Fe standard solution‡‡‡.  (Both versions of spiking would 
add ≈5 ppm Fe to the prepared sample.) 
For blank samples 500 µl of MQ-water was used.  All blank samples and reference samples 
were then treated in the same way as the liver slices; 1 ml nitric acid, 0.5 ml hydrochloric 
acid, incubated at 70°C overnight, added 500 µl of 10 ppm Sc, diluted to 5 ml with MQ-
water. 
3.3.4.2. Analysis by ICP-AES 
An analysis program was set up on an electronic ICP-AES reader (Optima 3300 DV from 
PerkinE) with the appropriate software, and was run twice with 50 samples, 6 blank samples, 
and 9 reference samples in each run.  The program included five standard solutions of 
0-20 ppm Fe and K§§§, to which the instrument was calibrated before each run and between 
samples.  Blanks and references were divided in three groups and placed before, in the 
middle, and after the other samples.  All samples, blanks, references and standard solutions 
contained 1 ppm Sc as internal standard. 
 
††† 20 mM ferrous sulphate: Weigh out 556.0 mg of FeSO4·7H2O (F-2387 from Sigma) and transfer 
quantitatively to a 100 ml flask.  Dissolve in ≈50 ml of MQ-water, add 10 ml of concentrated hydrochloric acid 
(30% HCl from ChemScan), and allow for temperature equalisation.  Fill to 100 ml with MQ-water to obtain an 
intermediate of 200 mM Fe.  Pipette 10.0 ml of this solution into a new 100 ml flask and fill with MQ-water.  
Corresponds to 112 ppm Fe. 
‡‡‡ 100 ppm Fe standard: Pipette 10.0 ml of 1000±3 ppm Fe (Spectrascan 8004 from Teknolab) into a 100 ml 
flask and fill with MQ-water. 
§§§ Standard solutions of  20, 5.0, 1.0, 0.50, and 0.00 ppm Fe and K: Use acid-washed full pipettes and 100 ml 
flasks.  Prepare intermediate solutions of 100 and 10 ppm Fe and 100 and 10 ppm K using 1000±3 ppm Fe and 
1000±3 ppm K (Spectrascan 8004 and 8007 from Teknolab), and MQ-water.  Prepare the standards from these 
intermediates and MQ-water, with the addition of concentrated nitric and hydrochloric acids (from Chemscan), 
and 10 ppm Sc (see separate footnote for Sc), so that the final standards have a matrix of ≈20% nitric acid, 
≈10% hydrochloric acid, and 1 ppm Sc. 
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Iron (Fe) was detected at 259.939 nm, potassium (K) at 766.490 nm, and scandium (Sc) at 
424.683 nm.  The blank samples were used to calculate zero levels, detection limits (DL), 
and quantification limits (QL). 
The measured Fe concentrations (result: µg/ml) were adjusted for slice weights (result: 
µg/mg) and reported as percentages relative to the negative controls at 0 hours. 
3.3.5. Analysis of potassium content 
Potassium was measured simultaneously with iron, using the same samples and methods as 
described in section 3.3.4. 
3.3.6. Histology 
3.3.6.1. Tissue fixation, sectioning, and staining 
One or two slices from each treatment group, in addition to slices taken immediately after 
slicing, were stored individually in 10 ml of 10% NBF (neutral-buffered formalin)****.  
After fixation, slices were infiltrated with paraffin wax (VO-5-11050 from Vogel) by a 
vacuum infiltration processor (VIP-E150B / Tissue-Tek from Sakura) and embedded in 
blocks of paraffin wax.  Slices were sectioned at a nominal thickness of 3-5 µm using a 
rotation microtome (RM2155 from Leica), and the sections were mounted on object slides.  
The slides were heated to 60°C for 1 hour in order to remove most of the wax, before they 
were stained with hematoxylin and eosin by an automatic slide stainer (DRS-60 from Sakura) 
(for details on the staining process see appendix A–3).  Finally, the stained sections were 
fixed in pertex glue (00801 from Histolab) under cover slips. 
 
**** 10% NBF: Dissolve 8.90 g (=50.0 mmol) Na2HPO4·2H2O (1.06580 from Merck) and 
4.14 g (=30.0 mmol) NaH2PO4·H2O (1.06346 from Merck) in approximately 0.5 litres of RO-water.  
Add 100 ml formalin (1.03999 from Merck) and fill with RO-water to 1.00 litre; pH 6.9.  
(Formalin is a solution of 37% (w/v) formaldehyde gas in water with 10-15% methanol, so 10% NBF contains 
less than 4% formaldehyde.) 
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3.3.6.2. Morphological description 
The morphology of the tissue sections was assessed qualitatively with respect to tissue 
damage using a microscope.  Organelle degradation, nuclear shrinkage, and tissue necrosis 
were estimated.  Samples from each treatment group were compared to negative controls and 
positive controls from the same experiment. 
3.4. STATISTICAL METHODS 
The number of treatment groups was 6 or 7 in each experiment.  The number of replicates in 
each group, that is, the number of liver slices or incubation media analysed the same way, 
ranged from 2 (MTT test) to 7 (slice weights and enzyme leakage).  This was based partly on 
practical restraints and partly on measures of variation obtained in preliminary studies (data 
not shown).  Thus, from each analysis of a treatment group, the sample mean of 2 to 7 liver 
slices or incubation media was used for further calculations. 
In three of the four main study designs, 2 identical experiments were performed (n=2), using 
1 animal per experiment.  In the fourth design, 4 experiments were performed (n=4).  
However, several treatment groups were the same in various experiments, and data from 
analogue groups could be pooled for every parameter to achieve up to 10 sample means (n=2 
to 10), each representing 2 to 7 liver slices.  A higher n allows greater power of hypothesis 
testing, i.e. greater possibility of detecting statistically significant differences between 
treatment groups. 
Excel 97 (from Microsoft Co.) was used to calculate the number of replicates (number of 
slices), the sample mean, and the standard deviation (SD) for each parameter in all treatment 
groups and all experiments, and to present the results graphically.  SigmaStat 2.0 for 
Windows (from Jandel Co.) was used to calculate the number of experiments (n, number of 
animals), the average of sample means, and the standard error of the mean (SE) for each 
parameter in the pooled data, and to perform the following statistical analyses: 
All data sets were assumed to belong to a normal distribution, and the variances of different 
data sets were assumed to be homogeneous.  Thus, parametric analyses were performed.  
To detect effects of treatment, a one-way analysis of variance (ANOVA) was executed for 
each parameter observed at each observation time (3, 6, or 24 hours), comparing different 
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treatment groups at each time point.  To detect any effects of the length of treatment, 
ANOVA was also carried out with different observation times of a single treatment, e.g. only 
negative control or only FeSO4 100 µM.  Significant ANOVA results (p < 0.05) were 
followed by post-hoc multiple comparison tests between control group and other groups, 
using Dunnett’s t test to identify significant differences (p < 0.05). 
To check the above assumptions of normality and homogeneity, data sets comprising at least 
3 sample means were assessed for normality using the Kolmogorov-Smirnov test with 
Lilliefors’ correction, and for homogeneity of variance using the Levene median test.  (These 
methods do not apply to data sets with less than 3 observations.)  Positive results from both 
the normality test (p≥0.05) and the variance test (p≥0.05) supported the choice of parametric 
analyses, whereas negative results from either test suggested non-parametric analyses. 
Although the data were still assumed to be normal and homogeneous, additional non-
parametric analyses were performed for these data sets, and any discrepancies between the 
parametric and non-parametric analyses were noted.  Kruskal-Wallis ANOVA on ranks was 
executed for each parameter and observation time to identify effects of treatment, and for 
different time points of a single treatment to identify effects of the length of treatment.  
Significant ANOVA results (p < 0.05) were followed by post-hoc multiple comparisons 
using Dunn’s rank sum test to identify significant differences (p < 0.05). 
 
 
4. RESULTS AND DISCUSSION 
4.1. PRELIMINARY RESULTS 
4.1.1. Method development 
In total 16 experiments were performed. 
The first three experiments were aimed at operator training and method development, e.g. the 
testing of a new incubator and solving problems regarding the preparation of tissue cores 
from the small rat livers. 
The operation of equipment and performance of experiments was relatively straightforward, 
but time consuming.  Each experiment required 2 persons for approximately 1 full day to 
prepare and incubate the rat liver slices and carry out analyses immediately after incubation 
(slice weights, MTT test, enzyme leakage), plus many hours of follow-up analyses over a 
period of weeks (MTT test, enzyme leakage, Fe and K content, and histology). 
The first experiments were largely exploratory, and quantitative results are not presented.  
However, these experiments involved different concentrations of menadione and were used 
to pick the concentration of menadione for positive controls in later experiments (200 µM) 
and also formed the basis for the methods and materials presented in chapter 3. 
In the first three experiments the animals were fed normally until study start, and 
microscopic analysis of the rat liver slices showed large numbers of white starch crystals 
inside the cells.  These crystals impaired visual observation of the cells in histology, and in 
all subsequent studies the animals were starved for the last part of the last night to eliminate 
or reduce the amount of starch crystals. 
Results from 13 experiments indicate that an exsanguinous, starved rat liver should be 
8 grams or more in order to get 50 good slices of 8 mm diameter and 250 µm thickness.  
The exsanguinous liver constituted approximately 3.5% of the starved body weight, which 
must therefore be 230 grams at study start, and the normal body weight the previous day 
must be 250 grams (see appendix A–2). 
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4.1.2. Histology results 
Histological analysis from the first three experiments showed extensive tissue damage in all 
samples.  This may be due to treatment or sample preparation.  The quality of the histological 
samples did not improve through further experiments.  Therefore, the histological analysis 
was not completed, and histology results are not presented. 
4.1.3. Excluded experiments 
As described above, quantitative results from the first three experiments are not presented. 
Another two experiments are excluded because of divergent study parameters (wrong method 
of sacrifice, and wrong composition of test medium). 
One experiment is excluded because the rat was female instead of male.  As mentioned in 
section 3.1.1 (page 29), only male Sprague-Dawley rats should be used, and they should be 
between 6 and 8 weeks old at study start.  By mistake a female rat aged 8 ½ weeks was used 
in one experiment, and the observed parameters in that experiment (data not shown) diverged 
considerably from those obtained with male rats.  The female rat did not gain any weight 
during acclimatisation (see appendix A–2), which suggests that its lifetime growth had 
flattened off, the individual had reached adulthood, and its physiological conditions were 
probably not comparable to the other animals with respect to the parameters of interest.  
It may be difficult to establish whether the sex as such or the state of growth was decisive in 
this case, but the ages and weights of subsequent animals were examined with extra scrutiny. 
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4.2. PRESENTATION OF RESULTS 
Results from 10 experiments are reported henceforth.  For raw data see appendix A–5. 
The results are generally presented by graphic charts rather than tables or line-listings.  
The graphs display the results as averages of sample means, with error bars representing 
±SE.  Chapters 4.3 through 4.6 describe the findings from 4 different study designs, and the 
appropriate graphs are placed in appendix A–4.1 through A–4.4.  Chapter 4.7 compares all 
experiments collectively by parameters observed, and the graphs for this are given in 
appendix A–4.5. 
The numbers of experiments (n=2 to 10) and replicates (2 to 7) are given for each data set.  
Significant differences between treatment groups or treatment times are indicated by the 
following symbols above the respective chart bars, single symbols meaning p < 0.05 and 
double symbols meaning p < 0.01: 
* or ** significantly different from negative control (* p<0.05, ** p<0.01)  
(applies to positive control vs. neg. ctrl., and FeSO4 vs. neg. ctrl.);  
# or ## significantly different from earliest observation of the same treatment  
(# p<0.05, ## p<0.01) (applies to neg. ctrl. 24h vs. 0h,  
or pos. ctrl. 24h vs. 3h, or FeSO4 100 µM 24h vs. 3h);  
¢ or ¢¢ significantly different from lowest concentration of same substance  
(¢ p<0.05, ¢¢ p<0.01) (5000 and 1000 µM of FeSO4 vs. lover FeSO4). 
A treatment group may satisfy more than one of these conditions, indicated by more than one 
symbol at the respective bar (e.g., * and #). 
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4.3. RESULTS FROM TREATMENT WITH MENADIONE 200 µM 
FOR 3, 6, OR 24 HOURS 
Two experiments (n=2) were performed with 7 treatment groups; 0, 3, 6, and 24 hours 
negative control and 3, 6, and 24 hours positive control (menadione).  For the number of 
replicates (slices or media) see Table 3.3, page 36. 
Six quantitative parameters were recorded: 
1) Slice weights (mg),  
2) MTT test in the 3h and 24h groups (% of 24h negative control),  
3) ALAT leakage (% of total ALAT),  
4) ASAT leakage (% of total ASAT),  
5) GLDH leakage (% of total GLDH), and  
6) LDH leakage (% of total LDH) 
In the MTT test the actual variable measured was optical density at 570 nm (OD570), which 
was adjusted for slice weight and reported as percentages of 24h negative control.  The 
MTT test was not performed in the 0h and 6h groups. 
In the enzyme assays the measured variables were enzyme activities (U/l) in culture medium.  
The activities were reported as percentages of the sum of activity in medium and remaining 
enzymes in slices.  Enzyme leakage at 0h could not be determined. 
The results from the 2 experiments are presented graphically in appendix A–4.1, page 77 ff.  
The following significant differences were found: 
Table 4.1. Significant results from experiments with menadione 200 µM 
Assay Lower assay Higher assay p Cause 
Slice weights neg. controls, 24h pos. controls, 24h p < 0.05 Menadione treatment
MTT results pos. controls, 24h neg. controls, 24h p < 0.01 Menadione treatment
ASAT leakage pos. controls, 3h pos. ctrl., 6h, 24h p < 0.01 Incubation time 
LDH leakage pos. controls, 3h pos. ctrl., 6h, 24h p < 0.05 Incubation time 
LDH leakage neg. controls, 6h pos. controls, 6h p < 0.01 Menadione treatment
 
The slice weights increased with menadione treatment.  Many of the slices treated with 
menadione were visibly harder than the others after treatment.  This may indicate an 
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encapsulation of the outer cells as they reacted to the added toxin, and an apparent resistance 
to subsequent mechanical stress. 
Slice viability (MTT results) decreased with menadione treatment, and LDH leakage 
increased with menadione treatment.  In slices treated with menadione the leakage of ASAT 
and LDH increased with longer treatment time. 
Leeman et al. (1995), using an oxygen level of 40%, found that MTT results were 
significantly lower in rat liver slices treated for 4 hours with 50, 100, 200 or 400 µM 
menadione than in negative controls.  They also found that LDH leakage was significantly 
higher in slices treated with 100, 200 or 400 µM menadione than in negative controls. 
Chan et al. (1992) reported cytotoxic effects in rat liver slices treated with 100-300 µM 
menadione with 95% oxygen.  Wright and Paine (1992) reported cytotoxic effects of 200 µM 
menadione only in isolated hepatocytes and not in liver slices with 21% oxygen.  This was 
explained by low absorption of menadione in the inner cells of liver slices or low levels of 
oxygen in the inner cells of slices compared to isolated cells. 
In the present experiments, several assays confirmed the expected cytotoxic effects of 
menadione on rat liver slices.  The culture media, incubation system, gas supply (95% O2 / 
5% CO2) and analyses were sufficient to demonstrate the toxicity of menadione compared to 
negative controls.  This model may probably be used in hepatotoxicological studies on other 
substances. 
4.4. RESULTS FROM TREATMENT WITH 
FERROUS SULPHATE 100 µM FOR 3, 6, OR 24 HOURS 
Two experiments (n=2) were performed with 7 treatment groups; 0, 3, 6, and 24 hours 
negative control and 3, 6, and 24 hours FeSO4 100 µM.  There was no positive control group 
(menadione) in these experiments.  For the number of replicates see Table 3.5, page 37. 
Six parameters were recorded as described in the previous section.  In addition the contents 
of potassium and iron were measured, increasing the number of parameters to 8: 
7) Potassium (K) content (% of 0h negative control), and  
8) Iron (Fe) content (% of 0h negative control) 
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In these assays the variables measured were metal concentrations (ppm, or µg/ml) in sample 
after dissolution of slice.  The concentrations were adjusted for slice weight and reported as 
percentages of 0h negative control. 
The results from the 2 experiments are presented graphically in appendix A–4.2, page 80 ff.  
The following significant differences were found: 
Table 4.2.  Significant results from experiments with FeSO4 100 µM 
Assay Lower assay Higher assay p Cause 
MTT results FeSO4 100 µM, 24h FeSO4 100 µM, 3h p < 0.05 Incubation time 
MTT results FeSO4 100 µM, 24h neg. controls, 24h p < 0.05 FeSO4 treatment 
GLDH leak. neg. controls, 0h neg. controls, 6h, 24h p < 0.05 Incubation time 
K content neg. controls, 0h neg. ctrl., 3h, 6h, 24h p < 0.05 Incubation time 
 
MTT results decreased with time and with iron treatment.  GLDH leakage increased with 
time, but no differences were evident between iron-treated slices and negative controls with 
regard to GLDH leakage. 
The K content in slices increased significantly from 0 hours to 3 hours in negative controls.  
Increased K content during the first hours of incubation may be caused by potassium in the 
culture medium (the medium contained the buffer NaHPO4 / KH2PO4 plus KCl) or by a 
transitory potassium leakage during slice preparation and subsequent recovery.  If the latter 
is the case, the recovery must take longer time than the one hour of pre-incubation but is 
probably complete within 3 to 6 hours, according to the peak in K content at 6 hours. 
Studies on in vitro treatment of rat liver slices with iron (II) sulphate were not found in 
literature, so the results of the present study are not directly comparable to others.  However, 
several studies have shown that iron (II) sulphate causes lipid peroxidation in rat liver 
homogenate (Pushpendran et al., 1998), isolated rat liver mitochondria (Pushpendran et al., 
1998; Bacon et al., 1986), and isolated rat liver lysosomes (Mak and Weglicki, 1985).  Lipid 
peroxidation can disrupt cellular integrity and mitochondrial function, which may then result 
in enzyme leakage and reduced MTT reduction capability. 
The reduction in MTT results with iron treatment can be explained by lipid peroxidation.  
The lack of other differences between FeSO4 100 µM and negative controls may be due to 
this concentration of iron being too low to cause severe cytotoxicity in rat liver slices.  
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An indication of the lack of effect is the almost identical Fe content in slices treated with 
FeSO4 100 µM and negative controls (see the last graph in appendix A–4.2). 
4.5. RESULTS FROM TREATMENT WITH 
FERROUS SULPHATE 100, 200, OR 400 µM FOR 24 HOURS 
Two experiments (n=2) were performed with 6 treatment groups; 0 and 24 hours negative 
control, 24 hours positive control (menadione), and 24 hours FeSO4 100, 200, or 400 µM.  
For the number of replicates see Table 3.6, page 38. 
The same eight parameters were recorded (see sections 4.3 and 4.4), but now the MTT test 
was performed in all groups. 
The results from the 2 experiments are presented graphically in appendix A–4.3, page 84 ff.  
The following significant differences were found: 
Table 4.3.  Significant results from experiments with FeSO4 100, 200, or 400 µM 
Assay Lower assay Higher assay p Cause 
MTT results pos. controls, 24h neg. controls, 24h p < 0.01 Menadione treatment 
LDH leakage neg. controls, 24h pos. controls, 24h p < 0.05 Menadione treatment 
K content pos. controls, 24h neg. controls, 24h p < 0.05 Menadione treatment 
 
MTT results decreased and LDH leakage increased with menadione treatment (positive 
control).  These results are similar to those obtained in earlier experiments (section 4.3, page 
53) and can be explained by mitochondrial dysfunction and cellular disruption. 
The K content also decreased with menadione treatment.  This may be due to cell membrane 
dysfunction reducing the influx of K, or cellular disruption causing leakage of K.  
The reduced K content may also be caused by mitochondrial dysfunction that leads to 
reduced ATP levels and less energy available to the Na/K-ATPase pumping K into the cell 
(Vickers, 1997). 
No differences were evident between slices treated with the three concentrations of iron, or 
between iron treatment and negative controls.  The Fe content was almost identical in 
negative controls and slices treated with FeSO4 100, 200 or 400 µM (last graph in appendix 
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A–4.3).  These iron concentrations are apparently not sufficient to cause measurable toxic 
effects in rat liver slices with this study design. 
4.6. RESULTS FROM TREATMENT WITH 
FERROUS SULPHATE 200, 1000, OR 5000 µM FOR 24 HOURS 
Four experiments (n=4) were performed with 6 treatment groups; 0 and 24 hours negative 
control, 24 hours positive control (menadione), and 24 hours FeSO4 200, 1000, or 5000 µM.  
For the number of replicates see Table 3.6, page 38. 
The same eight parameters were recorded.  The MTT test was performed in all groups. 
In the category negative controls at 24h, one of four sample means from GLDH leakage was 
excluded because of extreme deviation from the rest.  The GLDH leakage in question was 
28.6%, which was ten times higher than the average of the others in the range 1.8% to 4.5%.  
The high leakage percent was due to a very low content of remaining GLDH in the reference 
slice in that particular experiment compared to the other experiments, but the reason for the 
low reference value is not clear.  By excluding the one value, the average was changed from 
5.5±8.2 % to 2.9±1.0 % (mean ±SE). 
The results from the 4 experiments are presented graphically in appendix A–4.4, page 88 ff.  
The following significant differences were found: 
Table 4.4. Significant results from experiments with FeSO4 200, 1000, or 5000 µM 
Assay Lower assay Higher assay p Cause 
Slice weights neg. controls, 24h neg. controls, 0h p < 0.01 Incubation time 
MTT results pos. controls, 24h neg. controls, 24h p < 0.01 Menadione 
treatment 
MTT results FeSO4 5000 µM, 24h neg. controls, 24h p < 0.05 FeSO4 treatment 
ASAT leakage neg. controls, 24h FeSO4 5000 µM, 24h p < 0.01 FeSO4 treatment 
ASAT leakage FeSO4 200 µM, 24h FeSO4 5000 µM, 24h p < 0.05 FeSO4 treatment 
ASAT leakage FeSO4 200 µM, 24h FeSO4 1000 µM, 24h p < 0.05 FeSO4 treatment 
GLDH leakage neg. controls, 24h FeSO4 5000 µM, 24h p < 0.01 FeSO4 treatment 
K content neg. controls, 0h neg. controls, 24h p < 0.05 Incubation time 
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Assay Lower assay Higher assay p Cause 
Fe content neg. controls, 24h FeSO4 5000 µM, 24h p < 0.01 FeSO4 treatment 
Fe content FeSO4 200 µM, 24h FeSO4 5000 µM, 24h p < 0.05 FeSO4 treatment 
Note: Concerning GLDH leakage, the difference between FeSO4 5000 µM at 24h and negative controls at 24h 
was found using parametric analyses (ANOVA, t test).  However, the GLDH results in the FeSO4 5000 µM 
group failed the test of normality (p < 0.01), and so additional non-parametric analyses were performed (rank-
ANOVA, rank sum test) and showed no significant differences with respect to GLDH leakage (p≥0.05). 
Slice weights and K content decreased with treatment time.  Leakage of ASAT and GLDH 
increased with high iron concentrations in the medium (1000-5000 µM).  Slice viability 
(MTT results) decreased with menadione treatment and with the highest iron concentration. 
The effect of high FeSO4 concentrations on enzyme leakage was more pronounced than that 
of lower FeSO4 concentrations both here and in earlier experiments (sections 4.4 and 4.5).  
As could be expected, the Fe content in slices increased with high Fe concentrations in the 
medium.  It is not certain if the cells had actually absorbed all this iron or if it was only 
adsorbed to the slice surfaces, but to minimise the influence of incubation media on the iron 
assay, slices assigned for this analysis had been rinsed in cold PBS prior to drying and 
weighing (Figure 3.5-b, page 41), and the filter paper used for drying had been moistened 
with PBS instead of incubation medium (see sections 3.3.1 p. 40, and 3.3.4 p. 45).  It is 
assumed that most of the non-absorbed iron was removed during rinsing and drying, and that 
the measured biochemical effects were due to iron absorbed by cells. 
Iron (II) sulphate causes lipid peroxidation in rat liver tissue (Bacon et al., 1986; Mak and 
Weglicki, 1985; Pushpendran et al., 1998).  Lipid peroxidation can disrupt cellular integrity 
and mitochondrial function, and this may explain the increased enzyme leakage (ASAT, 
GLDH) and the reduced MTT results with iron treatment. 
4.7. POOLED DATA FROM DIFFERENT STUDY DESIGNS 
In order to identify trends that may not be demonstrable in each experiment, data from 
groups that had received the same treatment in different experiments were pooled and 
analysed together.  This also made it possible to compare treatments that had not been part of 
the same experiment.  Results were compared from up to 10 animals (n=2 to 10; see Table 
4.5), each representing 2 to 7 slices in the various treatments and analyses performed. 
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The results are presented graphically in appendix A–4.5, page 92 ff. 
Table 4.5. Number of animals compared in the pooled data from 
various treatments and analyses 






n (K  
and Fe) 
Negative control 0h 10 – 6 8 
Negative control 3h 4 4 4 2 
Negative control 6h 4 4 – 2 
Negative control 24h 10 10 10 8 
Positive control 3h 2 2 2 – 
Positive control 6h 2 2 – – 
Positive control 24h 8 8 8 6 
FeSO4 100 µM 3h 2 2 2 2 
FeSO4 100 µM 6h 2 2 – 2 
FeSO4 100 µM 24h 4 4 4 4 
FeSO4 100 µM 24h 4 4 4 4 
FeSO4 200 µM 24h 6 6 6 6 
FeSO4 400 µM 24h 2 2 2 2 
FeSO4 1000 µM 24h 4 4 4 4 
FeSO4 5000 µM 24h 4 4 4 4 
 
Because the FeSO4 100 µM 24h category was part of time-effect studies as well as 
concentration-effect studies, that category has got two lines in Table 4.5, and it is represented 
by two identical but differently coloured bars in the pooled charts. 
4.7.1. Slice weights 
Average slice weights ranged from 19.2 mg in negative controls at 24h, to 26.1 mg in 
positive controls at 6h (appendix A–4.5, 1st chart).  The following significant differences 
were found: 
Table 4.6. Significant differences in slice weights 
Assay Lower assay Higher assay p Cause 
Slice w. neg. controls, 24h (n=10) neg. controls, 0h (n=10) p < 0.01 Incubation 
time 
Slice w. neg. controls, 24h (n=10) pos. controls, 24h (n=8) p < 0.05 Menadione 
treatment 
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Slice weights decreased with longer treatment time.  The main reasons for weight reduction 
of slices during dynamic organ culture incubation are wear and tear from the continuously 
stirred culture medium and the friction of slices against the metal mesh or other surface on 
which they rest.  The outer cell layers are disrupted and torn off by the mechanical stress, and 
washed away by the medium.  Cells disrupted by toxic influence and swelling can be washed 
away even more rapidly. 
However, slice weights increased with menadione treatment (positive control).  Many of the 
slices treated with menadione were visibly harder than the others after treatment.  This may 
indicate an encapsulation of the outer cells as they reacted to the added toxin, and then a 
resistance to mechanical stress. 
Menadione had a quite different effect than FeSO4 on slice weights.  This may reflect the two 
compounds’ different modes of toxicity (Stubberfield and Cohen, 1989; Griffiths et al., 
1999).  These differences may also influence on parameters that are normalised according to 
slice weights. 
4.7.2. MTT results 
Average MTT results ranged from 37.5% in positive controls at 24h, to 101.6% in FeSO4 
400 µM at 24h (appendix A–4.5, 2nd chart).  (Negative controls at 24h were set to 100%.)  
The following significant differences were found: 
Table 4.7. Significant differences in MTT results 
Assay Lower assay Higher assay p Cause 
MTT pos. controls, 24h (n=8) neg. controls, 24h (n=10) p < 0.01 Menadione 
treatment 
MTT FeSO4 5000 µM, 24h (n=4) neg. controls, 24h (n=10) p < 0.01 FeSO4 
treatment 
Note: In the case of FeSO4 5000 µM at 24h versus negative controls at 24h, the difference was found using 
parametric analyses (ANOVA, t test).  However, the MTT results in the FeSO4 5000 µM group failed the test of 
normality (p < 0.05), and non-parametric analyses (rank-ANOVA, rank sum test) showed no significant 
differences between the FeSO4 5000 µM group and other groups with respect to MTT (p≥0.05). 
Large variations in the MTT results between experiments made it difficult to compare the 
results.  To enable comparison of different experiments, the results were related to slice 
weights and then normalised against one of the control groups.  Negative controls at 24 hours 
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was the only group included in the MTT test in all experiments, and so the results for this 
group was set to 100% in each experiment. 
Slices treated with menadione (positive control) had a significantly lower ability to convert 
MTT to formazan.  The viability of slices also seemed to decrease with high concentrations 
of FeSO4 and with longer treatment times, but the results were not conclusive. 
The MTT test appears to be more sensitive to menadione than to iron.  Again this may reflect 
the two compounds’ different modes of toxicity; oxidative stress and/or arylation of thiols by 
menadione (Stubberfield and Cohen, 1989), and free radical lipid peroxidation by iron 
(Griffiths et al., 1999). 
4.7.3. Enzyme leakage 
4.7.3.1. ALAT results 
Average ALAT leakage ranged from 4.7% in negative controls at 3h, to 20.2% in FeSO4 
5000 µM at 24h (appendix A–4.5, 3rd chart).  The ALAT leakage increased with longer 
treatment.  However, no significant differences were found between any treatments (p≥0.05), 
possibly due to large standard errors (SE) resulting from different study designs and 
performance between experiments. 
ALAT is a liver-specific enzyme in rats, but leakage of ALAT does not seem to be a very 
sensitive parameter for in vitro toxicity in rat liver slices based on these results. 
4.7.3.2. ASAT results 
Average ASAT leakage ranged from 1.8% in negative controls at 3h, to 14.4% in FeSO4 
5000 µM at 24h (appendix A–4.5, 4th chart).  These significant differences were found: 
Table 4.8. Significant differences in ASAT leakage 
Assay Lower assay Higher assay p Cause 
ASAT 
leakage 








FeSO4 100 µM, 24h (n=4) FeSO4 5000 µM, 24h (n=4) p < 0.01 FeSO4 
treatment 
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Assay Lower assay Higher assay p Cause 
ASAT 
leakage 












neg. controls, 3h (n=4) neg. controls, 24h (n=10) p < 0.01 Incubation 
time 
 
ASAT leakage increased with time, but the results were almost the same in negative controls, 
positive controls, and FeSO4 100 µM. 
With higher concentrations of FeSO4 the ASAT leakage increased significantly.  At 24 hours 
the ASAT leakage was much higher in slices treated with the highest concentrations of 
FeSO4 (1000 and 5000 µM) compared to either negative controls or FeSO4 100 µM. 
ASAT is less liver-specific than ALAT in rats, but the proportion of mitochondrial to 
cytosolic forms is greater with ASAT than with ALAT, and higher leakage of ASAT 
indicates more severe damage to subcellular organelles (Evans GO, 1996).  Given that FeSO4 
promotes lipid peroxidation of organelles (Bacon et al., 1986; Mak and Weglicki, 1985; 
Pushpendran et al., 1998), ASAT leakage may be a sensitive marker of iron toxicity in tissue 
slices. 
4.7.3.3. GLDH results 
Average GLDH leakage ranged from 0.2% in negative controls at 3h, to 13.7% in FeSO4 
5000 µM at 24h (appendix A–4.5, 5th chart).  These significant differences were found: 
Table 4.9. Significant differences in GLDH leakage 
Assay Lower assay Higher assay p Cause 
GLDH 
leakage 








FeSO4 100 µM, 24h (n=4) FeSO4 5000 µM, 24h (n=4) p < 0.05 FeSO4 
treatment 
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Assay Lower assay Higher assay p Cause 
GLDH 
leakage 








pos. controls, 3h (n=2) pos. controls, 24h (n=8) p < 0.01 Incubation 
time 
Note: In the experiments involving 200-1000-5000 µM FeSO4, one sample mean was excluded from the 
negative controls at 24h (see explanation in section 4.6, page 57).  Therefore n=9 instead of 10. 
GLDH leakage increased significantly with longer treatment time, but the results were 
almost the same in negative controls, positive controls, and FeSO4 100 µM. 
With higher concentrations of FeSO4 the GLDH leakage was more pronounced, and the 
greatest difference in enzyme leakage between different iron concentrations is exhibited by 
GLDH.  At 24 hours the leakage was 3.7 times higher with FeSO4 5000 µM than with 
100 µM.  The corresponding factors for the other enzymes at 24 hours are between 1.3 and 
2.1.  Based on this, GLDH leakage in liver slices may be particularly sensitive to iron 
toxicity. 
Although the GLDH leakage was small, the relative increase in GLDH leakage from 3 hours 
to 24 hours was greater than for the other enzymes measured in the same period.  In the 
groups observed at 3 and 24 hours – i.e. positive controls, negative controls, and FeSO4 
100 µM – GLDH leakage grew by factors of 16, 18 and 19, respectively (see Table 4.10).  
Leakage of the other enzymes in the same period only grew by factors between 2.2 and 4.4.  
This indicates that GLDH may be a more sensitive marker than the other enzymes with 
respect to the length of treatment.  GLDH is essentially a mitochondrial enzyme, and leakage 
of GLDH indicates severe organelle damage, which happens in the later stages of cellular 
damage (Evans GO, 1996). 
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Table 4.10. Increased enzyme leakage from 3 hours to 24 hours 
The tabulated values correspond to the 3h and 24h bars in the enzyme leakage charts (appendix A–4.5; 
Pooled data from different study designs).  The p values for the differences between 3h and 24h enzyme 
leakage are given elsewhere in section 4.7.3 (except from ALAT leakage for which p≥0.05). 
 Leakage at 3h (%) Leakage at 24h (%) Factor 24h / 3h 
Enzyme neg.c. pos.c. Fe-100 neg.c. pos.c. Fe-100 neg.c. pos.c. Fe-100
ALAT 4.7 6.7 4.6 11.3 14.7 11.1 2.4 2.2 2.4 
ASAT 1.8 1.8 1.8 6.1 7.4 6.9 3.4 4.1 3.8 
GLDH 0.16 0.16 0.20 2.9 2.5 3.7 18. 16. 19. 
LDH 8.1 11.0 9.6 20.8 48.7 26.8 2.6 4.4 2.8 
 
 
4.7.3.4. LDH results 
Average LDH leakage ranged from 8.1% in negative controls at 3h, to 48.7% in positive 
controls at 24h (appendix A–4.5, 6th chart).  The following significant differences were 
found: 
Table 4.11. Significant differences in LDH leakage 
Assay Lower assay Higher assay p Cause 
LDH 
leakage 
















neg. controls, 3h (n=4) neg. controls, 24h (n=10) p < 0.01 Incubation 
time 
 
LDH leakage was almost the same in FeSO4 100 µM and negative controls at all time points, 
and higher concentrations of FeSO4 did not make a big difference. 
On the other hand, LDH leakage increased markedly with menadione treatment.  
The differences in LDH leakage between menadione and negative controls, and also between 
menadione for 24h and 3h, suggest that LDH leakage is very sensitive to menadione 
treatment.  This was also shown in individual experiments involving menadione (results in 
sections 4.3 p. 53, and 4.5 p. 56). 
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The results of the present study agree with Leeman et al. (1995) who found that 
LDH leakage was significantly higher in slices treated for 4 hours with 100, 200 or 400 µM 
menadione than in negative controls.  LDH has low organ specificity and is mainly cytosolic, 
and LDH leakage happens early in cellular damage (Evans GO, 1996).  LDH leakage seems 
to be more sensitive to menadione than to FeSO4. 
4.7.3.5. Summary of enzyme leakage results 
Disruption of cells due to mechanical or chemical factors leads to enzyme leakage as well as 
weight reduction.  In early stages of tissue damage, cytoplasmic enzymes leak from cells 
when plasma membrane permeability is altered.  As the tissue damage becomes more severe, 
enzymes normally present in subcellular organelles will also be released (Evans GO, 1996).  
This is reflected by the cytosolic enzymes ALAT and LDH leaking 5-10% already at 3 hours 
and up to 20% and 50% at 24 hours, respectively, whereas the mitochondrial enzymes 
GLDH and ASAT only leak 0.2-1.8% at 3 hours and less than 15% at 24 hours in the present 
study. 
Leakage of all enzymes increased with longer treatment time and with chemical treatment, 
but for ALAT leakage the differences were not significant.  ASAT and GLDH leakage were 
most sensitive to iron treatment, while LDH leakage was most sensitive to menadione 
treatment. 
4.7.4. Potassium content 
Average K content ranged from 77.0% in positive controls at 24h, to 269% in negative 
controls at 6h (appendix A–4.5, 7th chart).  (Negative controls at 0h were set to 100%.)  
The following significant differences were found: 
Table 4.12. Significant differences in K content 
Assay Lower assay Higher assay p Cause 
K  neg. controls, 0h (n=8) neg. controls, 3h (n=2), 
6h (n=2), 24h (n=8) 
p < 0.01 Medium and 
incubation time 
K  pos. controls, 24h (n=6) neg. controls, 24h (n=8) p < 0.01 Menadione 
treatment 
K  FeSO4 1000 µM, 24h (n=4) neg. controls, 24h (n=8) p < 0.01 FeSO4 treatment 
K  FeSO4 5000 µM, 24h (n=4) neg. controls, 24h (n=8) p < 0.01 FeSO4 treatment 
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The K content in slices increased significantly from 0 hours to 3 hours in negative controls.  
Increased K content during the first hours of incubation may be caused by potassium in the 
culture medium (the medium contained the buffer NaHPO4 / KH2PO4 plus KCl) or by a 
transitory potassium leakage during slice preparation and subsequent recovery.  If the latter 
is the case, the recovery must take longer time than the one hour of pre-incubation but is 
probably complete within 3 to 6 hours, according to the peak in K content at 6 hours. 
The K content decreased with chemical treatment, or did not increase as much as in negative 
controls.  Compared to negative controls, K content was significantly lower with 1000 µM 
and 5000 µM FeSO4, and even lower with menadione (positive controls).  This may be 
caused by damage to the plasma membrane or a block in ATP synthesis impairing energy-
dependent cellular ion pumping mechanisms, allowing sodium and calcium to enter and 
potassium to escape (Vickers, 1997). 
4.7.5. Iron content 
Iron content was not a marker of toxicity in itself but may contribute in the evaluation of the 
other assays. 
Average Fe content ranged from 63.3% in positive controls at 24h, to 218% in FeSO4 
5000 µM at 24h (appendix A–4.5, last chart).  (Negative controls at 0h were set to 100%.)  
The following significant differences were found: 
Table 4.13. Significant differences in Fe content 
Assay Lower assay Higher assay p Cause 
Fe  neg. controls, 24h (n=8) FeSO4 5000 µM, 24h (n=4) p < 0.01 FeSO4 treatment 
Fe  FeSO4 100 µM, 24h (n=4) FeSO4 5000 µM, 24h (n=4) p < 0.01 FeSO4 treatment 
Note: These differences were found using parametric analyses (ANOVA, t test).  However, all treatment groups 
failed the test on homogeneity of variance (p < 0.05), and the additional non-parametric analyses (rank-
ANOVA, rank sum test) showed no significant differences in Fe content between any groups (p≥0.05). 
Iron content was reasonably constant in all groups except from FeSO4 5000 µM at 24 hours.  
Although not significant due to non-homogeneity of variance, the iron content in slices from 
the FeSO4 5000 µM group at 24 hours is higher than in FeSO4 100 µM and in negative 
control at the same time. 
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The increased Fe content is expected, but it may have several explanations; significant 
uptake of soluble iron into cells, adsorption of iron onto the surface of slices without cellular 
uptake, or excess iron in culture medium not rinsed away properly before assaying.  The 
toxic effects observed with high concentrations of iron in medium (i.e. MTT test, 
ASAT leakage, GLDH leakage, and K leakage), in particular the leakage of mitochondrial 
enzymes, suggest that the iron was indeed absorbed and exerted its effects inside the cells. 
 
5. CONCLUSION 
A new incubator at GE Healthcare was tested with rat liver slices and various concentrations 
of menadione and iron (II) sulphate in William’s medium E.  The operation of the equipment 
was relatively straightforward, albeit time consuming.  And the quality of slices did not seem 
to have improved since previous studies at GE Healthcare, illustrated by large variation in 
results between different experiments and also the poor quality of histology samples.  More 
experiments and more practical training of personnel in using the equipment is required to 
improve the performance of the rat liver slice model. 
To obtain toxic effects on tissue slices in vitro, where most physiological processes are not 
present in the test model, the test substances must be directly cytotoxic.  Isolated hepatocytes 
may be easier to culture and often used for toxicity screening, and liver slices may be more 
useful for studies on metabolism and for inter-species comparison. 
Certain in vitro assays for toxicity in rat liver slices, particularly enzyme leakage and 
potassium (K) content, were found to be sensitive to treatment with iron (II) sulphate and 
menadione.  Some effects observed in the rat liver slices treated with these substances were: 
• LDH leakage increased significantly with exposure to menadione 
• ASAT leakage and GLDH leakage increased significantly with iron (II) sulphate 
• K content decreased significantly with iron (II) sulphate or menadione treatment 
Of the assays evaluated in the present study, GLDH leakage seemed to be the most predictive 
of iron (II) sulphate toxicity in rat liver slice in vitro, and LDH leakage the most predictive of 
menadione toxicity. 
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APPENDIX 
A–1. MANUFACTURERS AND SUPPLIERS OF MATERIALS 
Short 
name 
Full name and address of headquarters or affiliate 
AGA AGA, Strømsveien 324, PB 123 Leirdal, N-1081 Oslo, Norway 
Alabama Alabama Research & Development, P.O.Box 739, Munford, Alabama 36268 USA 
Arcus Arcus Produkter, Haslevangen 16, PB 6764 Rodeløkka, N-0503 Oslo, Norway 
Baxter Baxter Healthcare, 95 Spring Street, New Providence, New Jersey 07974 USA 
B&K B & K Universal, Box 6023, S-19106 Sollentuna, Sweden 
BioWhit BioWhittaker, 8830 Biggs Ford Road, P.O.Box 127, Walkersville, MD 21793 USA 
Braun B. Braun Medical, CH-6020 Emmenbrücke, Switzerland 
ChemScan ChemScan, Grindalsveien 14, N-2400 Elverum, Norway 
Desaga Desaga Sarstedt Gruppe, D-69123 Heidelberg, Germany 
Dynatech Dynatech Laboratories, 14340 Sullyfield Circle, Chantilly, Virginia 22021 USA 
Hamilton Hamilton Bonaduz, CH-7402 Bonaduz, Switzerland 
Harvard Harvard Apparatus, 84 October Hill Road, Holliston, Massachusetts 01746 USA 
Histolab Histolab Products, Hulda Lindgrensgata 6, S-42131 Västra Frölunda, Sweden 
Leica Leica Microsystems, Imneuenheimer Feld 518, D-69120 Heidelberg, Germany 
LifeTech Life Technologies, 9800 Medical Center Dr, POB 6482, Rockville, MD 20849 
USA 
Merck E. Merck, Frankfurterstrasse 250, D-64293 Darmstadt, Germany 
Mettler Mettler Instruments, 1900 Polaris Parkway, Columbus, Ohio 43240 USA 
Nat.Diag National Diagnostics, 305 Patton Drive, Atlanta, Georgia 30336 USA 
NIST National Institute of Standards & Technology, 100 Bureau Drive,  
Stop 3460, Gaithersburg, Maryland 20899 USA 
Nunc Nunc, Postbox 280 Kamstrup, DK-4000 Roskilde, Denmark 
Packard Packard Instrument, 800 Research Parkway, Meriden, Connecticut 06450 USA 
PerkinE PerkinElmer Instruments, 710 Bridgeport Avenue, Shelton, CT 06484 USA 
Roche Roche Diagnostics, D-68298 Mannheim, Germany 
Sakura Sakura / Bayer Diagnostics, Bayer Norway, PB 311, N-1324 Lysaker, Norway 
Sarstedt Sarstedt, D-51588 Nümbrecht, Germany 
Schleicher Schleicher & Schuell, Postfach 4, D-37582 Dassel, Germany 
Sigma Sigma-Aldrich Norway, Tevlingveien 23, PB 188 Leirdal, N-1011 Oslo, Norway 
Sigma-D Sigma Diagnostics, St. Louis, Missouri 63178 USA 
Skil Skil Europe, Konijnenberg 60, Breda, Netherlands 
SDS Special Diets Services, Postbox 180, NL-5830 AD Boxmeer, Netherlands 
Teknolab Teknolab, PB 131, N-1441 Drøbak, Norway 
Vitron Vitron, 8320 South Wentworth Road, Tucson, Arizona 85747 USA 
Vogel Vogel medizinischer Technik und Elektronik, Marburgerstr. 81, D-35396 Glessen 
 
Summary of animal characteristics
All animals were male Sprague-Dawley rats (type BKL from B&K), except animal 0389-01 which was female.
The animals were starved for the last part of the last night, except animals 13xx-00 which were fed normally.
"Arrival weight" was measured the morning after arrival, except for animal 063x-01 which was measured two days after arrival.
One animal was used in each experiment, except in EGN-05-01 where two animals were used.
Highlighted experiments are presented in the thesis.  The other experiments were excluded as explained in the results chapter.



























EGN-01-00 1335-00 200 17-sep-00 25-okt-00 5,43    172 31-okt-00 6,29    218 6 27 % 9,6     4,4 %
EGN-02-00 1371-00 200 21-sep-00 8-nov-00 6,86    152 14-nov-00 7,71    200 6 32 % 11,1    5,6 %
EGN-03-00 1385-00 200 10-okt-00 22-nov-00 6,14    198 27-nov-00 6,86    245 5 24 % 10,2    4,2 %
EGN-04-00 1444-00 200 26-okt-00 6-des-00 5,86  196 11-des-00 6,57  215 5 10 % 7,4   3,4 %
EGN-01-01 0204-01 150 28-nov-00 3-jan-01 5,14    154 10-jan-01 6,14    192 7 25 % 6,1     3,2 %
EGN-02-01 0210-01 210 11-des-00 24-jan-01 6,29  199 31-jan-01 7,29  249 7 25 % 9,3   3,7 %
EGN-03-01 0321-01 210 6 29-des-00 7-feb-01 5,71  195 14-feb-01 6,71  238 7 22 % 8,4   3,5 %
EGN-04-01 0389-01 210 6 31-des-00 21-feb-01 7,43    204 27-feb-01 8,29    203 6 0 % 6,0     3,0 %
EGN-05-01 0473-01 210 6 24-jan-01 7-mar-01 6,00  212 14-mar-01 7,00  240 7 13 % 8,1   3,4 %
EGN-05-01 0474-01 210 6 24-jan-01 7-mar-01 6,00  217 14-mar-01 7,00  245 7 13 % 8,5   3,5 %
EGN-06-01 0472-01 150-180 28-jan-01 7-mar-01 5,43  170 21-mar-01 7,43  257 14 51 % 7,8   3,0 %
EGN-07-01 0478-01 210 6 11-feb-01 21-mar-01 5,43  206 29-mar-01 6,57  258 8 25 % 9,8   3,8 %
EGN-08-01 0483-01 210 6 16-feb-01 28-mar-01 5,71    209 4-apr-01 6,71    254 7 22 % 9,5     3,7 %
EGN-09-01 0584-01 160 6 19-mar-01 25-apr-01 5,29  163 7-mai-01 7,00  260 12 60 % 9,5   3,7 %
EGN-10-01 0617-01 210 6 1-apr-01 9-mai-01 5,43  216 14-mai-01 6,14  246 5 14 % 9,3   3,8 %
EGN-11-01 0636-01 210-230 6 15-apr-01 23-mai-01 5,43  233 28-mai-01 6,14  240 5 3 % 8,0   3,3 %
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A–2. SUMMARY OF ANIMAL CHARACTERISTICS 
A–3. THE HEMATOXYLIN / EOSIN STAINING PROCESS 
This staining process was used in section 3.3.6 Histology, page 47.  An automatic slide stainer (DRS-60 from 
Sakura) carried out the process in accordance with the following scheme set up at GE Healthcare, Dept. of 
Regulatory Toxicology.  Dyes and ammonia were stored in tight containers between runs.  Dyes were filtered 
before every run and changed every 20 runs.  Other solutions were changed depending on use and degree of 
discoloration (e.g., solutions no. 11, 14, and 15 picked up colour quickly). 
Time Step 
min sec 
Solution (supplier, article no.) Notes 
1 5  Histoclear (HS-202 from Nat.Diag) Dissolve remaining wax 
2 5  Histoclear  
3 1  100% ethanol (1004857 from Arcus) Prepare hydration 
4 1  100% ethanol  
5 1  96% ethanol (1003203 from Arcus)  
6 1  96% ethanol  
7 1  80% ethanol*  
8 1  Running water  
9 8  Harris hematoxylin (01800, Histolab)† Basic blue dye staining nuclei 
10 10  Running water Wash off excess dye 
11  10 1% ammonia solution‡ Alkalinise to fixate dyes 
12 10  Running water Wash off excess ammonia 
13 6  Eosin Y (HT110-1-32 from Sigma-D)§ Acid red dye staining cytoplasm 
14  20 96% ethanol Wash off excess dye; dehydrate 
15  20 96% ethanol  
16  20 100% ethanol  
17  20 100% ethanol  
18  20 Histoclear  
19 1  Histoclear  
20 1  Histoclear  
21 1  Histoclear Dehydration complete 
sum 54 50 plus transfer time between steps  
 
                                                 
* 80% ethanol: Prepare using 100% ethanol (1004857 from Arcus) and RO-water. 
† This is a water- and propylene glycol-based solution of 0.4% hematoxylin and additives. 
‡ 1% ammonia solution: Prepare using 25% ammonia solution (1.05432 from Merck) and RO-water. 
§ This is an ethanol-based solution of eosin Y, or eosin yellowish–(YS). 
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A–4. GRAPHS FOR THE RESULTS AND DISCUSSION 











neg ctrl 0h neg ctrl 3h neg ctrl 6h neg ctrl 24h pos ctrl 3h pos ctrl 6h pos ctrl 24h
Negative and positive control (200 µM menadione):  Mean ± SE from n=2 animals x 5 replicates









neg ctrl 3h neg ctrl 24h pos ctrl 3h pos ctrl 24h
Negative and positive control (200 µM menadione):  Mean ± SE from n=2 animals x 2 replicates
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Menadione 200 µM (continued; see legend p. 52, discussion p. 53) 










neg ctrl 3h neg ctrl 6h neg ctrl 24h pos ctrl 3h pos ctrl 6h pos ctrl 24h
Negative and positive control (200 µM menadione):  Mean ± SE from n=2 animals x 5 replicates












neg ctrl 3h neg ctrl 6h neg ctrl 24h pos ctrl 3h pos ctrl 6h pos ctrl 24h
Negative and positive control (200 µM menadione):  Mean ± SE from n=2 animals x 5 replicates
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Menadione 200 µM (continued; see legend p. 52, discussion p. 53) 











neg ctrl 3h neg ctrl 6h neg ctrl 24h pos ctrl 3h pos ctrl 6h pos ctrl 24h
Negative and positive control (200 µM menadione):  Mean ± SE from n=2 animals x 5 replicates











neg ctrl 3h neg ctrl 6h neg ctrl 24h pos ctrl 3h pos ctrl 6h pos ctrl 24h
Negative and positive control (200 µM menadione):  Mean ± SE from n=2 animals x 5 replicates
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neg ctrl 0h neg ctrl 3h neg ctrl 6h neg ctrl 24h Fe-100 3h Fe-100 6h Fe-100 24h
Negative control and 100 µM FeSO4:  Mean ± SE from n=2 animals x 4-7 replicates
MTT test (% of 24h negative control; OD-570 / mg slice weight)








neg ctrl 3h neg ctrl 24h Fe-100 3h Fe-100 24h
Negative control and 100 µM FeSO4:  Mean ± SE from n=2 animals x 2 replicates
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Ferrous sulphate 100 µM (continued; see legend p. 52, discussion p. 54) 










neg ctrl 3h neg ctrl 6h neg ctrl 24h Fe-100 3h Fe-100 6h Fe-100 24h
Negative control and 100 µM FeSO4:  Mean ± SE from n=2 animals x 4-7 replicates










neg ctrl 3h neg ctrl 6h neg ctrl 24h Fe-100 3h Fe-100 6h Fe-100 24h
Negative control and 100 µM FeSO4:  Mean ± SE from n=2 animals x 4-7 replicates
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Ferrous sulphate 100 µM (continued; see legend p. 52, discussion p. 54) 













neg ctrl 3h neg ctrl 6h neg ctrl 24h Fe-100 3h Fe-100 6h Fe-100 24h
Negative control and 100 µM FeSO4:  Mean ± SE from n=2 animals x 4-7 replicates









neg ctrl 3h neg ctrl 6h neg ctrl 24h Fe-100 3h Fe-100 6h Fe-100 24h
Negative control and 100 µM FeSO4:  Mean ± SE from n=2 animals x 4-7 replicates
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Ferrous sulphate 100 µM (continued; see legend p. 52, discussion p. 54) 











neg ctrl 0h neg ctrl 3h neg ctrl 6h neg ctrl 24h Fe-100 3h Fe-100 6h Fe-100 24h
Negative control and 100 µM FeSO4:  Mean ± SE from n=2 animals x 2 replicates








neg ctrl 0h neg ctrl 3h neg ctrl 6h neg ctrl 24h Fe-100 3h Fe-100 6h Fe-100 24h
Negative control and 100 µM FeSO4:  Mean ± SE from n=2 animals x 2 replicates
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A–4.3. Ferrous sulphate 100, 200, or 400 µM 










neg ctrl 0h neg ctrl 24h pos ctrl 24h Fe-100 24h Fe-200 24h Fe-400 24h
100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=2 animals x 6-7 replicates









neg ctrl 0h neg ctrl 24h pos ctrl 24h Fe-100 24h Fe-200 24h Fe-400 24h
100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=2 animals x 2 replicates
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Ferrous sulphate 100, 200, or 400 µM (cont.; legend p. 52, discussion p. 56) 










neg ctrl 24h pos ctrl 24h Fe-100 24h Fe-200 24h Fe-400 24h
100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=2 animals x 6-7 replicates










neg ctrl 24h pos ctrl 24h Fe-100 24h Fe-200 24h Fe-400 24h
100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=2 animals x 6-7 replicates
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Ferrous sulphate 100, 200, or 400 µM (cont.; legend p. 52, discussion p. 56) 











neg ctrl 24h pos ctrl 24h Fe-100 24h Fe-200 24h Fe-400 24h
100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=2 animals x 6-7 replicates










neg ctrl 24h pos ctrl 24h Fe-100 24h Fe-200 24h Fe-400 24h
100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=2 animals x 6-7 replicates
Page 86 of 182 
Appendix 
 
Ferrous sulphate 100, 200, or 400 µM (cont.; legend p. 52, discussion p. 56) 









neg ctrl 0h neg ctrl 24h pos ctrl 24h Fe-100 24h Fe-200 24h Fe-400 24h
100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=2 animals x 2 replicates








neg ctrl 0h neg ctrl 24h pos ctrl 24h Fe-100 24h Fe-200 24h Fe-400 24h
100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=2 animals x 2 replicates
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A–4.4. Ferrous sulphate 200, 1000, or 5000 µM 











neg ctrl 0h neg ctrl 24h pos ctrl 24h Fe-200 24h Fe-1000 24h Fe-5000 24h
200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=4 animals x 6-7 replicates










neg ctrl 0h neg ctrl 24h pos ctrl 24h Fe-200 24h Fe-1000 24h Fe-5000 24h
200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=4 animals x 2 replicates
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Ferrous sulphate 200, 1000, or 5000 µM (cont.; legend p. 52, discussion p. 57) 










neg ctrl 24h pos ctrl 24h Fe-200 24h Fe-1000 24h Fe-5000 24h
200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=4 animals x 6-7 replicates












neg ctrl 24h pos ctrl 24h Fe-200 24h Fe-1000 24h Fe-5000 24h
200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=4 animals x 6-7 replicates
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Ferrous sulphate 200, 1000, or 5000 µM (cont.; legend p. 52, discussion p. 57) 












neg ctrl 24h pos ctrl 24h Fe-200 24h Fe-1000 24h Fe-5000 24h
200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=4 animals x 6-7 replicates









neg ctrl 24h pos ctrl 24h Fe-200 24h Fe-1000 24h Fe-5000 24h
200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=4 animals x 6-7 replicates
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Ferrous sulphate 200, 1000, or 5000 µM (cont.; legend p. 52, discussion p. 57) 









neg ctrl 0h neg ctrl 24h pos ctrl 24h Fe-200 24h Fe-1000 24h Fe-5000 24h
200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=4 animals x 2 replicates









neg ctrl 0h neg ctrl 24h pos ctrl 24h Fe-200 24h Fe-1000 24h Fe-5000 24h
200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):  Mean ± SE from n=4 animals x 2 replicates
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A–4.5. Pooled data from different study designs 














































Pooled data:  Average ± SE from n=2-10 animals x 4-7 replicates










































Pooled data:  Average ± SE from n=2-10 animals x 2 replicates
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Pooled data from different study designs (cont.; legend p. 52, discussion p. 61) 














































Pooled data:  Average ± SE from n=2-10 animals x 4-7 replicates



















































Pooled data:  Average ± SE from n=2-10 animals x 4-7 replicates
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Pooled data from different study designs (cont.; legend p. 52, discussion p. 62) 















































Pooled data:  Average ± SE from n=2-10 animals x 4-7 replicates
















































Pooled data:  Average ± SE from n=2-10 animals x 4-7 replicates
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Pooled data from different study designs (cont.; legend p. 52, discussion p. 65) 
















































Pooled data:  Average ± SE from n=2-8 animals x 2 replicates











































Pooled data:  Average ± SE from n=2-8 animals x 2 replicates
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A–5. RAW DATA 
The next pages include raw data and calculations from the following experiments: 
• Single-concentration, 3-/6-/24-hour experiments: 
- Experiments EGN-04-00 and EGN-02-01: 
0 or 200 µM menadione for 0, 3, 6, or 24 hours (negative and positive control) 
- Experiments EGN-03-01 and EGN-05-01: 
0 or 100 µM ferrous sulphate for 0, 3, 6, or 24 hours (no positive control) 
• Three-concentration, 24-hour experiments: 
- Experiments EGN-06-01 and EGN-07-01: 
0, 100, 200, or 400 µM ferrous sulphate for 24 hours (pos. ctrl.: 200 µM menadione) 
- Experiments EGN-09-01 through EGN-12-01: 
0, 200, 1000, or 5000 µM ferrous sulphate for 24 h (pos. ctrl.: 200 µM menadione) 
The data include: 
• Slice weights (mg) 
• ASAT leakage (% of total ASAT; U / litre) ** 
• ALAT leakage (% of total ALAT; U / litre)  
• GLDH leakage (% of total GLDH; U / litre) ** 
• LDH leakage (% of total LDH; U / litre) ** 
• MTT test (% of 24h negative control; OD-570 / mg slice weight) †† 
• Potassium content (% of 0h negative control; µg K / g slice weight) ‡‡ 
• Iron content (% of 0h negative control; µg Fe / g slice weight) ‡‡ 
 
                                                 
** Enzyme activity (U/litre) was measured in slice incubation medium and calculated as % of total enzyme 
(sum of enzyme in medium and enzyme remaining in slice). 
†† Optical density of formazan blue (absorbency at 570 nm) was measured in isopropanol extract of slice after 
treatment with MTT, adjusted for slice weight, and calculated as % of the result of negative controls in the 
same experiment at 24 hours. 
‡‡ Metal concentration (ppm) was measured in slice digested in acids, adjusted for slice weight, and calculated 
as % of the result of negative controls in the same experiment at 0 hours. 
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EGN-04-00: Effects of exposure time of menadione on rat liver slices
Groups: Group A (menadione 200 uM / DMSO 1%)
Group B (DMSO 1%) B1-B5 (0h-control) - not treated
Slice weights (mg)
time sample weight comments
3h A6 22,0         
A7 25,8         Regarding all slices:
A8 19,9         Incubator heat was not turned on until 2,5 hours before
A9 21,0         pre-incubation, so temperature was around 3-5 degrees
A10 22,7         too low during pre-incubation, and 1-3 degrees too low
mean 22,3         for the first 2-3 hours of incubation.
SD 2,2           (Data is available from trials determining temperature
6h A11 28,8         equilibration times for incubator.  36-37 degrees C is
A12 22,6         regarded optimal temperature.)
A13 22,0         At the end of treatment (24h) the heat sensor indicated
A14 26,0         almost 50 degrees C, but it is not known for how long
A15 27,0         the slices were treated under too hot conditions.
mean 25,3         24h-treated slices in group A looked like cooked ham.
SD 2,9           
24h A16 21,4         
A17 21,1         
A18 22,6         
A19 22,6         
A20 23,4         
mean 22,2         
SD 0,9           
0h B1 21,0         
B2 21,7         
B3 24,2         
B4 26,1         
B5 19,2         
mean 22,4         
SD 2,7           
3h B6 22,2         
B7 22,0         
B8 19,0         
B9 19,4         
B10 26,1         
mean 21,7         
SD 2,8           
6h B11 18,1         
B12 22,8         
B13 23,3         
B14 17,8         
B15 23,2         
mean 21,0         
SD 2,8           
24h B16 14,3         
B17 15,5         
B18 18,1         
B19 17,0         
B20 19,9         
mean 17,0         
SD 2,2           
EGN-04-00-data.xls / Weight
EGN-04-00: Effects of exposure time of menadione on rat liver slices
Groups: Group A (menadione 200 uM / DMSO 1%)
Group B (DMSO 1%) B1-B5 (0h-control) - not treated
MTT test (OD-570);  raw data minus background
time sample OD-570 versus weight and v. 24-h neg. (%) slice
3h A8-1 0,599       0,030       58,7 %
A8-2 0,608       0,031       59,6 % 59,1 %
A9-1 0,759       0,036       70,5 %
A9-2 0,751       0,036       69,7 % 70,1 %
mean 0,679       0,033       64,6 % 64,6 %
SD 0,088       0,003       6,4 % 7,8 %
24h A18-1 0,167       0,007       14,4 %
A18-2 0,162       0,007       14,0 % 14,2 %
A19-1 0,344       0,015       29,7 %
A19-2 0,340       0,015       29,3 % 29,5 %
mean 0,253       0,011       21,9 % 21,9 %
SD 0,103       0,005       8,8 % 10,8 %
3h B8-1 0,893       0,047       91,7 %
B8-2 0,933       0,049       95,8 % 93,7 %
B9-1 1,231       0,063       123,7 %
B9-2 1,233       0,064       123,9 % 123,8 %
mean 1,073       0,056       108,8 % 108,8 %
SD 0,185       0,009       17,5 % 21,3 %
24h B18-1 1,013       0,056       109,1 %
B18-2 1,064       0,059       114,6 % 111,9 %
B19-1 0,753       0,044       86,4 %
B19-2 0,783       0,046       89,8 % 88,1 %
mean 0,903       0,051       100,0 % 100,0 %
SD 0,158       0,007       14,0 % 16,8 %
Abs.570nm / mg 
slice wet weight
EGN-04-00-data.xls / MTT
EGN-04-00: Effects of exposure time of menadione on rat liver slices
Groups: Group A (menadione 200 uM / DMSO 1%)
Group B (DMSO 1%) B1-B5 (0h-control) - not treated
background: medium 2 0 0,1 48
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
3h A6 40 18 1,8           502          
A7 48 21 1,7           626          
A8 30 12 1,4           395          
A9 33 15 1,3           387          
A10 29 13 1,0           382          
mean 36,0         15,8         1,4           458          
SD 8,0           3,7           0,3           106          
6h A11 108 38 3,8           1 330       
A12 59 21 2,6           722          
A13 77 23 4,9           856          
A14 59 21 2,5           707          
A15 83 31 3,1           941          
mean 77,2         26,8         3,4           911          
SD 20,3         7,5           1,0           253          
24h A16 77 15 8,7           1 067       
A17 100 17 14,7         1 313       
A18 78 15 14,5         1 169       
A19 49 9 10,3         1 229       
A20 71 10 13,5         1 169       
mean 75,0         13,2         12,3         1 189       
SD 18,2         3,5           2,7           90            
0h
3h B6 21 9 1,3           303          
B7 35 19 1,0           436          
B8 27 15 1,2           339          
B9 27 13 0,8           301          
B10 27 15 1,3           325          
mean 27,4         14,2         1,1           341          
SD 5,0           3,6           0,2           56            
6h B11 34 18 2,3           363          
B12 47 23 3,1           548          
B13 56 23 4,1           584          
B14 30 16 1,9           377          
B15 42 18 4,8           429          
mean 41,8         19,6         3,2           460          
SD 10,4         3,2           1,2           100          
24h B16 44 14 8,4           346          
B17 57 13 12,9         439          
B18 51 14 14,3         394          
B19 72 16 20,4         577          
B20 94 19 29,7         703          
mean 63,6         15,2         17,1         492          
SD 19,9         2,4           8,2           146          
EGN-04-00-data.xls / Enzyme
Triton supernatant enzyme activities (U/L);  raw data





A10 132 14 73,4         221          
mean 132,0       14,0         73,4         221          
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
6h A11
A12
A13 103 11 66,4         132          
A14 133 16 84,1         214          
A15 142 16 87,7         183          
mean 126,0       14,3         79,4         176          





A20 67 2 19,9         43            
mean 67,0         2,0           19,9         43            
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
0h B1
B2
B3 133 19 87,0         327          
B4 144 17 86,6         293          
B5 134 15 71,6         244          
mean 137,0       17,0         81,7         288          





B10 138 20 84,1         295          
mean 138,0       20,0         84,1         295          
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
6h B11
B12
B13 165 21 98,1         280          
B14 146 19 77,0         237          
B15 172 26 97,7         326          
mean 161,0       22,0         90,9         281          





B20 127 10 60,0         175          
mean 127,0       10,0         60,0         175          
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-04-00-data.xls / Enzyme
EGN-02-01: Effects of exposure time of menadione on rat liver slices
Groups: Group A (menadione 200 uM / DMSO 1%)
Group B (DMSO 1%) B1-B5 (0h-control) - not treated
Slice weights (mg)
time sample weight comments
3h A6 25,9         
A7 24,1         
A8 29,8         
A9 30,1         
A10 31,0         
mean 28,2         
SD 3,0           
6h A11 27,6         
A12 24,1         
A13 31,7         
A14 23,7         
A15 27,6         
mean 26,9         
SD 3,2           
24h A16 23,8         
A17 20,8         
A18 27,2         
A19 23,3         
A20 28,3         
mean 24,7         
SD 3,0           
0h B1 FALSE slice missing after pre-incubation
B2 29,4         
B3 27,9         
B4 26,5         
B5 26,1         
mean 27,5         
SD 1,5           
3h B6 23,7         
B7 22,7         
B8 23,1         
B9 23,8         
B10 25,7         
mean 23,8         
SD 1,2           
6h B11 17,8         
B12 23,1         
B13 21,2         
B14 23,3         
B15 24,9         
mean 22,1         
SD 2,7           
24h B16 20,5         
B17 17,3         
B18 19,2         
B19 19,9         
B20 19,6         
mean 19,3         
SD 1,2           
EGN-02-01-data.xls / Weight
EGN-02-01: Effects of exposure time of menadione on rat liver slices
Groups: Group A (menadione 200 uM / DMSO 1%)
Group B (DMSO 1%) B1-B5 (0h-control) - not treated
MTT test (OD-570);  raw data minus background
time sample OD-570 versus weight and v. 24-h neg. (%) slice
3h A8-1 0,907       0,030       53,1 %
A8-2 0,900       0,030       52,7 % 52,9 %
A9-1 0,495       0,016       28,7 %
A9-2 0,500       0,017       29,0 % 28,9 %
mean 0,701       0,023       40,9 % 40,9 %
SD 0,234       0,008       13,9 % 17,0 %
24h A18-1 0,542       0,020       34,8 %
A18-2 0,557       0,020       35,8 % 35,3 %
A19-1 0,402       0,017       30,1 %
A19-2 0,401       0,017       30,0 % 30,1 %
mean 0,476       0,019       32,7 % 32,7 %
SD 0,086       0,002       3,0 % 3,7 %
3h B8-1 1,165       0,050       88,1 %
B8-2 1,145       0,050       86,5 % 87,3 %
B9-1 1,095       0,046       80,3 %
B9-2 1,090       0,046       80,0 % 80,1 %
mean 1,124       0,048       83,7 % 83,7 %
SD 0,037       0,002       4,2 % 5,1 %
24h B18-1 1,213       0,063       110,3 %
B18-2 1,175       0,061       106,8 % 108,6 %
B19-1 1,050       0,053       92,1 %
B19-2 1,034       0,052       90,7 % 91,4 %
mean 1,118       0,057       100,0 % 100,0 %
SD 0,089       0,006       10,0 % 12,1 %
Abs.570nm / mg 
slice wet weight
EGN-02-01-data.xls / MTT
EGN-02-01: Effects of exposure time of menadione on rat liver slices
Groups: Group A (menadione 200 uM / DMSO 1%)
Group B (DMSO 1%) B1-B5 (0h-control) - not treated
background: medium 1 0 0,2 41
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
3h A6 40 19 2,5           587          
A7 35 16 2,2           558          
A8 43 20 3,3           673          
A9 37 24 2,6           614          
A10 41 23 2,1           698          
mean 39,2         20,4         2,5           626          
SD 3,2           3,2           0,5           58            
6h A11 86 31 7,8           1 123       
A12 96 34 10,3         1 287       
A13 118 38 12,0         1 522       
A14 85 30 7,0           1 170       
A15 116 34 14,6         1 238       
mean 100,2       33,4         10,3         1 268       
SD 15,9         3,1           3,1           155          
24h A16 119 14 16,4         1 739       
A17 117 12 18,0         1 474       
A18 131 16 17,6         1 791       
A19 138 14 25,2         1 708       
A20 129 19 17,2         1 826       
mean 126,8       15,0         18,9         1 708       
SD 8,7           2,6           3,6           138          
0h
3h B6 31 16 2,2           454          
B7 28 14 2,2           392          
B8 28 16 1,7           440          
B9 30 16 2,6           403          
B10 34 19 3,5           444          
mean 30,2         16,2         2,4           427          
SD 2,5           1,8           0,7           27            
6h B11 47 21 7,7           552          
B12 71 23 14,3         606          
B13 63 21 11,5         552          
B14 72 24 14,2         670          
B15 89 24 18,4         734          
mean 68,4         22,6         13,2         623          
SD 15,3         1,5           3,9           79            
24h B16 140 25 32,7         1 090       
B17 88 18 24,8         664          
B18 104 20 31,1         780          
B19 119 21 40,1         907          
B20 159 27 47,3         1 207       
mean 122,0       22,2         35,2         930          
SD 28,2         3,7           8,7           221          
EGN-02-01-data.xls / Enzyme
Triton supernatant enzyme activities (U/L);  raw data





A10 159 23 95,4         448          
mean 159,0       23,0         95,4         448          
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
6h A11
A12
A13 109 9 72,9         156          
A14 137 15 85,0         229          
A15 132 15 85,2         254          
mean 126,0       13,0         81,0         213          





A20 126 8 66,5         119          
mean 126,0       8,0           66,5         119          
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
0h B1
B2
B3 100 25 86,3         496          
B4 111 29 89,7         543          
B5 115 25 93,4         473          
mean 108,7       26,3         89,8         504          





B10 117 27 90,9         424          
mean 117,0       27,0         90,9         424          
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
6h B11
B12
B13 121 22 89,6         349          
B14 130 24 94,0         374          
B15 142 22 98,6         389          
mean 131,0       22,7         94,1         371          





B20 116 9 74,6         177          
mean 116,0       9,0           74,6         177          
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-02-01-data.xls / Enzyme
EGN-03-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: Group A (untreated / only pre-incubation)
Group B (negative control)
Group C (ferrous sulphate 100 uM)
Slice weights (mg)
time sample weight comments
0h A2 23,6         
A3 45,6         looked very large and thick; two slices stick tohether?
A4 22,5         
A5 23,3         
mean 28,8         
SD 11,2         
3h B1 46,2         looked very large and thick; two slices stick tohether?
B2 21,4         
B3 21,5         
B4 44,4         looked very large and thick; two slices stick tohether?
B5 42,3         looked very large and thick; two slices stick tohether?
B6 20,9         
mean 32,8         
SD 12,7         
6h B7 31,0         
B8 27,9         
B9 FALSE slice missing after incubation
B10 23,1         
mean 27,3         
SD 4,0           
24h B11 21,2         
B12 20,9         
B13 16,1         
B14 16,4         
B15 16,2         
B16 16,8         
mean 17,9         
SD 2,4           
3h C1 22,0         
C2 20,7         
C3 39,0         looked very large and thick; two slices stick tohether?
C4 20,4         
C5 44,3         looked very large and thick; two slices stick tohether?
C6 20,1         
C7 17,5         
mean 26,3         
SD 10,7         
6h C8 21,5         
C9 24,5         
C10 28,8         
C11 27,4         
C12 21,4         
mean 24,7         
SD 3,4           
24h C13 22,9         
C14 23,2         
C15 19,1         
C16 21,1         
C17 18,7         
C18 19,0         
C19 19,9         
mean 20,6         
SD 1,9           
EGN-03-01-data.xls / Weight
EGN-03-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: Group A (untreated / only pre-incubation)
Group B (negative control)
Group C (ferrous sulphate 100 uM)
MTT test (OD-570);  raw data minus background
time sample OD-570 versus weight and v. 24-h neg. (%) slice
3h B5-1 0,921       0,022       31,6 %
B5-2 0,901       0,021       30,9 % 31,3 %
B6-1 1,203       0,058       83,6 %
B6-2 1,166       0,056       81,0 % 82,3 %
mean 1,048       0,039       56,8 % 56,8 %
SD 0,159       0,020       29,5 % 36,1 %
24h B15-1 1,016       0,063       91,1 %
B15-2 0,997       0,062       89,4 % 90,2 %
B16-1 1,295       0,077       111,9 %
B16-2 1,246       0,074       107,7 % 109,8 %
mean 1,139       0,069       100,0 % 100,0 %
SD 0,154       0,008       11,5 % 13,9 %
3h C6-1 1,036       0,052       74,8 %
C6-2 1,026       0,051       74,1 % 74,5 %
C7-1 1,307       0,075       108,4 %
C7-2 1,274       0,073       105,7 % 107,1 %
mean 1,161       0,063       90,8 % 90,8 %
SD 0,150       0,013       18,9 % 23,0 %
24h C18-1 0,640       0,034       48,9 %
C18-2 0,626       0,033       47,8 % 48,4 %
C19-1 1,040       0,052       75,9 %
C19-2 1,012       0,051       73,8 % 74,9 %
mean 0,830       0,042       61,6 % 61,6 %
SD 0,227       0,011       15,3 % 18,7 %
Abs.570nm / mg 
slice wet weight
EGN-03-01-data.xls / MTT
EGN-03-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: Group A (untreated / only pre-incubation)
Group B (negative control)
Group C (ferrous sulphate 100 uM)
background: medium 3 1 0,4 35
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
0h
3h B1 58 37 2,2         1 065     
B2 19 11 1,6         401        
B3 26 14 2,0         442        
B4 69 43 2,6         1 296     
B5 53 32 2,4         990        
B6 27 14 1,6         482        
mean 42,0         25,2        2,1         779        
SD 20,6         13,8        0,4         384        
6h B7 86 40 10,9       1 182     
B8 96 38 15,1       1 193     
B9 FALSE FALSE FALSE FALSE
B10 60 24 11,0       843        
mean 80,7         34,0        12,3       1 073     
SD 18,6         8,7          2,4         199        
24h B11 122 27 29,2       1 194     
B12 114 25 31,1       1 065     
B13 59 14 14,5       552        
B14 56 15 14,1       543        
B15 84 19 18,8       747        
B16 60 13 15,0       540        
mean 82,5         18,8        20,5       774        
SD 29,4         5,9          7,7         290        
3h C1 25 14 2,2         426        
C2 17 9 1,7         324        
C3 62 39 4,2         1 168     
C4 21 9 1,4         405        
C5 56 35 2,0         1 077     
C6 21 11 1,4         444        
C7 15 7 1,1         258        
mean 31,0         17,7        2,0         586        
SD 19,5         13,4        1,0         373        
6h C8 72 28 12,4       989        
C9 63 25 11,8       842        
C10 70 33 9,7         1 114     
C11 68 26 11,8       979        
C12 58 22 8,8         807        
mean 66,2         26,8        10,9       946        
SD 5,7           4,1          1,6         124        
24h C13 179 30 38,0       1 913     
C14 138 23 30,8       1 555     
C15 107 25 24,1       1 034     
C16 138 22 40,5       1 420     
C17 118 23 28,1       1 158     
C18 150 26 40,1       1 329     
C19 103 22 27,4       1 050     
mean 133,3       24,4        32,7       1 351     
SD 26,6         2,9          6,7         314        
EGN-03-01-data.xls / Enzyme
Triton supernatant enzyme activities (U/L);  raw data




A5 67 21 63,8       417        
mean 67,0         21,0        63,8       417        




B4 181 23 99,3       462        
B5
B6
mean 181,0       23,0        99,3       462        




B10 87 18 75,6       350        
mean 87,0         18,0        75,6       350        




B14 109 12 56,3       254        
B15
B16
mean 109,0       12,0        56,3       254        





C5 202 24 100,5     486        
C6
C7
mean 202,0       24,0        100,5     486        





C12 92 17 72,6       332        
mean 92,0         17,0        72,6       332        





C17 98 10 60,8       193        
C18
C19
mean 98,0         10,0        60,8       193        
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-03-01-data.xls / Enzyme
EGN-05-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: Group A (untreated / only pre-incubation)
Group B (negative control)
Group C (ferrous sulphate 100 uM)
Slice weights (mg)
time sample weight comments
0h A2 21,5         
A3 24,8         Regarding all slices:
A4 20,8         Slices were prepared from two livers instead of one,
A5 25,6         and were pooled to some degree before they were
mean 23,2         divided into treatment groups and incubated.
SD 2,4           
3h B1 24,2         
B2 24,4         
B3 23,5         
B4 26,1         
B5 23,0         
B6 22,8         
mean 24,0         
SD 1,2           
6h B7 26,8         
B8 21,1         
B9 22,0         
B10 25,2         
mean 23,8         
SD 2,7           
24h B11 17,2         
B12 18,5         
B13 18,0         
B14 19,2         
B15 19,7         
B16 18,3         
mean 18,5         
SD 0,9           
3h C1 26,4         
C2 19,4         
C3 26,0         
C4 22,7         
C5 23,0         
C6 24,9         
C7 20,9         
mean 23,3         
SD 2,6           
6h C8 35,5         
C9 23,8         
C10 21,7         
C11 27,2         
C12 25,3         
mean 26,7         
SD 5,3           
24h C13 17,4         
C14 16,0         
C15 18,7         
C16 19,3         
C17 16,7         
C18 18,5         
C19 21,4         
mean 18,3         
SD 1,8           
EGN-05-01-data.xls / Weight
EGN-05-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: Group A (untreated / only pre-incubation)
Group B (negative control)
Group C (ferrous sulphate 100 uM)
MTT test (OD-570);  raw data minus background
time sample OD-570 versus weight and v. 24-h neg. (%) slice
3h B5-1 1,410       0,061       91,4 %
B5-2 1,398       0,061       90,7 % 91,1 %
B6-1 1,297       0,057       84,9 %
B6-2 1,274       0,056       83,4 % 84,1 %
mean 1,345       0,059       87,6 % 87,6 %
SD 0,069       0,003       4,1 % 4,9 %
24h B15-1 1,239       0,063       93,8 %
B15-2 1,222       0,062       92,5 % 93,2 %
B16-1 1,324       0,072       107,9 %
B16-2 1,297       0,071       105,7 % 106,8 %
mean 1,271       0,067       100,0 % 100,0 %
SD 0,048       0,005       7,9 % 9,7 %
3h C6-1 1,525       0,061       91,4 %
C6-2 1,488       0,060       89,1 % 90,3 %
C7-1 1,472       0,070       105,1 %
C7-2 1,470       0,070       104,9 % 105,0 %
mean 1,489       0,065       97,6 % 97,6 %
SD 0,025       0,006       8,6 % 10,4 %
24h C18-1 0,887       0,048       71,5 %
C18-2 0,878       0,047       70,8 % 71,2 %
C19-1 1,017       0,048       70,9 %
C19-2 0,989       0,046       68,9 % 69,9 %
mean 0,943       0,047       70,5 % 70,5 %
SD 0,071       0,001       1,1 % 0,9 %
Abs.570nm / mg 
slice wet weight
EGN-05-01-data.xls / MTT
EGN-05-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: Group A (untreated / only pre-incubation)
Group B (negative control)
Group C (ferrous sulphate 100 uM)
background: medium 4 0 59
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
0h
3h B1 36 13 2,7         465        
B2 39 16 2,5         526        
B3 45 16 2,2         566        
B4 48 20 3,1         646        
B5 25 13 1,9         403        
B6 35 25 1,8         480        
mean 38,0         17,2        2,4         514        
SD 8,1           4,6          0,5         85          
6h B7 47 23 5,0         647        
B8 47 24 6,0         571        
B9 48 25 7,1         572        
B10 59 37 5,6         842        
mean 50,3         27,3        5,9         658        
SD 5,9           6,6          0,9         128        
24h B11 98 37 20,5       793        
B12 99 36 25,0       821        
B13 87 32 22,7       676        
B14 71 27 14,4       535        
B15 81 28 16,3       669        
B16 60 21 14,2       488        
mean 82,7         30,2        18,9       664        
SD 15,3         6,0          4,5         133        
3h C1 37 16 2,5         513        
C2 24 9 1,6         316        
C3 40 28 2,0         545        
C4 35 15 1,6         512        
C5 41 17 2,0         559        
C6 37 13 2,1         524        
C7 36 14 2,1         464        
mean 35,7         16,0        2,0         490        
SD 5,6           5,9          0,3         83          
6h C8 80 47 13,3       949        
C9 47 24 7,2         550        
C10 54 26 8,7         558        
C11 60 36 6,4         787        
C12 66 36 11,3       703        
mean 61,4         33,8        9,4         709        
SD 12,6         9,2          2,9         167        
24h C13 119 47 25,7       1 003     
C14 78 30 19,6       605        
C15 92 35 21,9       785        
C16 68 27 15,1       584        
C17 139 60 26,5       1 171     
C18 190 75 37,6       1 689     
C19 122 44 21,8       1 059     
mean 115,4       45,4        24,0       985        
SD 41,6         17,2        7,1         383        
EGN-05-01-data.xls / Enzyme
Triton supernatant enzyme activities (U/L);  raw data




A5 102 44 76,3       564        
mean 102,0       44,0        76,3       564        




B4 100 39 75,4       399        
B5
B6
mean 100,0       39,0        75,4       399        




B10 111 45 77,3       312        
mean 111,0       45,0        77,3       312        




B14 125 46 74,9       299        
B15
B16
mean 125,0       46,0        74,9       299        





C5 104 40 64,1       348        
C6
C7
mean 104,0       40,0        64,1       348        





C12 100 46 74,2       322        
mean 100,0       46,0        74,2       322        





C17 155 48 82,5       271        
C18
C19
mean 155,0       48,0        82,5       271        
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-05-01-data.xls / Enzyme
EGN-06-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.)
C (24h pos.ctrl.; menadione 200 uM)
D (24h FeSO4 100 uM)
E (24h FeSO4 200 uM)
F (24h FeSO4 400 uM)
Slice weights (n=6 or 7) mg
Treatment category (untreated, neAnalysis category (histology n=9, triton n=6, iron n=12, MTT n=12)
sample weight sample weight
A histology
A2 15,1         A2 15,1       
A3 19,3         B2 16,9       
A4 17,1         C2 20,0       
A5 21,7         D1 19,3       
A6 17,6         D2 16,5       
A7 16,6         E1 17,9       
mean 17,9         E2 19,5       
SD 2,3           F1 19,8       
B B2 16,9         F2 19,3       
B3 16,6         mean 18,3       
B4 18,7         SD 1,7         
B5 14,1         triton A5 21,7       
B6 15,7         B5 14,1       
B7 14,9         C5 22,9       
mean 16,2         D5 14,2       
SD 1,6           E5 16,3       
C C2 20,0         F5 15,2       
C3 20,1         mean 17,4       
C4 20,3         SD 3,9         
C5 22,9         iron A3 19,3       
C6 20,3         A4 17,1       
C7 17,9         B3 16,6       
mean 20,3         B4 18,7       
SD 1,6           C3 20,1       
D D1 19,3         C4 20,3       
D2 16,5         D3 19,9       
D3 19,9         D4 13,3       
D4 13,3         E3 16,4       
D5 14,2         E4 19,5       
D6 14,8         F3 16,1       
D7 18,6         F4 15,6       
mean 16,7         mean 17,7       
SD 2,6           SD 2,2         
E E1 17,9         MTT A6 17,6       
E2 19,5         A7 16,6       
E3 16,4         B6 15,7       
E4 19,5         B7 14,9       
E5 16,3         C6 20,3       
E6 16,2         C7 17,9       
E7 15,7         D6 14,8       
mean 17,4         D7 18,6       
SD 1,6           E6 16,2       
F F1 19,8         E7 15,7       
F2 19,3         F6 17,1       
F3 16,1         F7 15,8       
F4 15,6         mean 16,8       
F5 15,2         SD 1,6         
F6 17,1         
F7 15,8         
mean 17,0         
SD 1,9           
EGN-06-01-data.xls / Weight
EGN-06-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.)
C (24h pos.ctrl.; menadione 200 uM)
D (24h FeSO4 100 uM)
E (24h FeSO4 200 uM)
F (24h FeSO4 400 uM)
Comment: The isopropanol extract of slice B6 had partly evaporated (about 1/3 was missing), and
the MTT-value was too high.  The cause of the evaporation has not been established.
MTT test (n=2; each with 2 parallels) (B: n=1; with 2 parallels)
time sample OD-570 versus weight and v. 24-h neg. (%) slice
0h A6-1 1,210       0,069       93,6 %
A6-2 1,175       0,067       90,9 % 92,2 %
A7-1 1,321       0,080       108,3 %
A7-2 1,297       0,078       106,4 % 107,4 %
mean 1,264       0,073       99,8 % 99,8 %
SD 0,078       0,006       8,8 % 10,7 %
24h B6-1 FALSE 1,783       FALSE FALSE
B6-2 FALSE 1,724       FALSE FALSE FALSE
B7-1 1,090       0,073       99,6 %
B7-2 1,099       0,074       100,4 % 100,0 %
mean 1,095       0,073       100,0 % 100,0 %
SD 0,006       0,000       0,6 % #DIV/0!
24h C6-1 0,343       0,017       23,0 %
C6-2 0,338       0,017       22,7 % 22,8 %
C7-1 0,410       0,023       31,2 %
C7-2 0,405       0,023       30,8 % 31,0 %
mean 0,384       0,020       26,9 % 26,9 %
SD 0,040       0,003       4,7 % 5,8 %
24h D6-1 1,200       0,081       110,4 %
D6-2 1,166       0,079       107,3 % 108,8 %
D7-1 1,096       0,059       80,2 %
D7-2 1,086       0,058       79,5 % 79,9 %
mean 1,116       0,069       94,3 % 94,3 %
SD 0,044       0,012       16,8 % 20,5 %
24h E6-1 1,053       0,065       88,5 %
E6-2 1,052       0,065       88,4 % 88,4 %
E7-1 1,480       0,094       128,3 %
E7-2 1,448       0,092       125,6 % 126,9 %
mean 1,258       0,079       107,7 % 107,7 %
SD 0,238       0,016       22,3 % 27,2 %
24h F6-1 1,296       0,076       103,2 %
F6-2 1,294       0,076       103,0 % 103,1 %
F7-1 1,296       0,082       111,7 %
F7-2 1,294       0,082       111,5 % 111,6 %
mean 1,295       0,079       107,3 % 107,3 %
SD 0,001       0,004       4,9 % 6,0 %
Abs.570nm / mg 
slice wet weight
EGN-06-01-data.xls / MTT
EGN-06-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.) Titles: Culture media 
B (24h neg.ctrl.) activities 
C (24h pos.ctrl.; menadione 200 uM) leakage 
D (24h FeSO4 100 uM) (n=4, 5, 6, or 7) 
E (24h FeSO4 200 uM) U/L
F (24h FeSO4 400 uM) % of total 
background: medium 3 0 0,2         43
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
0h
24h B2 66            16           11,8       513        
B3 58            14           11,9       408        
B4 108          22           26,1       668        
B5 38            9             5,2         316        
B6 70            12           15,3       463        
B7 70            14           17,2       517        
mean 68,3         14,5        14,6       480,8     
SD 22,9         4,4          7,0         118,5     
24h C2 94            11           14,1       1 255     
C3 106          17           11,4       1 349     
C4 118          17           12,8       1 293     
C5 100          16           12,4       1 443     
C6 94            10           8,4         1 304     
C7 101          12           10,0       1 173     
mean 102,2       13,8        11,5       1 302,8  
SD 9,0           3,2          2,1         90,6       
24h D1 63            12           12,0       400        
D2 93            18           18,3       657        
D3 143          26           36,9       897        
D4 79            18           21,5       595        
D5 74            16           15,6       494        
D6 88            22           15,9       579        
D7 113          21           25,0       803        
mean 93,3         19,0        20,7       632,1     
SD 27,0         4,5          8,3         171,8     
24h E1 106          16           27,0       543        
E2 113          20           32,5       647        
E3 127          24           30,3       695        
E4 125          25           27,0       814        
E5 65            12           13,7       365        
E6 105          17           26,7       629        
E7 66            12           13,5       311        
mean 101,0       18,0        24,4       572,0     
SD 25,7         5,3          7,7         180,0     
24h F1 140          25           32,3       895        
F2 72            15           15,1       388        
F3 100          23           20,6       604        
F4 87            20           17,6       513        
F5 103          20           27,3       672        
F6 101          19           24,4       533        
F7 64            12           15,0       359        
mean 95,3         19,1        21,8       566,3     
SD 24,8         4,5          6,6         182,3     
EGN-06-01-data.xls / Enzyme
Culture media ASAT activities (n=4, 5, 6, or 7)ASAT leakage (n=4, 5, 6, or 7) % of total ASAT
Culture media ALAT activities (n=4, 5, 6, or 7)ALAT leakage (n=4, 5, 6, or 7) % of total ALAT
Culture media GLDH activities (n=4, 5, 6, or 7 GLDH leakage (n=4, 5, 6, or 7) % of total GLDH
Culture media LDH activities (n=4, 5, 6, or 7) LDH leakage (n=4, 5, 6, or 7) % of total LDH
Comment: Noise occurred while measuring triton values of slice E5, thus omitted.
Triton supernatant enzyme activities (n=1) (E: n=0; values are calculated as averages of D and F)
Triton supernatant enzyme activities (U/L);  raw data





A5 91            29           66,1       387        
A6
A7
mean 91,0         29,0        66,1       387,0     




B5 108          15           34,8       156        
B6
B7
mean 108,0       15,0        34,8       156,0     




C5 81            9             37,0       98          
C6
C7
mean 81,0         9,0          37,0       98,0       





D5 95            14           26,1       151        
D6
D7
mean 95,0         14,0        26,1       151,0     





E5 116          16           57,1       261        
E6
E7
mean 91,5         12,5        20,1       153,5     





F5 88            11           14,1       156        
F6
F7
mean 88,0         11,0        14,1       156,0     
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-06-01-data.xls / Enzyme
EGN-07-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.)
C (24h pos.ctrl.; menadione 200 uM)
D (24h FeSO4 100 uM)
E (24h FeSO4 200 uM)
F (24h FeSO4 400 uM)
Slice weights (n=6 or 7) mg
Treatment category (untreated, neAnalysis category (histology n=9, triton n=6, iron n=12, MTT n=12)
sample weight sample weight
A histology
A2 29,9         A2 29,9       
A3 27,0         B2 23,9       
A4 26,4         C2 26,2       
A5 28,6         D1 24,5       
A6 28,4         D2 21,6       
A7 29,6         E1 26,5       
mean 28,3         E2 23,1       
SD 1,4           F1 26,8       
B B2 23,9         F2 25,8       
B3 24,1         mean 25,4       
B4 21,5         SD 2,4         
B5 23,6         triton A5 28,6       
B6 23,1         B5 23,6       
B7 18,8         C5 29,4       
mean 22,5         D5 24,9       
SD 2,0           E5 28,6       
C C2 26,2         F5 25,1       
C3 33,6         mean 26,7       
C4 32,8         SD 2,4         
C5 29,4         iron A3 27,0       
C6 29,7         A4 26,4       
C7 24,7         B3 24,1       
mean 29,4         B4 21,5       
SD 3,5           C3 33,6       
D D1 24,5         C4 32,8       
D2 21,6         D3 23,5       
D3 23,5         D4 23,9       
D4 23,9         E3 20,7       
D5 24,9         E4 16,2       
D6 22,6         F3 21,9       
D7 19,4         F4 23,1       
mean 22,9         mean 24,6       
SD 1,9           SD 4,9         
E E1 26,5         MTT A6 28,4       
E2 23,1         A7 29,6       
E3 20,7         B6 23,1       
E4 16,2         B7 18,8       
E5 28,6         C6 29,7       
E6 23,5         C7 24,7       
E7 23,7         D6 22,6       
mean 23,2         D7 19,4       
SD 4,0           E6 23,5       
F F1 26,8         E7 23,7       
F2 25,8         F6 22,2       
F3 21,9         F7 22,3       
F4 23,1         mean 24,0       
F5 25,1         SD 3,6         
F6 22,2         
F7 22,3         
mean 23,9         
SD 2,0           
EGN-07-01-data.xls / Weight
EGN-07-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.)
C (24h pos.ctrl.; menadione 200 uM)
D (24h FeSO4 100 uM)
E (24h FeSO4 200 uM)
F (24h FeSO4 400 uM)
MTT test (n=2; each with 2 parallels)
time sample OD-570 versus weight and v. 24-h neg. (%) slice
0h A6-1 1,011       0,036       115,6 %
A6-2 0,968       0,034       110,7 % 113,1 %
A7-1 0,856       0,029       93,9 %
A7-2 0,859       0,029       94,2 % 94,1 %
mean 0,894       0,032       103,6 % 103,6 %
SD 0,064       0,003       11,2 % 13,5 %
24h B6-1 0,786       0,034       110,5 %
B6-2 0,779       0,034       109,5 % 110,0 %
B7-1 0,519       0,028       89,6 %
B7-2 0,523       0,028       90,3 % 90,0 %
mean 0,607       0,031       100,0 % 100,0 %
SD 0,149       0,004       11,6 % 14,1 %
24h C6-1 0,457       0,015       50,0 %
C6-2 0,442       0,015       48,3 % 49,1 %
C7-1 0,313       0,013       41,2 %
C7-2 0,312       0,013       41,0 % 41,1 %
mean 0,356       0,014       45,1 % 45,1 %
SD 0,075       0,001       4,7 % 5,7 %
24h D6-1 0,885       0,039       127,2 %
D6-2 0,853       0,038       122,6 % 124,9 %
D7-1 0,568       0,029       95,1 %
D7-2 0,555       0,029       92,9 % 94,0 %
mean 0,659       0,034       109,4 % 109,4 %
SD 0,168       0,006       17,9 % 21,8 %
24h E6-1 0,916       0,039       126,6 %
E6-2 0,915       0,039       126,4 % 126,5 %
E7-1 0,520       0,022       71,3 %
E7-2 0,504       0,021       69,1 % 70,2 %
mean 0,714       0,030       98,3 % 98,3 %
SD 0,233       0,010       32,5 % 39,8 %
24h F6-1 0,537       0,024       78,6 %
F6-2 0,526       0,024       76,9 % 77,7 %
F7-1 0,796       0,036       115,9 %
F7-2 0,767       0,034       111,7 % 113,8 %
mean 0,657       0,029       95,8 % 95,8 %
SD 0,145       0,006       20,9 % 25,5 %
Abs.570nm / mg 
slice wet weight
EGN-07-01-data.xls / MTT
EGN-07-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.) Titles: Culture media 
B (24h neg.ctrl.) activities 
C (24h pos.ctrl.; menadione 200 uM) leakage 
D (24h FeSO4 100 uM) (n=4, 5, 6, or 7) 
E (24h FeSO4 200 uM) U/L
F (24h FeSO4 400 uM) % of total 
background: medium 0 3 0,1         46
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
0h
24h B2 130          22           37,7       1 368     
B3 131          28           26,4       1 536     
B4 91            8             19,6       1 012     
B5 137          29           32,7       1 093     
B6 97            19           21,5       1 027     
B7 63            14           12,5       550        
mean 108,2       20,0        25,1       1 097,7  
SD 29,3         8,1          9,2         339,9     
24h C2 102          16           12,5       1 753     
C3 111          14           17,8       2 156     
C4 127          16           23,1       2 071     
C5 106          16           16,7       2 238     
C6 106          21           13,6       1 741     
C7 98            11           14,1       1 704     
mean 108,3       15,7        16,3       1 943,8  
SD 10,1         3,3          3,9         237,8     
24h D1 111          29           25,7       1 300     
D2 121          26           31,3       1 236     
D3 126          22           33,6       1 220     
D4 122          27           22,1       1 172     
D5 139          34           33,5       1 591     
D6 111          22           27,5       1 127     
D7 78            22           17,1       824        
mean 115,4       26,0        27,3       1 210,0  
SD 19,1         4,5          6,2         227,8     
24h E1 139          34           32,2       1 495     
E2 153          38           35,1       1 354     
E3 98            27           22,5       1 067     
E4 95            20           18,9       910        
E5 158          28           39,8       1 944     
E6 155          28           39,8       1 392     
E7 131          25           30,7       1 499     
mean 132,7       28,6        31,3       1 380,1  
SD 26,5         5,9          8,1         333,0     
24h F1 138          32           32,6       1 708     
F2 170          32           44,2       1 486     
F3 119          28           25,4       1 145     
F4 141          32           33,2       1 494     
F5 155          31           36,8       1 503     
F6 139          29           31,4       1 462     
F7 137          29           29,0       1 157     
mean 142,7       30,4        33,2       1 422,1  
SD 16,0         1,7          6,0         202,6     
EGN-07-01-data.xls / Enzyme
Culture media ASAT activities (n=4, 5, 6, or 7)ASAT leakage (n=4, 5, 6, or 7) % of total ASAT
Culture media ALAT activities (n=4, 5, 6, or 7)ALAT leakage (n=4, 5, 6, or 7) % of total ALAT
Culture media GLDH activities (n=4, 5, 6, or 7 GLDH leakage (n=4, 5, 6, or 7) % of total GLDH
Culture media LDH activities (n=4, 5, 6, or 7) LDH leakage (n=4, 5, 6, or 7) % of total LDH
Triton supernatant enzyme activities (n=1)
Triton supernatant enzyme activities (U/L);  raw data





A5 100          32           74,5       604        
A6
A7
mean 100,0       32,0        74,5       604,0     




B5 111          13           63,2       273        
B6
B7
mean 111,0       13,0        63,2       273,0     




C5 99            7             41,9       106        
C6
C7
mean 99,0         7,0          41,9       106,0     





D5 109          10           52,9       182        
D6
D7
mean 109,0       10,0        52,9       182,0     





E5 93            6             42,7       111        
E6
E7
mean 93,0         6,0          42,7       111,0     





F5 102          10           49,5       158        
F6
F7
mean 102,0       10,0        49,5       158,0     
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-07-01-data.xls / Enzyme
EGN-09-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.) Comments: A7 had a small and uneven
C (24h pos.ctrl.; menadione 200 uM) diameter, which may explain
D (24h FeSO4 0.200 mM) the low weight and possibly
E (24h FeSO4 1.00 mM) other deviant parameters.
F (24h FeSO4 5.00 mM)
Slice weights (n=6 or 7) mg
Treatment category (untreated, neAnalysis category (histology n=9, triton n=6, iron n=12, MTT n=12)
sample weight sample weight
A histology
A2 32,2         A2 32,2       
A3 29,9         B2 25,3       
A4 33,4         C2 26,5       
A5 32,9         D1 23,0       
A6 28,5         D2 25,5       
A7 22,2         E1 33,6       
mean 29,9         E2 25,0       
SD 4,2           F1 24,1       
B B2 25,3         F2 30,7       
B3 25,1         mean 27,3       
B4 24,3         SD 3,8         
B5 24,8         triton A5 32,9       
B6 21,7         B5 24,8       
B7 23,9         C5 28,9       
mean 24,2         D5 24,4       
SD 1,3           E5 26,5       
C C2 26,5         F5 25,7       
C3 24,7         mean 27,2       
C4 28,8         SD 3,2         
C5 28,9         iron A3 29,9       
C6 27,3         A4 33,4       
C7 23,2         B3 25,1       
mean 26,6         B4 24,3       
SD 2,3           C3 24,7       
D D1 23,0         C4 28,8       
D2 25,5         D3 20,4       
D3 20,4         D4 24,8       
D4 24,8         E3 28,0       
D5 24,4         E4 29,5       
D6 17,9         F3 25,3       
D7 29,1         F4 25,9       
mean 23,6         mean 26,7       
SD 3,6           SD 3,4         
E E1 33,6         MTT A6 28,5       
E2 25,0         A7 22,2       
E3 28,0         B6 21,7       
E4 29,5         B7 23,9       
E5 26,5         C6 27,3       
E6 26,9         C7 23,2       
E7 23,3         D6 17,9       
mean 27,5         D7 29,1       
SD 3,3           E6 26,9       
F F1 24,1         E7 23,3       
F2 30,7         F6 26,1       
F3 25,3         F7 29,5       
F4 25,9         mean 25,0       
F5 25,7         SD 3,5         
F6 26,1         
F7 29,5         
mean 26,8         
SD 2,4           
EGN-09-01-data.xls / Weight
EGN-09-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.)
C (24h pos.ctrl.; menadione 200 uM)
D (24h FeSO4 0.200 mM)
E (24h FeSO4 1.00 mM)
F (24h FeSO4 5.00 mM)
MTT test (n=2; each with 2 parallels)
time sample OD-570 versus weight and v. 24-h neg. (%) slice
0h A6-1 1,434       0,050       165,9 %
A6-2 1,394       0,049       161,3 % 163,6 %
A7-1 0,683       0,031       101,5 %
A7-2 0,674       0,030       100,1 % 100,8 %
mean 0,917       0,040       132,2 % 132,2 %
SD 0,413       0,011       36,3 % 44,4 %
24h B6-1 0,727       0,034       110,5 %
B6-2 0,704       0,032       107,0 % 108,7 %
B7-1 0,673       0,028       92,9 %
B7-2 0,650       0,027       89,7 % 91,3 %
mean 0,676       0,030       100,0 % 100,0 %
SD 0,027       0,003       10,3 % 12,3 %
24h C6-1 0,243       0,009       29,4 %
C6-2 0,232       0,008       28,0 % 28,7 %
C7-1 0,228       0,010       32,4 %
C7-2 0,219       0,009       31,1 % 31,8 %
mean 0,226       0,009       30,2 % 30,2 %
SD 0,007       0,001       1,9 % 2,2 %
24h D6-1 0,744       0,042       137,1 %
D6-2 0,753       0,042       138,7 % 137,9 %
D7-1 0,236       0,008       26,7 %
D7-2 0,230       0,008       26,1 % 26,4 %
mean 0,406       0,025       82,1 % 82,1 %
SD 0,300       0,020       64,4 % 78,8 %
24h E6-1 0,448       0,017       54,9 %
E6-2 0,442       0,016       54,2 % 54,6 %
E7-1 0,701       0,030       99,2 %
E7-2 0,695       0,030       98,4 % 98,8 %
mean 0,572       0,023       76,7 % 76,7 %
SD 0,146       0,008       25,5 % 31,3 %
24h F6-1 0,346       0,013       43,7 %
F6-2 0,343       0,013       43,3 % 43,5 %
F7-1 0,381       0,013       42,6 %
F7-2 0,375       0,013       41,9 % 42,3 %
mean 0,361       0,013       42,9 % 42,9 %
SD 0,020       0,000       0,8 % 0,9 %
Abs.570nm / mg 
slice wet weight
EGN-09-01-data.xls / MTT
EGN-09-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.) Titles: Culture media 
B (24h neg.ctrl.) activities 
C (24h pos.ctrl.; menadione 200 uM) leakage 
D (24h FeSO4 0.200 mM) (n=4, 5, 6, or 7) 
E (24h FeSO4 1.00 mM) U/L
F (24h FeSO4 5.00 mM) % of total 
background: medium 5 1 0,3         56
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
0h
24h B2 166          47           34,7       1 917     
B3 137          41           25,3       1 600     
B4 168          43           39,0       1 702     
B5 114          36           28,6       1 551     
B6 101          30           18,2       1 242     
B7 130          29           21,9       1 547     
mean 136,0       37,7        28,0       1 593,2  
SD 27,1         7,3          7,8         220,9     
24h C2 102          32           3,6         1 905     
C3 87            23           5,2         1 626     
C4 118          23           6,6         1 903     
C5 119          32           8,9         2 091     
C6 23            7             3,3         1 640     
C7 109          21           6,0         1 726     
mean 93,0         23,0        5,6         1 815,2  
SD 36,3         9,2          2,1         182,4     
24h D1 153          41           34,2       1 586     
D2 122          39           25,7       1 605     
D3 127          30           22,3       1 289     
D4 143          44           31,8       1 541     
D5 127          43           27,1       1 520     
D6 93            30           16,6       1 014     
D7 178          41           37,6       2 070     
mean 134,7       38,3        27,9       1 517,9  
SD 26,8         5,9          7,2         322,5     
24h E1 172          52           39,4       2 580     
E2 174          42           37,6       1 871     
E3 155          42           36,6       1 876     
E4 167          43           41,2       2 145     
E5 148          36           34,4       1 735     
E6 136          34           25,6       1 588     
E7 133          28           21,0       1 512     
mean 155,0       39,6        33,7       1 901,0  
SD 16,8         7,7          7,5         364,9     
24h F1 219          40           66,8       1 481     
F2 207          49           58,3       1 678     
F3 192          37           55,4       1 443     
F4 195          41           53,1       1 433     
F5 193          45           51,0       1 592     
F6 193          36           46,8       1 563     
F7 216          34           55,8       1 703     
mean 202,1       40,3        55,3       1 556,1  
SD 11,7         5,3          6,3         109,1     
EGN-09-01-data.xls / Enzyme
Culture media ASAT activities (n=4, 5, 6, or 7)ASAT leakage (n=4, 5, 6, or 7) % of total ASAT
Culture media ALAT activities (n=4, 5, 6, or 7)ALAT leakage (n=4, 5, 6, or 7) % of total ALAT
Culture media GLDH activities (n=4, 5, 6, or 7 GLDH leakage (n=4, 5, 6, or 7) % of total GLDH
Culture media LDH activities (n=4, 5, 6, or 7) LDH leakage (n=4, 5, 6, or 7) % of total LDH
Triton supernatant enzyme activities (n=1)
Triton supernatant enzyme activities (U/L);  raw data





A5 125          29           86,9       578        
A6
A7
mean 125,0       29,0        86,9       578,0     




B5 105          7             41,6       345        
B6
B7
mean 105,0       7,0          41,6       345,0     




C5 89            6             22,2       86          
C6
C7
mean 89,0         6,0          22,2       86,0       





D5 104          7             34,6       176        
D6
D7
mean 104,0       7,0          34,6       176,0     





E5 107          8             32,5       129        
E6
E7
mean 107,0       8,0          32,5       129,0     





F5 84            7             23,6       93          
F6
F7
mean 84,0         7,0          23,6       93,0       
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-09-01-data.xls / Enzyme
EGN-10-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.)
C (24h pos.ctrl.; menadione 200 uM)
D (24h FeSO4 0.200 mM)
E (24h FeSO4 1.00 mM)
F (24h FeSO4 5.00 mM)
Slice weights (n=6 or 7) mg
Treatment category (untreated, neAnalysis category (histology n=9, triton n=6, iron n=12, MTT n=12)
sample weight sample weight
A histology
A2 21,7         A2 21,7       
A3 26,3         B2 16,6       
A4 28,7         C2 20,3       
A5 23,0         D1 17,5       
A6 28,1         D2 17,2       
A7 25,2         E1 19,2       
mean 25,5         E2 17,4       
SD 2,8           F1 22,6       
B B2 16,6         F2 14,5       
B3 17,5         mean 18,6       
B4 19,5         SD 2,6         
B5 15,3         triton A5 23,0       
B6 16,6         B5 15,3       
B7 20,6         C5 20,3       
mean 17,7         D5 21,2       
SD 2,0           E5 16,8       
C C2 20,3         F5 20,0       
C3 22,2         mean 19,4       
C4 24,4         SD 2,9         
C5 20,3         iron A3 26,3       
C6 20,5         A4 28,7       
C7 24,4         B3 17,5       
mean 22,0         B4 19,5       
SD 2,0           C3 22,2       
D D1 17,5         C4 24,4       
D2 17,2         D3 19,3       
D3 19,3         D4 20,8       
D4 20,8         E3 21,1       
D5 21,2         E4 18,2       
D6 20,1         F3 21,8       
D7 14,3         F4 18,7       
mean 18,6         mean 21,5       
SD 2,4           SD 3,4         
E E1 19,2         MTT A6 28,1       
E2 17,4         A7 25,2       
E3 21,1         B6 16,6       
E4 18,2         B7 20,6       
E5 16,8         C6 20,5       
E6 20,4         C7 24,4       
E7 15,7         D6 20,1       
mean 18,4         D7 14,3       
SD 2,0           E6 20,4       
F F1 22,6         E7 15,7       
F2 14,5         F6 18,3       
F3 21,8         F7 21,0       
F4 18,7         mean 20,4       
F5 20,0         SD 4,0         
F6 18,3         
F7 21,0         
mean 19,6         
SD 2,7           
EGN-10-01-data.xls / Weight
EGN-10-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.)
C (24h pos.ctrl.; menadione 200 uM)
D (24h FeSO4 0.200 mM)
E (24h FeSO4 1.00 mM)
F (24h FeSO4 5.00 mM)
MTT test (n=2; each with 2 parallels)
time sample OD-570 versus weight and v. 24-h neg. (%) slice
0h A6-1 0,964       0,034       66,4 %
A6-2 0,934       0,033       64,3 % 65,4 %
A7-1 1,310       0,052       100,6 %
A7-2 1,285       0,051       98,7 % 99,6 %
mean 1,176       0,043       82,5 % 82,5 %
SD 0,210       0,010       19,8 % 24,2 %
24h B6-1 0,793       0,048       92,4 %
B6-2 0,788       0,047       91,9 % 92,2 %
B7-1 1,164       0,057       109,3 %
B7-2 1,132       0,055       106,3 % 107,8 %
mean 1,028       0,052       100,0 % 100,0 %
SD 0,208       0,005       9,1 % 11,1 %
24h C6-1 0,604       0,029       57,0 %
C6-2 0,597       0,029       56,4 % 56,7 %
C7-1 0,538       0,022       42,7 %
C7-2 0,526       0,022       41,7 % 42,2 %
mean 0,554       0,026       49,4 % 49,4 %
SD 0,038       0,004       8,4 % 10,2 %
24h D6-1 0,788       0,039       75,9 %
D6-2 0,774       0,039       74,5 % 75,2 %
D7-1 0,706       0,049       95,5 %
D7-2 0,691       0,048       93,5 % 94,5 %
mean 0,724       0,044       84,9 % 84,9 %
SD 0,044       0,006       11,2 % 13,7 %
24h E6-1 0,868       0,043       82,3 %
E6-2 0,864       0,042       82,0 % 82,2 %
E7-1 0,993       0,063       122,4 %
E7-2 0,961       0,061       118,5 % 120,4 %
mean 0,922       0,052       101,3 % 101,3 %
SD 0,065       0,011       22,2 % 27,1 %
24h F6-1 0,852       0,047       90,1 %
F6-2 0,848       0,046       89,7 % 89,9 %
F7-1 0,855       0,041       78,8 %
F7-2 0,840       0,040       77,4 % 78,1 %
mean 0,849       0,043       84,0 % 84,0 %
SD 0,007       0,004       6,8 % 8,3 %
Abs.570nm / mg 
slice wet weight
EGN-10-01-data.xls / MTT
EGN-10-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.) Titles: Culture media 
B (24h neg.ctrl.) activities 
C (24h pos.ctrl.; menadione 200 uM) leakage 
D (24h FeSO4 0.200 mM) (n=4, 5, 6, or 7) 
E (24h FeSO4 1.00 mM) U/L
F (24h FeSO4 5.00 mM) % of total 
background: medium 2 1 0,1         49
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
0h
24h B2 83            11           18,1       671        
B3 94            14           21,4       759        
B4 102          15           16,1       1 075     
B5 82            11           18,9       655        
B6 139          13           40,7       934        
B7 132          14           23,8       1 145     
mean 105,3       13,0        23,2       873,2     
SD 24,6         1,7          9,0         209,7     
24h C2 104          10           12,1       1 357     
C3 104          9             12,8       1 422     
C4 116          10           15,9       1 624     
C5 103          10           12,5       1 302     
C6 93            9             9,6         1 372     
C7 120          11           12,2       1 572     
mean 106,7       9,8          12,5       1 441,5  
SD 9,8           0,8          2,0         128,2     
24h D1 115          12           22,1       918        
D2 159          19           33,6       1 257     
D3 218          18           62,9       1 345     
D4 148          16           30,6       1 345     
D5 133          16           30,0       1 129     
D6 104          13           22,7       967        
D7 78            11           14,5       682        
mean 136,4       15,0        30,9       1 091,9  
SD 45,2         3,1          15,5       248,5     
24h E1 117          16           25,0       861        
E2 115          15           25,8       927        
E3 169          19           38,9       1 146     
E4 127          17           28,8       1 078     
E5 136          15           35,3       993        
E6 147          18           32,5       1 083     
E7 79            11           17,5       622        
mean 127,1       15,9        29,1       958,6     
SD 28,3         2,6          7,2         177,9     
24h F1 259          26           70,1       1 452     
F2 129          14           32,2       792        
F3 246          26           57,7       1 413     
F4 231          23           63,1       1 254     
F5 158          20           37,7       1 058     
F6 239          17           67,0       1 174     
F7 193          19           49,5       1 072     
mean 207,9       20,7        53,9       1 173,6  
SD 49,2         4,5          14,6       227,5     
EGN-10-01-data.xls / Enzyme
Culture media ASAT activities (n=4, 5, 6, or 7)ASAT leakage (n=4, 5, 6, or 7) % of total ASAT
Culture media ALAT activities (n=4, 5, 6, or 7)ALAT leakage (n=4, 5, 6, or 7) % of total ALAT
Culture media GLDH activities (n=4, 5, 6, or 7 GLDH leakage (n=4, 5, 6, or 7) % of total GLDH
Culture media LDH activities (n=4, 5, 6, or 7) LDH leakage (n=4, 5, 6, or 7) % of total LDH
Triton supernatant enzyme activities (n=1)
Triton supernatant enzyme activities (U/L);  raw data





A5 85            19           42,8       457        
A6
A7
mean 85,0         19,0        42,8       457,0     




B5 68            7             4,4         152        
B6
B7
mean 68,0         7,0          4,4         152,0     




C5 79            6             28,7       113        
C6
C7
mean 79,0         6,0          28,7       113,0     





D5 107          7             42,7       211        
D6
D7
mean 107,0       7,0          42,7       211,0     





E5 79            6             30,8       151        
E6
E7
mean 79,0         6,0          30,8       151,0     





F5 100          7             29,1       186        
F6
F7
mean 100,0       7,0          29,1       186,0     
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-10-01-data.xls / Enzyme
EGN-11-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.) Comments: E2 was weighed but the
C (24h pos.ctrl.; menadione 200 uM) value was not recorded
D (24h FeSO4 0.200 mM) due to some distraction
E (24h FeSO4 1.00 mM)
F (24h FeSO4 5.00 mM)
Slice weights (n=6 or 7) mg
Treatment category (untreated, neAnalysis category (histology n=9, triton n=6, iron n=12, MTT n=12)
sample weight sample weight
A histology
A2 28,8         A2 28,8       
A3 31,9         B2 25,0       
A4 26,3         C2 26,2       
A5 25,2         D1 25,6       
A6 25,3         D2 21,3       
A7 26,1         E1 23,4       
mean 27,3         E2 FALSE
SD 2,6           F1 28,5       
B B2 25,0         F2 22,7       
B3 19,5         mean 25,2       
B4 22,2         SD 2,7         
B5 18,3         triton A5 25,2       
B6 16,8         B5 18,3       
B7 17,0         C5 25,1       
mean 19,8         D5 21,2       
SD 3,2           E5 25,5       
C C2 26,2         F5 26,5       
C3 25,6         mean 23,6       
C4 21,6         SD 3,2         
C5 25,1         iron A3 31,9       
C6 24,5         A4 26,3       
C7 20,3         B3 19,5       
mean 23,9         B4 22,2       
SD 2,4           C3 25,6       
D D1 25,6         C4 21,6       
D2 21,3         D3 22,6       
D3 22,6         D4 20,3       
D4 20,3         E3 24,0       
D5 21,2         E4 25,0       
D6 18,4         F3 26,9       
D7 16,1         F4 23,5       
mean 20,8         mean 24,1       
SD 3,0           SD 3,4         
E E1 23,4         MTT A6 25,3       
E2 FALSE A7 26,1       
E3 24,0         B6 16,8       
E4 25,0         B7 17,0       
E5 25,5         C6 24,5       
E6 21,7         C7 20,3       
E7 19,2         D6 18,4       
mean 23,1         D7 16,1       
SD 2,3           E6 21,7       
F F1 28,5         E7 19,2       
F2 22,7         F6 20,5       
F3 26,9         F7 18,6       
F4 23,5         mean 20,4       
F5 26,5         SD 3,4         
F6 20,5         
F7 18,6         
mean 23,9         
SD 3,6           
EGN-11-01-data.xls / Weight
EGN-11-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.)
C (24h pos.ctrl.; menadione 200 uM)
D (24h FeSO4 0.200 mM)
E (24h FeSO4 1.00 mM)
F (24h FeSO4 5.00 mM)
MTT test (n=2; each with 2 parallels)
time sample OD-570 versus weight and v. 24-h neg. (%) slice
0h A6-1 1,287       0,051       87,6 %
A6-2 1,290       0,051       87,8 % 87,7 %
A7-1 1,235       0,047       81,5 %
A7-2 1,219       0,047       80,4 % 81,0 %
mean 1,248       0,049       84,3 % 84,3 %
SD 0,037       0,002       3,9 % 4,8 %
24h B6-1 1,096       0,065       112,3 %
B6-2 1,089       0,065       111,6 % 112,0 %
B7-1 0,873       0,051       88,4 %
B7-2 0,865       0,051       87,6 % 88,0 %
mean 0,942       0,058       100,0 % 100,0 %
SD 0,127       0,008       13,8 % 16,9 %
24h C6-1 0,503       0,021       35,4 %
C6-2 0,495       0,020       34,8 % 35,1 %
C7-1 0,394       0,019       33,4 %
C7-2 0,391       0,019       33,2 % 33,3 %
mean 0,427       0,020       34,2 % 34,2 %
SD 0,059       0,001       1,1 % 1,3 %
24h D6-1 0,945       0,051       88,4 %
D6-2 0,922       0,050       86,3 % 87,4 %
D7-1 0,648       0,040       69,3 %
D7-2 0,626       0,039       67,0 % 68,1 %
mean 0,732       0,045       77,7 % 77,7 %
SD 0,165       0,006       11,2 % 13,6 %
24h E6-1 0,748       0,034       59,4 %
E6-2 0,750       0,035       59,5 % 59,4 %
E7-1 0,760       0,040       68,2 %
E7-2 0,758       0,039       68,0 % 68,1 %
mean 0,754       0,037       63,8 % 63,8 %
SD 0,006       0,003       5,0 % 6,1 %
24h F6-1 0,746       0,036       62,7 %
F6-2 0,740       0,036       62,2 % 62,4 %
F7-1 0,731       0,039       67,7 %
F7-2 0,728       0,039       67,4 % 67,5 %
mean 0,736       0,038       65,0 % 65,0 %
SD 0,008       0,002       3,0 % 3,6 %
Abs.570nm / mg 
slice wet weight
EGN-11-01-data.xls / MTT
EGN-11-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.) Titles: Culture media 
B (24h neg.ctrl.) activities 
C (24h pos.ctrl.; menadione 200 uM) leakage 
D (24h FeSO4 0.200 mM) (n=4, 5, 6, or 7) 
E (24h FeSO4 1.00 mM) U/L
F (24h FeSO4 5.00 mM) % of total 
background: medium 4 0 0,1         43
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
0h
24h B2 124          20           28,4       1 209     
B3 138          19           36,7       1 150     
B4 109          17           23,1       1 157     
B5 104          15           23,9       922        
B6 77            12           17,4       657        
B7 95            13           20,7       839        
mean 107,8       16,0        25,0       989,0     
SD 21,5         3,2          6,8         219,0     
24h C2 104          13           15,6       1 594     
C3 121          14           19,5       1 493     
C4 81            12           10,5       1 301     
C5 128          13           20,3       1 618     
C6 116          10           17,3       1 389     
C7 88            7             12,2       1 220     
mean 106,3       11,5        15,9       1 435,8  
SD 18,8         2,6          3,9         160,3     
24h D1 120          20           26,4       1 366     
D2 128          21           28,8       1 346     
D3 121          19           26,3       1 285     
D4 72            13           14,1       773        
D5 97            19           20,2       1 038     
D6 101          16           26,3       860        
D7 92            14           21,0       779        
mean 104,4       17,4        23,3       1 063,9  
SD 19,8         3,1          5,1         267,0     
24h E1 139          22           34,0       1 424     
E2 202          25           57,6       1 688     
E3 129          24           27,5       1 120     
E4 205          28           49,8       1 629     
E5 190          28           48,4       1 583     
E6 131          23           29,8       1 270     
E7 93            17           19,9       970        
mean 155,6       23,9        38,1       1 383,4  
SD 43,4         3,8          13,9       273,2     
24h F1 240          31           71,8       1 448     
F2 261          39           71,8       781        
F3 322          35           88,8       1 359     
F4 187          29           47,4       1 043     
F5 201          30           55,9       1 394     
F6 144          21           35,2       789        
F7 162          22           43,6       826        
mean 216,7       29,6        59,2       1 091,4  
SD 61,9         6,5          19,0       303,0     
EGN-11-01-data.xls / Enzyme
Culture media ASAT activities (n=4, 5, 6, or 7)ASAT leakage (n=4, 5, 6, or 7) % of total ASAT
Culture media ALAT activities (n=4, 5, 6, or 7)ALAT leakage (n=4, 5, 6, or 7) % of total ALAT
Culture media GLDH activities (n=4, 5, 6, or 7 GLDH leakage (n=4, 5, 6, or 7) % of total GLDH
Culture media LDH activities (n=4, 5, 6, or 7) LDH leakage (n=4, 5, 6, or 7) % of total LDH
Triton supernatant enzyme activities (n=1)
Triton supernatant enzyme activities (U/L);  raw data





A5 111          25           66,2       461        
A6
A7
mean 111,0       25,0        66,2       461,0     




B5 106          8             38,1       206        
B6
B7
mean 106,0       8,0          38,1       206,0     




C5 84            7             44,6       118        
C6
C7
mean 84,0         7,0          44,6       118,0     





D5 120          8             48,2       194        
D6
D7
mean 120,0       8,0          48,2       194,0     





E5 98            7             42,9       147        
E6
E7
mean 98,0         7,0          42,9       147,0     





F5 77            6             34,8       128        
F6
F7
mean 77,0         6,0          34,8       128,0     
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-11-01-data.xls / Enzyme
EGN-12-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.) Comments: B5 looked thick and large, and
C (24h pos.ctrl.; menadione 200 uM) may have consisted of two or
D (24h FeSO4 0.200 mM) more parts sticking together.
E (24h FeSO4 1.00 mM) The recorded weight of 26,1 mg
F (24h FeSO4 5.00 mM) is not used any further.
Slice weights (n=6 or 7) mg
Treatment category (untreated, neAnalysis category (histology n=9, triton n=6, iron n=12, MTT n=12)
sample weight sample weight
A histology
A2 27,5         A2 27,5       
A3 23,1         B2 19,6       
A4 23,9         C2 26,4       
A5 28,0         D1 20,2       
A6 24,8         D2 17,5       
A7 24,4         E1 20,3       
mean 25,3         E2 20,9       
SD 2,0           F1 20,8       
B B2 19,6         F2 20,5       
B3 18,6         mean 21,5       
B4 19,3         SD 3,3         
B5 FALSE triton A5 28,0       
B6 19,3         B5 FALSE
B7 18,7         C5 22,1       
mean 19,1         D5 18,4       
SD 0,4           E5 19,5       
C C2 26,4         F5 21,9       
C3 25,4         mean 22,0       
C4 21,7         SD 3,7         
C5 22,1         iron A3 23,1       
C6 23,4         A4 23,9       
C7 23,7         B3 18,6       
mean 23,8         B4 19,3       
SD 1,8           C3 25,4       
D D1 20,2         C4 21,7       
D2 17,5         D3 19,7       
D3 19,7         D4 18,8       
D4 18,8         E3 18,6       
D5 18,4         E4 17,8       
D6 19,4         F3 18,9       
D7 19,6         F4 19,9       
mean 19,1         mean 20,5       
SD 0,9           SD 2,5         
E E1 20,3         MTT A6 24,8       
E2 20,9         A7 24,4       
E3 18,6         B6 19,3       
E4 17,8         B7 18,7       
E5 19,5         C6 23,4       
E6 20,5         C7 23,7       
E7 19,7         D6 19,4       
mean 19,6         D7 19,6       
SD 1,1           E6 20,5       
F F1 20,8         E7 19,7       
F2 20,5         F6 18,1       
F3 18,9         F7 20,3       
F4 19,9         mean 21,0       
F5 21,9         SD 2,4         
F6 18,1         
F7 20,3         
mean 20,1         
SD 1,3           
EGN-12-01-data.xls / Weight
EGN-12-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.)
B (24h neg.ctrl.)
C (24h pos.ctrl.; menadione 200 uM)
D (24h FeSO4 0.200 mM)
E (24h FeSO4 1.00 mM)
F (24h FeSO4 5.00 mM)
MTT test (n=2; each with 2 parallels)
time sample OD-570 versus weight and v. 24-h neg. (%) slice
0h A6-1 1,275       0,051       89,7 %
A6-2 1,234       0,050       86,9 % 88,3 %
A7-1 1,071       0,044       76,6 %
A7-2 1,062       0,044       76,0 % 76,3 %
mean 1,122       0,047       82,3 % 82,3 %
SD 0,097       0,004       7,0 % 8,5 %
24h B6-1 0,997       0,052       90,2 %
B6-2 0,988       0,051       89,4 % 89,8 %
B7-1 1,182       0,063       110,3 %
B7-2 1,180       0,063       110,1 % 110,2 %
mean 1,117       0,057       100,0 % 100,0 %
SD 0,111       0,007       11,8 % 14,5 %
24h C6-1 0,851       0,036       63,5 %
C6-2 0,839       0,036       62,6 % 63,0 %
C7-1 0,772       0,033       56,9 %
C7-2 0,759       0,032       55,9 % 56,4 %
mean 0,790       0,034       59,7 % 59,7 %
SD 0,043       0,002       3,9 % 4,7 %
24h D6-1 1,144       0,059       102,9 %
D6-2 1,149       0,059       103,4 % 103,2 %
D7-1 1,095       0,056       97,5 %
D7-2 1,078       0,055       96,0 % 96,8 %
mean 1,107       0,057       100,0 % 100,0 %
SD 0,037       0,002       3,7 % 4,5 %
24h E6-1 1,124       0,055       95,7 %
E6-2 1,106       0,054       94,2 % 94,9 %
E7-1 1,206       0,061       106,9 %
E7-2 1,182       0,060       104,7 % 105,8 %
mean 1,155       0,057       100,4 % 100,4 %
SD 0,047       0,004       6,4 % 7,7 %
24h F6-1 1,040       0,057       100,3 %
F6-2 1,042       0,058       100,5 % 100,4 %
F7-1 0,911       0,045       78,3 %
F7-2 0,912       0,045       78,4 % 78,4 %
mean 0,976       0,051       89,4 % 89,4 %
SD 0,075       0,007       12,7 % 15,6 %
Abs.570nm / mg 
slice wet weight
EGN-12-01-data.xls / MTT
EGN-12-01: Effects of ferrous iron (Fe2+) on rat liver slices
Groups: A (untreated / pre-inc.) Titles: Culture media 
B (24h neg.ctrl.) activities 
C (24h pos.ctrl.; menadione 200 uM) leakage 
D (24h FeSO4 0.200 mM) (n=4, 5, 6, or 7) 
E (24h FeSO4 1.00 mM) U/L
F (24h FeSO4 5.00 mM) % of total 
background: medium 4 1 0,4         48
Culture media enzyme activities (U/L);  raw data
time sample ASAT ALAT GLDH LDH
0h
24h B2 56            11           14,5       409        
B3 62            10           15,1       451        
B4 54            8             12,2       363        
B5 133          22           38,7       920        
B6 80            15           22,8       512        
B7 61            10           15,7       368        
mean 74,3         12,7        19,8       503,8     
SD 30,2         5,1          9,9         211,3     
24h C2 63            16           5,0         806        
C3 65            12           5,1         937        
C4 107          12           17,2       1 156     
C5 74            14           6,8         986        
C6 86            15           13,7       643        
C7 87            14           9,5         943        
mean 80,3         13,8        9,6         911,8     
SD 16,5         1,6          5,0         173,3     
24h D1 47            12           10,0       352        
D2 103          18           28,1       628        
D3 90            12           23,6       541        
D4 49            11           13,2       301        
D5 67            14           20,8       422        
D6 73            14           14,3       577        
D7 82            17           22,4       559        
mean 73,0         14,0        18,9       482,9     
SD 20,6         2,6          6,5         124,5     
24h E1 110          21           29,1       836        
E2 100          18           22,2       570        
E3 91            17           21,1       516        
E4 105          18           25,4       553        
E5 103          18           27,4       665        
E6 105          15           26,5       637        
E7 103          16           27,7       541        
mean 102,4       17,6        25,6       616,9     
SD 5,9           1,9          3,0         110,3     
24h F1 194          23           65,8       666        
F2 171          21           55,6       500        
F3 171          20           62,6       438        
F4 172          21           62,3       460        
F5 201          26           63,1       639        
F6 165          15           59,1       526        
F7 198          23           61,5       625        
mean 181,7       21,3        61,4       550,6     
SD 15,2         3,4          3,3         91,9       
EGN-12-01-data.xls / Enzyme
Culture media ASAT activities (n=4, 5, 6, or 7)ASAT leakage (n=4, 5, 6, or 7) % of total ASAT
Culture media ALAT activities (n=4, 5, 6, or 7)ALAT leakage (n=4, 5, 6, or 7) % of total ALAT
Culture media GLDH activities (n=4, 5, 6, or 7 GLDH leakage (n=4, 5, 6, or 7) % of total GLDH
Culture media LDH activities (n=4, 5, 6, or 7) LDH leakage (n=4, 5, 6, or 7) % of total LDH
Triton supernatant enzyme activities (n=1)
Triton supernatant enzyme activities (U/L);  raw data





A5 54            24           42,8       381        
A6
A7
mean 54,0         24,0        42,8       381,0     




B5 88            13           58,3       242        
B6
B7
mean 88,0         13,0        58,3       242,0     




C5 93            11           36,5       165        
C6
C7
mean 93,0         11,0        36,5       165,0     





D5 72            15           19,3       130        
D6
D7
mean 72,0         15,0        19,3       130,0     





E5 74            11           6,4         133        
E6
E7
mean 74,0         11,0        6,4         133,0     





F5 85            14           20,1       211        
F6
F7
mean 85,0         14,0        20,1       211,0     
SD #DIV/0! #DIV/0! #DIV/0! #DIV/0!
EGN-12-01-data.xls / Enzyme
Nycomed Imaging AS
Analytical Sciences R&D, ICP-Lab.
Task number: DEV 047.01.0036
Journal no: -
Task: Fe and K in liver slices
Method: -





Apparatus: * Perkin Elmer Optima 3300 DV ICP-AES, Perkin Elmer AS-91 Autosampler and HP Laserjet 2100.
* Laboratory balance, Mettler AT261 Delta Range, 
  with LC-P45 Printer, Investment no. 1004022, SOP FKA.058.15
*Autodiluter, Hamilton Microlab1000
* Finnpipette Digital, Labsystems: 40-200 µL # -
200-1000 µL # ICP-3
1-5 mL # ICP-2
Reagents: * Spectrascan Element Standards for Atomic Spectroscopy, Teknolab AS, Drøbak, Norway
  (A) 1000 µg Fe/mL Prod.no. 8004 Lot no. 6
  (B) 1000 µg K/mL Prod.no. 8007 Lot no. -
  (C) 1000 µg Sc/mL Prod.no. 8055 Lot no. -
* (FeSO4:7H2O) Ferrous sulphate heptahydrate, Sigma (prod.no. F-2387) Lot no: -
* (HNO3) Nitric Acid 60%, Scanpure, Chem Scan AS, Elverum Lot no: -
* (HCl) Hydrochloric Acid 30%, Scanpure, Chem Scan AS, Elverum Lot no: -
Water: Milli Q Water system, purified with reverse osmosis and deionization, room 421, FoU II-4
Solutions: (D) 100 µg Fe/mL and 100 µg K/mL: Preparation date: 16.aug.01
      10 mL (A) + 10 mL (B).  Dilute to 100 mL with water Reference: -
(E) 10 µg Fe/mL and 10 µg K/mL: Preparation date: 16.aug.01
      10 mL (D).  Dilute to 100 mL with water Reference: -
(F) 10 µg Sc/mL: Preparation date: 16.aug.01
      5 mL (C).  Dilute to 500 mL with water Reference: -
(G) 100 µg Fe/mL: Preparation date: 20.aug.01
      10 mL (A).  Dilute to 100 mL with water Reference: -
(H) ca. 20.0 mM ferrous sulphate equiv. ca. 1120 µg Fe/mL: Preparation date: 20.aug.01
      556 mg FeSO4:7H2O + 50 mL water + 10 mL HCl.  Dilute to 100 mL with waReference: -
(J) ca. 2.00 mM ferrous sulphate equiv. ca. 112 µg Fe/mL: Preparation date: 20.aug.01
      10 mL (H).  Dilute to 100 mL with water Reference: -
Standards: Prepare according to table below. Preparation date: 16.aug.01
Add 20 mL HNO3 + 10 mL HCl.  Dilute to 100 mL with water Reference: -
Conc Fe and K Vol A Vol B Vol D Vol E Vol F
(µg/mL) (mL) (mL) (mL) (mL) (mL)
std 0 - - - - - 10.00
std 0.5 0.50 - - - 5.00 10.00
std 1.0 1.00 - - - 10.00 10.00
std 5.0 5.00 - - 5.00 - 10.00
std 20 20.00 - - 20.00 - 10.00
std 50 50.00 5.00 5.00 - - 10.00
Sample preparation: Each sample consists of ca. 25 mg rat liver and 0.5 mL water.  Add 1 mL HNO3 + 0.5 mL HCl.
Digest at 70 degrees overnight.  Add 500 µL of 10 ppm Sc (sol. F).  Dilute to ca. 5 mL with water.
Blank samples: BL1-BL6: 500 µL water
Control samples: 1577 b Bovine Liver NIST standard reference material
C1-C3: 50 mg of 1577b, suspended in 500 µL water.
C4-C6: 50 mg of 1577b, suspended in 500 µL water.  Add 250 µL ca. 112 ppm Fe (sol. J).
C7-C9: 50 mg of 1577b, suspended in 500 µL water.  Add 250 µL of 100 ppm Fe (sol. G).
Fe og K analyse.xls / skjema
Sample ID Date Time Conc (Calib)SD (Calib) RSD (Conc) Analyte Name
03-01-A03 8/22/01 09:32:40 0,80165444 1,27E-02 1,57869977 Fe 259.939
03-01-B02 8/22/01 09:36:32 0,32227239 6,02E-03 1,86737493 Fe 259.939
03-01-B08 8/22/01 09:38:43 0,57808392 1,21E-02 2,0994641 Fe 259.939
03-01-B12 8/22/01 09:40:54 0,42849 6,97E-03 1,62593275 Fe 259.939
03-01-C03 8/22/01 09:43:06 0,59164738 9,03E-03 1,52658787 Fe 259.939
03-01-C10 8/22/01 09:45:18 0,51258636 9,72E-03 1,89533931 Fe 259.939
03-01-C15 8/22/01 09:47:31 0,43057517 7,63E-03 1,77096649 Fe 259.939
05-01-A03 8/22/01 09:51:25 0,33625448 7,96E-03 2,36775575 Fe 259.939
05-01-B02 8/22/01 09:53:39 0,36031213 6,12E-03 1,69961669 Fe 259.939
05-01-B08 8/22/01 09:55:53 0,4841025 3,28E-03 0,67718626 Fe 259.939
05-01-B12 8/22/01 09:58:04 0,31856756 7,14E-03 2,24120008 Fe 259.939
05-01-C03 8/22/01 10:00:11 0,35213505 4,34E-03 1,23107408 Fe 259.939
05-01-C10 8/22/01 10:02:19 0,49124274 8,21E-03 1,67031429 Fe 259.939
05-01-C15 8/22/01 10:06:09 0,42484426 1,23E-02 2,88948957 Fe 259.939
06-01-A03 8/22/01 10:08:18 0,33702002 7,89E-03 2,34058651 Fe 259.939
06-01-B03 8/22/01 10:10:27 0,39736805 8,48E-03 2,13390304 Fe 259.939
06-01-C03 8/22/01 10:12:37 0,22782059 3,57E-03 1,56746637 Fe 259.939
06-01-D03 8/22/01 10:14:47 0,3141152 6,86E-03 2,18261045 Fe 259.939
06-01-E03 8/22/01 10:16:58 0,30881231 6,49E-03 2,10169146 Fe 259.939
06-01-F03 8/22/01 10:20:50 0,34531324 6,67E-03 1,93159243 Fe 259.939
07-01-A03 8/22/01 10:23:02 0,50857431 1,12E-02 2,20561941 Fe 259.939
07-01-B03 8/22/01 10:25:14 0,20686756 6,77E-03 3,2724115 Fe 259.939
07-01-C03 8/22/01 10:27:27 0,25316172 6,03E-03 2,38068288 Fe 259.939
07-01-D03 8/22/01 10:29:40 0,6704904 1,22E-02 1,82333576 Fe 259.939
07-01-E03 8/22/01 10:31:54 0,45188775 8,26E-03 1,8271978 Fe 259.939
07-01-F03 8/22/01 10:35:50 0,49030677 8,15E-03 1,66170628 Fe 259.939
09-01-A03 8/22/01 10:49:24 0,54529294 1,15E-02 2,11047432 Fe 259.939
09-01-B03 8/22/01 10:51:33 0,2508092 6,42E-03 2,55929552 Fe 259.939
09-01-C03 8/22/01 10:53:44 0,28770898 6,39E-03 2,22243923 Fe 259.939
09-01-D03 8/22/01 10:55:54 0,24491237 2,97E-03 1,21318188 Fe 259.939
09-01-E03 8/22/01 10:58:06 0,37336947 1,03E-02 2,76021198 Fe 259.939
09-01-F03 8/22/01 11:00:17 0,69653597 1,36E-02 1,9516317 Fe 259.939
10-01-A03 8/22/01 11:04:11 0,41137342 7,86E-03 1,91108744 Fe 259.939
10-01-B03 8/22/01 11:06:24 0,41701711 6,04E-03 1,4472936 Fe 259.939
10-01-C03 8/22/01 11:08:39 0,31704823 6,25E-03 1,97217394 Fe 259.939
10-01-D03 8/22/01 11:10:52 0,35212312 7,89E-03 2,24172662 Fe 259.939
10-01-E03 8/22/01 11:13:02 0,57309938 9,08E-03 1,58464974 Fe 259.939
10-01-F03 8/22/01 11:15:08 0,7010514 1,29E-02 1,83359601 Fe 259.939
11-01-A03 8/22/01 11:18:57 0,69330394 9,23E-03 1,33147919 Fe 259.939
11-01-B03 8/22/01 11:21:04 0,29292758 3,71E-03 1,26614633 Fe 259.939
11-01-C03 8/22/01 11:23:12 0,33598559 8,78E-03 2,6125242 Fe 259.939
11-01-D03 8/22/01 11:25:20 0,40712361 5,73E-03 1,40657849 Fe 259.939
11-01-E03 8/22/01 11:27:29 0,4811932 7,10E-03 1,4763372 Fe 259.939
11-01-F03 8/22/01 11:29:38 0,85557781 1,21E-02 1,41115814 Fe 259.939
12-01-A03 8/22/01 11:33:29 0,51703871 9,05E-03 1,75032888 Fe 259.939
12-01-B03 8/22/01 11:35:40 0,21825986 4,86E-03 2,22734365 Fe 259.939
12-01-C03 8/22/01 11:37:52 0,43932525 9,28E-03 2,11189056 Fe 259.939
12-01-D03 8/22/01 11:40:03 0,28638698 8,19E-03 2,85839381 Fe 259.939
12-01-E03 8/22/01 11:42:15 0,52974003 7,57E-03 1,42926227 Fe 259.939
12-01-F03 8/22/01 11:44:27 1,08372233 2,03E-02 1,87242007 Fe 259.939
BL1 8/22/01 09:23:22 -2,74E-02 8,41E-04 3,06787843 Fe 259.939
BL2 8/22/01 09:30:29 -4,73E-02 2,71E-03 5,74355045 Fe 259.939
BL3 8/22/01 10:38:00 -5,00E-02 1,28E-03 2,5603649 Fe 259.939
BL4 8/22/01 10:45:33 -4,63E-02 1,31E-03 2,83557132 Fe 259.939
BL5 8/22/01 11:48:21 -5,04E-02 1,10E-03 2,17940367 Fe 259.939
BL6 8/22/01 11:55:58 -4,64E-02 1,10E-03 2,38076437 Fe 259.939
C1 8/22/01 09:25:01 3,01817209 4,63E-02 1,53477597 Fe 259.939
C2 8/22/01 10:40:08 1,91514503 1,15E-02 0,6002402 Fe 259.939
C3 8/22/01 11:50:34 1,90826719 8,31E-03 0,43557958 Fe 259.939
Fe og K analyse.xls / rådata 2001-08-22
Sample ID Date Time Conc (Calib)SD (Calib) RSD (Conc) Analyte Name
C4 8/22/01 09:26:40 7,52431531 7,64E-02 1,01513268 Fe 259.939
C5 8/22/01 10:41:46 7,667583 4,71E-02 0,61489877 Fe 259.939
C6 8/22/01 11:52:14 7,70793319 5,84E-02 0,75770278 Fe 259.939
C7 8/22/01 09:28:20 7,00672403 7,06E-02 1,00820562 Fe 259.939
C8 8/22/01 10:43:25 7,07676438 4,67E-02 0,6598984 Fe 259.939
C9 8/22/01 11:53:52 6,97201463 3,18E-02 0,45555359 Fe 259.939
std 5.0 µg/mL8/22/01 09:21:13 5,0137206 5,50E-02 1,09742033 Fe 259.939
std 5.0 µg/mL8/22/01 09:34:21 4,97784196 3,05E-02 0,61257038 Fe 259.939
std 5.0 µg/mL8/22/01 09:49:13 4,98278006 2,47E-02 0,49593259 Fe 259.939
std 5.0 µg/mL8/22/01 10:03:59 4,98411484 2,01E-02 0,40420497 Fe 259.939
std 5.0 µg/mL8/22/01 10:18:39 4,99532256 2,26E-02 0,45217145 Fe 259.939
std 5.0 µg/mL8/22/01 10:33:37 4,99062902 2,33E-02 0,46726221 Fe 259.939
std 5.0 µg/mL8/22/01 10:47:14 4,99893178 2,58E-02 0,5154173 Fe 259.939
std 5.0 µg/mL8/22/01 11:02:00 4,99678695 2,68E-02 0,53566546 Fe 259.939
std 5.0 µg/mL8/22/01 11:16:48 4,99815587 2,29E-02 0,45907249 Fe 259.939
std 5.0 µg/mL8/22/01 11:31:18 5,00311228 2,63E-02 0,52567466 Fe 259.939
std 5.0 µg/mL8/22/01 11:46:09 5,00120273 2,82E-02 0,56340033 Fe 259.939
std 5.0 µg/mL8/22/01 11:57:38 5,00274588 2,54E-02 0,5086743 Fe 259.939
03-01-A03 8/22/01 09:32:40 5,70945566 9,33E-02 1,63471272 K 766.490
03-01-B02 8/22/01 09:36:22 7,56881176 0,12225979 1,61531017 K 766.490
03-01-B08 8/22/01 09:38:43 9,56484243 0,20377378 2,13044577 K 766.490
03-01-B12 8/22/01 09:40:54 8,33668322 0,10735202 1,28770665 K 766.490
03-01-C03 8/22/01 09:43:06 6,77191256 8,09E-02 1,19484735 K 766.490
03-01-C10 8/22/01 09:45:18 7,12851167 0,17959069 2,51932934 K 766.490
03-01-C15 8/22/01 09:47:31 8,18529192 0,12922623 1,57876144 K 766.490
05-01-A03 8/22/01 09:51:25 4,13240886 4,26E-02 1,03112617 K 766.490
05-01-B02 8/22/01 09:53:39 10,0548956 0,13119523 1,30478958 K 766.490
05-01-B08 8/22/01 09:55:53 11,4339134 0,12693481 1,11016068 K 766.490
05-01-B12 8/22/01 09:57:54 7,5321783 7,00E-02 0,92871174 K 766.490
05-01-C03 8/22/01 10:00:01 7,97869395 5,99E-02 0,7511654 K 766.490
05-01-C10 8/22/01 10:02:19 10,6612161 0,19123535 1,79374799 K 766.490
05-01-C15 8/22/01 10:06:09 8,11053815 0,21017303 2,59135738 K 766.490
06-01-A03 8/22/01 10:08:18 5,82455346 7,90E-02 1,35654113 K 766.490
06-01-B03 8/22/01 10:10:17 9,86116405 0,12696183 1,28749329 K 766.490
06-01-C03 8/22/01 10:12:37 3,82230689 5,81E-02 1,51985175 K 766.490
06-01-D03 8/22/01 10:14:37 7,5506671 5,90E-02 0,78202465 K 766.490
06-01-E03 8/22/01 10:16:48 7,35492043 5,93E-02 0,80593435 K 766.490
06-01-F03 8/22/01 10:20:40 8,13123104 0,13939525 1,71431909 K 766.490
07-01-A03 8/22/01 10:23:02 3,88391393 4,17E-02 1,07347922 K 766.490
07-01-B03 8/22/01 10:25:14 3,41629122 6,66E-02 1,95061287 K 766.490
07-01-C03 8/22/01 10:27:27 2,73837054 4,35E-02 1,5887192 K 766.490
07-01-D03 8/22/01 10:29:40 8,61704278 0,11907634 1,38187009 K 766.490
07-01-E03 8/22/01 10:31:54 7,01150381 0,16590787 2,36622375 K 766.490
07-01-F03 8/22/01 10:35:50 7,0727675 9,24E-02 1,30577974 K 766.490
09-01-A03 8/22/01 10:49:24 4,45084426 6,68E-02 1,50183458 K 766.490
09-01-B03 8/22/01 10:51:33 4,01919805 4,91E-02 1,22203987 K 766.490
09-01-C03 8/22/01 10:53:44 3,50506569 4,55E-02 1,29878959 K 766.490
09-01-D03 8/22/01 10:55:54 4,67192523 7,47E-02 1,59910491 K 766.490
09-01-E03 8/22/01 10:58:06 2,00616444 3,76E-02 1,8735654 K 766.490
09-01-F03 8/22/01 11:00:17 2,02423357 1,83E-02 0,90462944 K 766.490
10-01-A03 8/22/01 11:04:11 6,86923756 8,76E-02 1,2749349 K 766.490
10-01-B03 8/22/01 11:06:24 9,06125964 9,64E-02 1,0640999 K 766.490
10-01-C03 8/22/01 11:08:39 5,27830723 8,53E-02 1,61533574 K 766.490
10-01-D03 8/22/01 11:10:52 5,50913101 0,10542907 1,91371502 K 766.490
10-01-E03 8/22/01 11:13:02 8,42210397 0,10460001 1,24197009 K 766.490
10-01-F03 8/22/01 11:15:08 6,32500674 9,42E-02 1,48924115 K 766.490
11-01-A03 8/22/01 11:18:57 5,45483873 7,78E-02 1,42625586 K 766.490
11-01-B03 8/22/01 11:21:04 5,22161505 4,95E-02 0,94825912 K 766.490
11-01-C03 8/22/01 11:23:12 4,35836878 5,72E-02 1,31215859 K 766.490
Fe og K analyse.xls / rådata 2001-08-22
Sample ID Date Time Conc (Calib)SD (Calib) RSD (Conc) Analyte Name
11-01-D03 8/22/01 11:25:20 5,8280932 5,92E-02 1,01642243 K 766.490
11-01-E03 8/22/01 11:27:29 6,21246828 6,85E-02 1,10207251 K 766.490
11-01-F03 8/22/01 11:29:38 2,68192921 9,40E-03 0,35054106 K 766.490
12-01-A03 8/22/01 11:33:29 6,29555609 0,10561002 1,67753286 K 766.490
12-01-B03 8/22/01 11:35:30 10,2729406 0,12495206 1,21632224 K 766.490
12-01-C03 8/22/01 11:37:52 7,46172849 0,16065105 2,1530005 K 766.490
12-01-D03 8/22/01 11:39:53 10,0884615 0,10559329 1,04667384 K 766.490
12-01-E03 8/22/01 11:42:15 8,98220948 0,16424096 1,82851404 K 766.490
12-01-F03 8/22/01 11:44:27 7,86470924 0,15426613 1,9614982 K 766.490
BL1 8/22/01 09:23:22 4,30E-02 1,31E-02 30,5049015 K 766.490
BL2 8/22/01 09:30:29 0,22684013 5,21E-02 22,9667457 K 766.490
BL3 8/22/01 10:38:00 8,94E-02 1,27E-02 14,1594602 K 766.490
BL4 8/22/01 10:45:33 0,21850596 6,27E-02 28,7081805 K 766.490
BL5 8/22/01 11:48:21 9,86E-02 1,24E-02 12,5433389 K 766.490
BL6 8/22/01 11:55:58 0,23272652 1,77E-02 7,6017322 K 766.490
C1 8/22/01 09:25:01 91,3606423 1,89201357 2,07092849 K 766.490
C2 8/22/01 10:39:58 93,5358148 0,49778944 0,53219127 K 766.490
C3 8/22/01 11:50:24 97,6601161 0,47727369 0,48870892 K 766.490
C4 8/22/01 09:26:40 92,2744127 1,42024261 1,53915107 K 766.490
C5 8/22/01 10:41:46 97,66531 1,14286284 1,17018298 K 766.490
C6 8/22/01 11:52:14 98,2462445 1,35812458 1,38236793 K 766.490
C7 8/22/01 09:28:20 97,0318661 1,4171053 1,46045352 K 766.490
C8 8/22/01 10:43:25 97,1646986 1,27657413 1,31382503 K 766.490
C9 8/22/01 11:53:52 91,5192714 0,92925479 1,01536515 K 766.490
std 5.0 µg/mL8/22/01 09:21:13 5,02604386 7,33E-02 1,45832367 K 766.490
std 5.0 µg/mL8/22/01 09:34:21 4,97994575 2,74E-02 0,54938308 K 766.490
std 5.0 µg/mL8/22/01 09:49:13 4,93241094 2,40E-02 0,48607264 K 766.490
std 5.0 µg/mL8/22/01 10:03:59 4,93445043 3,52E-02 0,71422116 K 766.490
std 5.0 µg/mL8/22/01 10:18:39 4,88733094 3,39E-02 0,69347699 K 766.490
std 5.0 µg/mL8/22/01 10:33:37 4,89639696 4,28E-02 0,87483084 K 766.490
std 5.0 µg/mL8/22/01 10:47:14 4,93480241 6,76E-02 1,36999481 K 766.490
std 5.0 µg/mL8/22/01 11:02:00 4,87937125 5,57E-02 1,14219375 K 766.490
std 5.0 µg/mL8/22/01 11:16:48 4,8959648 5,12E-02 1,04488068 K 766.490
std 5.0 µg/mL8/22/01 11:31:18 4,88051126 1,06E-02 0,21754362 K 766.490
std 5.0 µg/mL8/22/01 11:46:09 4,85161922 3,97E-02 0,81896755 K 766.490
std 5.0 µg/mL8/22/01 11:57:38 4,91378972 4,00E-02 0,81480229 K 766.490
03-01-A03 8/22/01 09:32:30 1,01937558 2,51E-02 2,46446735 Sc 424.683
03-01-B02 8/22/01 09:36:22 1,03394356 2,52E-02 2,43603799 Sc 424.683
03-01-B08 8/22/01 09:38:33 1,05176149 2,27E-02 2,15675452 Sc 424.683
03-01-B12 8/22/01 09:40:44 1,04006513 1,78E-02 1,70997205 Sc 424.683
03-01-C03 8/22/01 09:42:55 1,04438438 2,32E-02 2,22208734 Sc 424.683
03-01-C10 8/22/01 09:45:08 1,08446527 2,94E-02 2,70934791 Sc 424.683
03-01-C15 8/22/01 09:47:21 1,09513028 2,63E-02 2,40324603 Sc 424.683
05-01-A03 8/22/01 09:51:15 1,06956058 2,70E-02 2,5251903 Sc 424.683
05-01-B02 8/22/01 09:53:29 1,08213198 1,81E-02 1,67483627 Sc 424.683
05-01-B08 8/22/01 09:55:43 1,06509451 1,97E-02 1,85006753 Sc 424.683
05-01-B12 8/22/01 09:57:54 1,03731542 2,33E-02 2,24695129 Sc 424.683
05-01-C03 8/22/01 10:00:01 1,06124524 2,31E-02 2,17785216 Sc 424.683
05-01-C10 8/22/01 10:02:09 1,06219364 1,54E-02 1,45155343 Sc 424.683
05-01-C15 8/22/01 10:05:59 1,0974505 2,40E-02 2,18479661 Sc 424.683
06-01-A03 8/22/01 10:08:07 1,07890643 2,35E-02 2,17774097 Sc 424.683
06-01-B03 8/22/01 10:10:17 1,06365069 2,39E-02 2,24686849 Sc 424.683
06-01-C03 8/22/01 10:12:27 1,02887309 1,74E-02 1,68900278 Sc 424.683
06-01-D03 8/22/01 10:14:37 1,10700142 1,61E-02 1,45788744 Sc 424.683
06-01-E03 8/22/01 10:16:48 1,05619232 2,30E-02 2,17564952 Sc 424.683
06-01-F03 8/22/01 10:20:40 1,00378631 1,39E-02 1,38018776 Sc 424.683
07-01-A03 8/22/01 10:22:52 1,5189858 3,00E-02 1,97747877 Sc 424.683
07-01-B03 8/22/01 10:25:04 1,05572379 2,45E-02 2,31716773 Sc 424.683
07-01-C03 8/22/01 10:27:16 1,05028948 1,92E-02 1,82659372 Sc 424.683
Fe og K analyse.xls / rådata 2001-08-22
Sample ID Date Time Conc (Calib)SD (Calib) RSD (Conc) Analyte Name
07-01-D03 8/22/01 10:29:30 1,05413199 1,75E-02 1,66463341 Sc 424.683
07-01-E03 8/22/01 10:31:44 1,06502431 1,52E-02 1,42600702 Sc 424.683
07-01-F03 8/22/01 10:35:39 1,05408093 2,01E-02 1,90381625 Sc 424.683
09-01-A03 8/22/01 10:49:14 1,08348885 2,25E-02 2,07541677 Sc 424.683
09-01-B03 8/22/01 10:51:23 1,01263533 2,27E-02 2,24361581 Sc 424.683
09-01-C03 8/22/01 10:53:34 1,06382984 2,08E-02 1,95674274 Sc 424.683
09-01-D03 8/22/01 10:55:44 1,03146674 1,89E-02 1,83161961 Sc 424.683
09-01-E03 8/22/01 10:57:56 1,02806163 2,01E-02 1,95228521 Sc 424.683
09-01-F03 8/22/01 11:00:07 1,04040491 1,61E-02 1,54853054 Sc 424.683
10-01-A03 8/22/01 11:04:01 1,05567038 1,82E-02 1,72404968 Sc 424.683
10-01-B03 8/22/01 11:06:14 1,05018186 1,96E-02 1,86946771 Sc 424.683
10-01-C03 8/22/01 11:08:29 1,03924412 1,83E-02 1,76499551 Sc 424.683
10-01-D03 8/22/01 11:10:42 1,09207484 2,69E-02 2,46702697 Sc 424.683
10-01-E03 8/22/01 11:12:52 1,05696874 1,88E-02 1,78078374 Sc 424.683
10-01-F03 8/22/01 11:14:58 1,0061802 1,76E-02 1,75296967 Sc 424.683
11-01-A03 8/22/01 11:18:47 1,00830132 1,49E-02 1,47890539 Sc 424.683
11-01-B03 8/22/01 11:20:54 1,05109481 1,63E-02 1,55159315 Sc 424.683
11-01-C03 8/22/01 11:23:01 1,06270867 2,13E-02 2,00700882 Sc 424.683
11-01-D03 8/22/01 11:25:10 1,0294465 1,82E-02 1,77001705 Sc 424.683
11-01-E03 8/22/01 11:27:19 1,03639661 1,71E-02 1,650916 Sc 424.683
11-01-F03 8/22/01 11:29:28 1,021479 2,17E-02 2,12080919 Sc 424.683
12-01-A03 8/22/01 11:33:19 0,98175635 2,07E-02 2,11080837 Sc 424.683
12-01-B03 8/22/01 11:35:30 1,04925504 1,79E-02 1,70627356 Sc 424.683
12-01-C03 8/22/01 11:37:42 1,03198734 1,77E-02 1,71881688 Sc 424.683
12-01-D03 8/22/01 11:39:53 1,04363555 2,31E-02 2,21018103 Sc 424.683
12-01-E03 8/22/01 11:42:04 1,06681227 2,09E-02 1,95702898 Sc 424.683
12-01-F03 8/22/01 11:44:17 1,05522881 1,81E-02 1,71276168 Sc 424.683
BL1 8/22/01 09:23:12 1,0565515 1,86E-02 1,75710394 Sc 424.683
BL2 8/22/01 09:30:19 1,15370325 1,26E-02 1,09420126 Sc 424.683
BL3 8/22/01 10:37:50 1,08035032 1,56E-02 1,44829217 Sc 424.683
BL4 8/22/01 10:45:23 1,11104091 1,16E-02 1,04600094 Sc 424.683
BL5 8/22/01 11:48:11 1,09669611 1,61E-02 1,46579647 Sc 424.683
BL6 8/22/01 11:55:48 1,14421956 1,07E-02 0,93329062 Sc 424.683
C1 8/22/01 09:25:01 1,14926648 1,93E-02 1,67917978 Sc 424.683
C2 8/22/01 10:40:08 1,14491462 6,02E-03 0,52576483 Sc 424.683
C3 8/22/01 11:50:34 1,12656871 3,80E-03 0,33721861 Sc 424.683
C4 8/22/01 09:26:40 1,09590371 2,13E-02 1,94427729 Sc 424.683
C5 8/22/01 10:41:46 1,0792229 1,53E-02 1,41344734 Sc 424.683
C6 8/22/01 11:52:14 1,11112079 1,57E-02 1,41569194 Sc 424.683
C7 8/22/01 09:28:20 1,12821221 2,07E-02 1,83899995 Sc 424.683
C8 8/22/01 10:43:25 1,1009277 1,67E-02 1,52035679 Sc 424.683
C9 8/22/01 11:53:52 1,14853081 1,80E-02 1,56818096 Sc 424.683
std 5.0 µg/mL8/22/01 09:21:13 1,05769573 2,14E-02 2,02304609 Sc 424.683
std 5.0 µg/mL8/22/01 09:34:21 1,06996939 1,43E-02 1,33625974 Sc 424.683
std 5.0 µg/mL8/22/01 09:49:13 1,07833797 1,18E-02 1,09544317 Sc 424.683
std 5.0 µg/mL8/22/01 10:03:59 1,07136354 1,82E-02 1,70092701 Sc 424.683
std 5.0 µg/mL8/22/01 10:18:39 1,07713539 1,79E-02 1,66056655 Sc 424.683
std 5.0 µg/mL8/22/01 10:33:37 1,07437672 1,66E-02 1,54327276 Sc 424.683
std 5.0 µg/mL8/22/01 10:47:14 1,07050789 1,58E-02 1,47320234 Sc 424.683
std 5.0 µg/mL8/22/01 11:02:00 1,06943781 1,38E-02 1,29497548 Sc 424.683
std 5.0 µg/mL8/22/01 11:16:48 1,06510639 1,91E-02 1,78997881 Sc 424.683
std 5.0 µg/mL8/22/01 11:31:18 1,066709 1,72E-02 1,60845811 Sc 424.683
std 5.0 µg/mL8/22/01 11:46:09 1,0731437 1,68E-02 1,56546868 Sc 424.683
std 5.0 µg/mL8/22/01 11:57:38 1,07196935 1,59E-02 1,48681074 Sc 424.683
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Defined values: Measured values:
Total volume (mL) 5,00             500-µL autodispenser this day (mL) 0,4956
Fe and K in std. 5 (µg/mL) 5,00             250-µL finnpipette this day (mL) 0,2503
Sc in stock solution (µg/mL) 10,00           weighed in FeSO4;7H2O (mg) 553,7
Fe in stock solution (µg/mL) 100,00         
Fe in std. bovine liver (µg/g) 184 Computed values:
K in std. bovine liver (wt.%) 0,994 Sc as int.std. in samples (µg/mL) 0,9912 (based on autodispenser performance this day)
FeSO4;7H2O - Mw (g/mol) 278,01 conc. of Fe in FeSO4-sol. (µg/mL) 111,23        
Fe - Mw (g/mol) 55,847 added Fe from FeSO4-sol. (µg) 27,84          (based on finnpipette performance this day)
added Fe from stock sol. (µg) 25,03 (based on finnpipette performance this day)
K in std. bovine liver (µg/g) 9940
Detection limits
Fe 259.939 K 766.490
Sample ID Conc (Calib) SD (Calib) RSD (Conc) Conc (Calib) SD (Calib) RSD (Conc)
BL1 -0,0274      0,0008        3,0679        0,0430        0,0131            30,5049      
BL2 -0,0473      0,0027        5,7436        0,2268        0,0521            22,9667      
BL3 -0,0500      0,0013        2,5604        0,0894        0,0127            14,1595      
BL4 -0,0463      0,0013        2,8356        0,2185        0,0627            28,7082      
BL5 -0,0504      0,0011        2,1794        0,0986        0,0124            12,5433      
BL6 -0,0464      0,0011        2,3808        0,2327        0,0177            7,6017        
Avg. -0,0446      0,1515        
SD 0,0086        DL: 0,1422        0,0839        DL: 1,3844        
%RSD 19,32 % QL: 0,4310        55,38 % QL: 4,1951        
DL = 3.3 * SD * total volume QL = 10 * SD * total volume
Controls Fe 259.939 K 766.490
Organ Analyte Analyte Total Analyte Analyte Total
dry weight measured from organ recovery measured from organ recovery
Sample ID g µg/mL µg/g % µg/mL µg/g %
std 5.0 µg/mL - 5,0137        - 100,27 % 5,0260        - 100,52 %
std 5.0 µg/mL - 4,9778        - 99,56 % 4,9799        - 99,60 %
std 5.0 µg/mL - 4,9828        - 99,66 % 4,9324        - 98,65 %
std 5.0 µg/mL - 4,9841        - 99,68 % 4,9345        - 98,69 %
std 5.0 µg/mL - 4,9953        - 99,91 % 4,8873        - 97,75 %
std 5.0 µg/mL - 4,9906        - 99,81 % 4,8964        - 97,93 %
std 5.0 µg/mL - 4,9989        - 99,98 % 4,9348        - 98,70 %
std 5.0 µg/mL - 4,9968        - 99,94 % 4,8794        - 97,59 %
std 5.0 µg/mL - 4,9982        - 99,96 % 4,8960        - 97,92 %
std 5.0 µg/mL - 5,0031        - 100,06 % 4,8805        - 97,61 %
std 5.0 µg/mL - 5,0012        - 100,02 % 4,8516        - 97,03 %
std 5.0 µg/mL - 5,0027        - 100,05 % 4,9138        - 98,28 %
Avg. - 4,9954        - 99,91 % 4,9177        - 98,35 %
SD - 0,0101        - 0,20 % 0,0481        - 0,96 %
%RSD - 0,20 % - 0,20 % 0,98 % - 0,98 %
C1 0,0484         3,0182        316,4044    171,96 % 91,3606      9 422,4318     94,79 %
C2 0,0506         1,9151        193,6529    105,25 % 93,5358      9 227,6989     92,83 %
C3 0,0512         1,9083        190,7119    103,65 % 97,6601      9 522,3256     95,80 %
C4 0,0481         7,5243        207,9902    103,15 % 92,2744      9 576,1861     96,34 %
C5 0,0515         7,6676        208,1683    103,34 % 97,6653      9 467,3600     95,25 %
C6 0,0511         7,7079        213,7460    104,08 % 98,2462      9 598,3114     96,56 %
C7 0,0502         7,0067        203,7198    102,89 % 97,0319      9 649,4387     97,08 %
C8 0,0508         7,0768        208,2073    103,58 % 97,1647      9 548,5430     96,06 %
C9 0,0491         6,9720        204,7492    102,99 % 91,5193      9 304,2535     93,60 %
Avg. 0,0501         5,6441        216,3722    111,21 % 95,1620      9 479,6166     95,37 %
SD 0,0013         2,5573        38,2220      22,79 % 2,9204        139,8498        1,41 %
%RSD 2,53 % 45,31 % 17,66 % 20,50 % 3,07 % 1,48 % 1,48 %
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NB!  Too much internal standard in sample 07-01-A03;  New values computed manually
Samples Fe 259.939 K 766.490
Organ Analyte Analyte Relative to Analyte Analyte Relative to
wet weight measured from organ pre-inc. measured from organ pre-inc.
Sample ID g µg/mL µg/g % µg/mL µg/g %
03-01-A03 0,0456         0,8017        92,7935      100,00 % 5,7095        609,4247        100,00 % A: pre-incubated
03-01-B02 0,0214         0,3223        85,7231      92,38 % 7,5688        1 733,0163     284,37 % B: 3-h negative
03-01-B08 0,0279         0,5781        111,5961    120,26 % 9,5648        1 686,9786     276,81 % B: 6-h negative
03-01-B12 0,0209         0,4285        113,1848    121,97 % 8,3367        1 958,1773     321,32 % B: 24-h negative
03-01-C03 0,0390         0,5916        81,5730      87,91 % 6,7719        848,7706        139,27 % C: 3-h test 100
03-01-C10 0,0288         0,5126        96,7376      104,25 % 7,1285        1 211,2864     198,76 % C: 6-h test 100
03-01-C15 0,0191         0,4306        124,3972    134,06 % 8,1853        2 103,0864     345,09 % C: 24-h test 100
05-01-A03 0,0248         0,3363        76,7897      100,00 % 4,1324        802,6022        100,00 % A: pre-incubated
05-01-B02 0,0244         0,3603        82,9784      108,06 % 10,0549      2 029,3839     252,85 % B: 3-h negative
05-01-B08 0,0211         0,4841        125,2902    163,16 % 11,4339      2 673,5572     333,11 % B: 6-h negative
05-01-B12 0,0185         0,3186        98,1594      127,83 % 7,5322        1 994,7774     248,54 % B: 24-h negative
05-01-C03 0,0260         0,3521        76,2995      99,36 % 7,9787        1 505,2292     187,54 % C: 3-h test 100
05-01-C10 0,0217         0,4912        123,4712    160,79 % 10,6612      2 421,5931     301,72 % C: 6-h test 100
05-01-C15 0,0187         0,4248        125,5258    163,47 % 8,1105        2 128,0845     265,15 % C: 24-h test 100
06-01-A03 0,0193         0,3370        98,8711      100,00 % 5,8246        1 469,7024     100,00 % A: pre-incubated
06-01-B03 0,0166         0,3974        133,1296    134,65 % 9,8612        2 924,5970     198,99 % B: 24-h negative
06-01-C03 0,0201         0,2278        67,7719      68,55 % 3,8223        913,1355        62,13 % C: 24-h positive
06-01-D03 0,0199         0,3141        90,1350      91,16 % 7,5507        1 859,0867     126,49 % D: 24-h test 100
06-01-E03 0,0164         0,3088        107,7545    108,98 % 7,3549        2 196,1641     149,43 % E: 24-h test 200
06-01-F03 0,0161         0,3453        121,0980    122,48 % 8,1312        2 478,1767     168,62 % F: 24-h test 400
07-01-A03 0,0270         0,7460        146,4152    100,00 % 5,2369        941,7404        100,00 % A: pre-incubated
07-01-B03 0,0241         0,2069        52,1763      35,64 % 3,4163        677,3422        71,92 % B: 24-h negative
07-01-C03 0,0336         0,2532        44,3131      30,27 % 2,7384        384,9507        40,88 % C: 24-h positive
07-01-D03 0,0235         0,6705        152,1516    103,92 % 8,6170        1 801,1789     191,26 % D: 24-h test 100
07-01-E03 0,0207         0,4519        119,9300    81,91 % 7,0115        1 657,0053     175,95 % E: 24-h test 200
07-01-F03 0,0219         0,4903        122,1299    83,41 % 7,0728        1 580,1976     167,80 % F: 24-h test 400
09-01-A03 0,0299         0,5453        98,6480      100,00 % 4,4508        718,9535        100,00 % A: pre-incubated
09-01-B03 0,0251         0,2508        58,8509      59,66 % 4,0192        770,4574        107,16 % B: 24-h negative
09-01-C03 0,0247         0,2877        67,2735      68,20 % 3,5051        678,8590        94,42 % C: 24-h positive
09-01-D03 0,0204         0,2449        70,9644      71,94 % 4,6719        1 107,9469     154,11 % D: 24-h test 0.200
09-01-E03 0,0280         0,3734        74,6414      75,66 % 2,0062        331,1897        46,07 % E: 24-h test 1.00
09-01-F03 0,0253         0,6965        146,4740    148,48 % 2,0242        370,1050        51,48 % F: 24-h test 5.00
10-01-A03 0,0263         0,4114        86,6912      100,00 % 6,8692        1 277,1360     100,00 % A: pre-incubated
10-01-B03 0,0175         0,4170        131,8970    152,15 % 9,0613        2 545,6450     199,32 % B: 24-h negative
10-01-C03 0,0222         0,3170        81,4573      93,96 % 5,2783        1 154,6859     90,41 % C: 24-h positive
10-01-D03 0,0193         0,3521        102,7838    118,56 % 5,5091        1 387,9868     108,68 % D: 24-h test 0.200
10-01-E03 0,0211         0,5731        146,3795    168,85 % 8,4221        1 959,8583     153,46 % E: 24-h test 1.00
10-01-F03 0,0218         0,7011        171,0261    197,28 % 6,3250        1 415,9414     110,87 % F: 24-h test 5.00
11-01-A03 0,0319         0,6933        115,6624    100,00 % 5,4548        831,2440        100,00 % A: pre-incubated
11-01-B03 0,0195         0,2929        86,5512      74,83 % 5,2216        1 300,0290     156,40 % B: 24-h negative
11-01-C03 0,0256         0,3360        74,3375      64,27 % 4,3584        821,6537        98,85 % C: 24-h positive
11-01-D03 0,0226         0,4071        99,9438      86,41 % 5,8281        1 255,8830     151,08 % D: 24-h test 0.200
11-01-E03 0,0240         0,4812        109,5449    94,71 % 6,2125        1 262,7013     151,91 % E: 24-h test 1.00
11-01-F03 0,0269         0,8556        167,3234    144,67 % 2,6819        470,3396        56,58 % F: 24-h test 5.00
12-01-A03 0,0231         0,5170        121,5716    100,00 % 6,2956        1 329,8818     100,00 % A: pre-incubated
12-01-B03 0,0186         0,2183        70,6672      58,13 % 10,2729      2 720,8168     204,59 % B: 24-h negative
12-01-C03 0,0254         0,4393        95,2653      78,36 % 7,4617        1 439,0210     108,21 % C: 24-h positive
12-01-D03 0,0197         0,2864        84,0125      69,11 % 10,0885      2 522,0709     189,65 % D: 24-h test 0.200
12-01-E03 0,0186         0,5297        154,3985    127,00 % 8,9822        2 373,8461     178,50 % E: 24-h test 1.00
12-01-F03 0,0189         1,0837        298,5039    245,54 % 7,8647        2 040,5310     153,44 % F: 24-h test 5.00
Fe og K analyse.xls / beregninger 2001-08-22
Sample ID Date Time Conc (Calib)SD (Calib) RSD (Conc) Analyte Name
03-01-A04 8/23/01 14:30:08 0,32635902 9,81E-03 3,00573924 Fe 259.939
03-01-B03 8/23/01 14:34:00 0,37250378 5,89E-03 1,58251568 Fe 259.939
03-01-B09 8/23/01 14:36:11 -7,60E-02 1,54E-03 2,03145391 Fe 259.939
03-01-B13 8/23/01 14:38:23 0,49459975 1,12E-02 2,27139925 Fe 259.939
03-01-C04 8/23/01 14:40:36 0,51147528 1,16E-02 2,26863112 Fe 259.939
03-01-C11 8/23/01 14:42:48 0,45216341 6,62E-03 1,46344015 Fe 259.939
03-01-C16 8/23/01 14:45:02 0,31750545 1,81E-03 0,57089945 Fe 259.939
05-01-A04 8/23/01 14:48:56 0,22412544 5,33E-03 2,37866615 Fe 259.939
05-01-B03 8/23/01 14:51:10 0,29415488 1,24E-02 4,20243887 Fe 259.939
05-01-B09 8/23/01 14:53:24 0,43155138 8,27E-03 1,91540197 Fe 259.939
05-01-B13 8/23/01 14:55:35 0,30809642 7,19E-03 2,33435329 Fe 259.939
05-01-C04 8/23/01 14:57:42 0,33410897 7,48E-03 2,23902568 Fe 259.939
05-01-C11 8/23/01 14:59:51 0,44351184 1,18E-02 2,66781115 Fe 259.939
05-01-C16 8/23/01 15:15:12 0,36611623 8,92E-03 2,43702664 Fe 259.939
06-01-A04 8/23/01 15:17:21 0,36523443 6,78E-03 1,85702727 Fe 259.939
06-01-B04 8/23/01 15:19:30 0,37801997 9,24E-03 2,44551503 Fe 259.939
06-01-C04 8/23/01 15:21:40 0,22290251 3,74E-03 1,67888604 Fe 259.939
06-01-D04 8/23/01 15:23:50 0,25387914 6,87E-03 2,70479189 Fe 259.939
06-01-E04 8/23/01 15:26:00 0,35109266 8,06E-03 2,29588541 Fe 259.939
06-01-F04 8/23/01 15:29:53 0,32681732 8,66E-03 2,64994826 Fe 259.939
07-01-A04 8/23/01 15:32:04 0,47572341 8,44E-03 1,77424979 Fe 259.939
07-01-B04 8/23/01 15:34:17 0,29252415 7,64E-03 2,61198319 Fe 259.939
07-01-C04 8/23/01 15:36:29 0,25318791 3,81E-03 1,50460766 Fe 259.939
07-01-D04 8/23/01 15:38:43 0,3344642 8,33E-03 2,48943933 Fe 259.939
07-01-E04 8/23/01 15:40:56 0,24398404 4,81E-03 1,97226846 Fe 259.939
07-01-F04 8/23/01 15:44:53 0,52311025 1,80E-02 3,44645797 Fe 259.939
09-01-A04 8/23/01 15:58:29 0,59625483 1,82E-02 3,04734957 Fe 259.939
09-01-B04 8/23/01 16:00:39 0,18540838 6,34E-03 3,42104525 Fe 259.939
09-01-C04 8/23/01 16:02:49 0,13404901 3,97E-03 2,96238076 Fe 259.939
09-01-D04 8/23/01 16:04:59 0,27975375 6,47E-03 2,31297725 Fe 259.939
09-01-E04 8/23/01 16:07:10 0,41916504 1,17E-02 2,78007997 Fe 259.939
09-01-F04 8/23/01 16:09:21 0,71032215 1,61E-02 2,26745853 Fe 259.939
10-01-A04 8/23/01 16:13:14 0,48913479 9,46E-03 1,93392844 Fe 259.939
10-01-B04 8/23/01 16:15:27 0,33825708 8,77E-03 2,59345865 Fe 259.939
10-01-C04 8/23/01 16:17:40 0,2161822 5,32E-03 2,46084139 Fe 259.939
10-01-D04 8/23/01 16:19:53 0,31065207 8,07E-03 2,59910618 Fe 259.939
10-01-E04 8/23/01 16:22:03 0,37806169 7,66E-03 2,02570633 Fe 259.939
10-01-F04 8/23/01 16:24:09 0,45814381 1,02E-02 2,22021362 Fe 259.939
11-01-A04 8/23/01 16:27:57 0,38612522 9,96E-03 2,58015086 Fe 259.939
11-01-B04 8/23/01 16:30:04 0,33017141 9,71E-03 2,93995456 Fe 259.939
11-01-C04 8/23/01 16:32:12 0,24740683 4,23E-03 1,70964961 Fe 259.939
11-01-D04 8/23/01 16:34:20 0,36276535 1,24E-02 3,40625309 Fe 259.939
11-01-E04 8/23/01 16:36:29 0,43872315 8,59E-03 1,95896871 Fe 259.939
11-01-F04 8/23/01 16:38:08 1,27228765 1,13E-02 0,88684198 Fe 259.939
12-01-A04 8/23/01 16:42:00 0,37811456 8,89E-03 2,35025027 Fe 259.939
12-01-B04 8/23/01 16:44:11 0,24836631 1,02E-02 4,0868461 Fe 259.939
12-01-C04 8/23/01 16:46:22 0,21218309 3,74E-03 1,76417769 Fe 259.939
12-01-D04 8/23/01 16:48:33 0,44956473 1,45E-02 3,22919858 Fe 259.939
12-01-E04 8/23/01 16:50:45 0,49217747 8,78E-03 1,784152 Fe 259.939
12-01-F04 8/23/01 16:52:27 1,36779413 1,13E-02 0,82552964 Fe 259.939
BL1 8/23/01 14:20:18 -7,52E-02 2,67E-03 3,55269522 Fe 259.939
BL2 8/23/01 14:27:57 -7,17E-02 1,61E-03 2,24096238 Fe 259.939
BL3 8/23/01 15:47:04 -7,68E-02 9,16E-04 1,19222575 Fe 259.939
BL4 8/23/01 15:54:37 -7,38E-02 8,06E-04 1,09135752 Fe 259.939
BL5 8/23/01 16:56:21 -7,56E-02 9,37E-04 1,23943053 Fe 259.939
BL6 8/23/01 17:03:58 -7,33E-02 1,84E-03 2,50668265 Fe 259.939
C1 8/23/01 14:22:27 1,54961235 9,41E-03 0,60726226 Fe 259.939
C2 8/23/01 15:49:12 1,78938067 2,51E-02 1,40374125 Fe 259.939
C3 8/23/01 16:58:34 1,90592143 1,29E-02 0,67582924 Fe 259.939
Fe og K analyse.xls / rådata 2001-08-23
Sample ID Date Time Conc (Calib)SD (Calib) RSD (Conc) Analyte Name
C4 8/23/01 14:24:07 7,49669693 5,86E-02 0,78172493 Fe 259.939
C5 8/23/01 15:50:50 7,71268228 5,50E-02 0,71360383 Fe 259.939
C6 8/23/01 17:00:15 7,53885007 4,75E-02 0,63013111 Fe 259.939
C7 8/23/01 14:25:48 7,03365366 0,10393474 1,47767784 Fe 259.939
C8 8/23/01 15:52:29 6,8731285 4,88E-02 0,7101509 Fe 259.939
C9 8/23/01 17:01:52 7,13024472 4,92E-02 0,68987125 Fe 259.939
std 5.0 µg/mL8/23/01 14:18:09 5,00604169 4,31E-02 0,86062092 Fe 259.939
std 5.0 µg/mL8/23/01 14:31:49 4,99259956 2,92E-02 0,58515433 Fe 259.939
std 5.0 µg/mL8/23/01 14:46:44 4,99416865 2,90E-02 0,58158673 Fe 259.939
std 5.0 µg/mL8/23/01 15:01:32 4,99635609 1,84E-02 0,3677588 Fe 259.939
std 5.0 µg/mL8/23/01 15:27:42 4,99995916 2,20E-02 0,43988022 Fe 259.939
std 5.0 µg/mL8/23/01 15:42:40 5,00440137 2,37E-02 0,47370071 Fe 259.939
std 5.0 µg/mL8/23/01 15:56:19 5,01300728 2,21E-02 0,44130369 Fe 259.939
std 5.0 µg/mL8/23/01 16:11:03 5,00866644 2,03E-02 0,40430141 Fe 259.939
std 5.0 µg/mL8/23/01 16:25:48 5,00907936 2,12E-02 0,42274873 Fe 259.939
std 5.0 µg/mL8/23/01 16:39:49 5,01702416 2,29E-02 0,45645847 Fe 259.939
std 5.0 µg/mL8/23/01 16:54:09 5,01006624 1,72E-02 0,34374778 Fe 259.939
std 5.0 µg/mL8/23/01 17:05:38 5,0178834 2,82E-02 0,56128615 Fe 259.939
03-01-A04 8/23/01 14:30:08 5,01260176 0,10266409 2,04811977 K 766.490
03-01-B03 8/23/01 14:33:50 9,59487406 0,1755721 1,82985314 K 766.490
03-01-B09 8/23/01 14:36:11 5,44E-02 1,14E-02 20,9469319 K 766.490
03-01-B13 8/23/01 14:38:23 8,98433791 0,16305789 1,81491267 K 766.490
03-01-C04 8/23/01 14:40:36 8,93907273 0,14537543 1,62629203 K 766.490
03-01-C11 8/23/01 14:42:48 6,35249196 0,10975045 1,72767558 K 766.490
03-01-C16 8/23/01 14:45:02 4,47902041 2,04E-02 0,45613113 K 766.490
05-01-A04 8/23/01 14:48:56 5,47966844 0,10725672 1,9573578 K 766.490
05-01-B03 8/23/01 14:51:00 10,759347 0,14725624 1,36863546 K 766.490
05-01-B09 8/23/01 14:53:24 10,8104903 0,25130256 2,32461759 K 766.490
05-01-B13 8/23/01 14:55:24 8,66484734 0,11541576 1,33199991 K 766.490
05-01-C04 8/23/01 14:57:32 9,82614983 0,16808326 1,71057094 K 766.490
05-01-C11 8/23/01 14:59:51 9,28721016 0,21979174 2,36660667 K 766.490
05-01-C16 8/23/01 15:03:42 8,85739658 0,80808627 9,12329336 K 766.490
06-01-A04 8/23/01 15:17:21 4,55137506 7,96E-02 1,74925576 K 766.490
06-01-B04 8/23/01 15:19:20 9,83420084 0,19011772 1,93322999 K 766.490
06-01-C04 8/23/01 15:21:40 3,72264066 7,18E-02 1,92983132 K 766.490
06-01-D04 8/23/01 15:23:50 5,38797209 8,74E-02 1,62143959 K 766.490
06-01-E04 8/23/01 15:25:50 8,44693957 0,13879294 1,64311505 K 766.490
06-01-F04 8/23/01 15:29:43 8,25935038 0,12108446 1,46602889 K 766.490
07-01-A04 8/23/01 15:32:04 5,17294838 7,43E-02 1,43588122 K 766.490
07-01-B04 8/23/01 15:34:07 8,24847254 0,12409928 1,50451227 K 766.490
07-01-C04 8/23/01 15:36:29 3,59051917 5,65E-02 1,57334099 K 766.490
07-01-D04 8/23/01 15:38:33 6,8900459 0,13707908 1,98952351 K 766.490
07-01-E04 8/23/01 15:40:56 5,59704946 6,04E-02 1,07858713 K 766.490
07-01-F04 8/23/01 15:44:53 5,46084993 0,15611548 2,85881282 K 766.490
09-01-A04 8/23/01 15:58:29 4,13471031 8,49E-02 2,05379873 K 766.490
09-01-B04 8/23/01 16:00:39 3,76108879 0,10156856 2,70050941 K 766.490
09-01-C04 8/23/01 16:02:49 1,84400418 2,58E-02 1,40055161 K 766.490
09-01-D04 8/23/01 16:04:59 3,90980058 7,19E-02 1,83890174 K 766.490
09-01-E04 8/23/01 16:07:10 1,7763692 1,51E-02 0,84742106 K 766.490
09-01-F04 8/23/01 16:09:21 2,52190862 2,38E-02 0,94366001 K 766.490
10-01-A04 8/23/01 16:13:14 6,96978115 0,1168737 1,67686329 K 766.490
10-01-B04 8/23/01 16:15:17 8,09040874 0,10384441 1,28354962 K 766.490
10-01-C04 8/23/01 16:17:40 3,95169253 7,24E-02 1,83089141 K 766.490
10-01-D04 8/23/01 16:19:43 6,44768548 6,71E-02 1,04022644 K 766.490
10-01-E04 8/23/01 16:22:03 6,19969347 9,39E-02 1,51423531 K 766.490
10-01-F04 8/23/01 16:24:09 5,40693248 0,1286895 2,38008339 K 766.490
11-01-A04 8/23/01 16:27:57 4,26686921 8,89E-02 2,08340744 K 766.490
11-01-B04 8/23/01 16:30:04 6,14097637 0,14270967 2,32389213 K 766.490
11-01-C04 8/23/01 16:32:12 4,02912408 6,10E-02 1,51443451 K 766.490
Fe og K analyse.xls / rådata 2001-08-23
Sample ID Date Time Conc (Calib)SD (Calib) RSD (Conc) Analyte Name
11-01-D04 8/23/01 16:34:10 6,5073433 0,10716161 1,64677969 K 766.490
11-01-E04 8/23/01 16:36:29 5,02574924 8,28E-02 1,64762269 K 766.490
11-01-F04 8/23/01 16:38:08 5,1504262 7,06E-02 1,37020853 K 766.490
12-01-A04 8/23/01 16:42:00 6,19587104 0,12376315 1,99751016 K 766.490
12-01-B04 8/23/01 16:44:01 12,2415471 0,23387695 1,91051788 K 766.490
12-01-C04 8/23/01 16:46:22 4,20868316 8,75E-02 2,07843249 K 766.490
12-01-D04 8/23/01 16:48:33 11,322086 0,27578867 2,43584677 K 766.490
12-01-E04 8/23/01 16:50:45 7,67386081 0,11736924 1,52946789 K 766.490
12-01-F04 8/23/01 16:52:27 8,41687905 7,63E-02 0,90680347 K 766.490
BL1 8/23/01 14:20:18 1,32E-02 1,98E-02 150,342854 K 766.490
BL2 8/23/01 14:27:57 0,18745591 3,42E-02 18,2670185 K 766.490
BL3 8/23/01 15:47:04 1,22E-02 1,10E-02 90,3668435 K 766.490
BL4 8/23/01 15:54:37 0,19480772 4,05E-02 20,7875641 K 766.490
BL5 8/23/01 16:56:21 4,74E-02 3,11E-02 65,621275 K 766.490
BL6 8/23/01 17:03:58 0,18492412 4,21E-02 22,7429562 K 766.490
C1 8/23/01 14:22:17 85,1277026 0,77069017 0,90533416 K 766.490
C2 8/23/01 15:49:02 94,3878554 1,44830579 1,53441964 K 766.490
C3 8/23/01 16:58:24 102,040983 0,13038337 0,12777549 K 766.490
C4 8/23/01 14:24:07 101,975111 1,36283769 1,33644149 K 766.490
C5 8/23/01 15:50:50 101,947237 1,32635084 1,30101695 K 766.490
C6 8/23/01 17:00:15 96,4572913 1,11253675 1,1533983 K 766.490
C7 8/23/01 14:25:48 102,375798 1,93308498 1,88822458 K 766.490
C8 8/23/01 15:52:29 94,6903182 1,27273304 1,3441005 K 766.490
C9 8/23/01 17:01:52 102,81159 1,42976841 1,39066851 K 766.490
std 5.0 µg/mL8/23/01 14:18:09 4,99898416 6,10E-02 1,21937669 K 766.490
std 5.0 µg/mL8/23/01 14:31:49 4,97074775 8,21E-02 1,65265734 K 766.490
std 5.0 µg/mL8/23/01 14:46:44 4,94395784 6,67E-03 0,13482254 K 766.490
std 5.0 µg/mL8/23/01 15:01:32 4,92775962 2,97E-02 0,60259169 K 766.490
std 5.0 µg/mL8/23/01 15:27:42 4,9138957 5,41E-02 1,1004893 K 766.490
std 5.0 µg/mL8/23/01 15:42:40 4,89864788 4,20E-02 0,85674997 K 766.490
std 5.0 µg/mL8/23/01 15:56:19 4,93525527 3,42E-02 0,69201466 K 766.490
std 5.0 µg/mL8/23/01 16:11:03 4,90700677 3,76E-02 0,76710706 K 766.490
std 5.0 µg/mL8/23/01 16:25:48 4,90681998 3,61E-02 0,7363879 K 766.490
std 5.0 µg/mL8/23/01 16:39:49 4,89689523 4,81E-02 0,98199454 K 766.490
std 5.0 µg/mL8/23/01 16:54:09 4,8631652 2,39E-02 0,491942 K 766.490
std 5.0 µg/mL8/23/01 17:05:38 4,91086447 2,65E-02 0,53988153 K 766.490
03-01-A04 8/23/01 14:29:58 1,02986883 2,86E-02 2,77845187 Sc 424.683
03-01-B03 8/23/01 14:33:50 1,04006399 1,71E-02 1,64028757 Sc 424.683
03-01-B09 8/23/01 14:36:01 1,00443296 1,42E-02 1,41098461 Sc 424.683
03-01-B13 8/23/01 14:38:13 1,01218333 2,14E-02 2,11684882 Sc 424.683
03-01-C04 8/23/01 14:40:26 1,05502017 2,10E-02 1,98723713 Sc 424.683
03-01-C11 8/23/01 14:42:38 1,02108027 1,50E-02 1,47077099 Sc 424.683
03-01-C16 8/23/01 14:44:52 1,06216371 1,42E-02 1,33229111 Sc 424.683
05-01-A04 8/23/01 14:48:46 1,01828715 1,81E-02 1,77288869 Sc 424.683
05-01-B03 8/23/01 14:51:00 1,03067707 1,84E-02 1,78475317 Sc 424.683
05-01-B09 8/23/01 14:53:14 1,0675629 2,33E-02 2,18434418 Sc 424.683
05-01-B13 8/23/01 14:55:24 1,00863849 1,52E-02 1,51127181 Sc 424.683
05-01-C04 8/23/01 14:57:32 0,94459535 1,86E-02 1,9660481 Sc 424.683
05-01-C11 8/23/01 14:59:41 1,04430359 2,01E-02 1,92635078 Sc 424.683
05-01-C16 8/23/01 15:03:32 1,07388174 2,56E-02 2,3851021 Sc 424.683
06-01-A04 8/23/01 15:17:11 1,0489662 1,78E-02 1,69390807 Sc 424.683
06-01-B04 8/23/01 15:19:20 0,98932074 1,92E-02 1,94460342 Sc 424.683
06-01-C04 8/23/01 15:21:30 0,97939577 1,76E-02 1,79855002 Sc 424.683
06-01-D04 8/23/01 15:23:40 1,01510893 2,20E-02 2,17044338 Sc 424.683
06-01-E04 8/23/01 15:25:50 1,00592725 1,72E-02 1,70681927 Sc 424.683
06-01-F04 8/23/01 15:29:43 1,00430048 1,95E-02 1,93978245 Sc 424.683
07-01-A04 8/23/01 15:31:54 1,02013565 1,48E-02 1,44955591 Sc 424.683
07-01-B04 8/23/01 15:34:07 1,02768062 2,14E-02 2,08454805 Sc 424.683
07-01-C04 8/23/01 15:36:19 0,98750543 1,46E-02 1,47646918 Sc 424.683
Fe og K analyse.xls / rådata 2001-08-23
Sample ID Date Time Conc (Calib)SD (Calib) RSD (Conc) Analyte Name
07-01-D04 8/23/01 15:38:33 1,08479709 2,36E-02 2,17962261 Sc 424.683
07-01-E04 8/23/01 15:40:46 0,96959977 1,79E-02 1,85045409 Sc 424.683
07-01-F04 8/23/01 15:44:43 1,0674398 2,20E-02 2,06176682 Sc 424.683
09-01-A04 8/23/01 15:58:19 1,04218065 2,31E-02 2,22103783 Sc 424.683
09-01-B04 8/23/01 16:00:28 1,05715237 2,75E-02 2,59874914 Sc 424.683
09-01-C04 8/23/01 16:02:39 1,02023845 2,65E-02 2,59309106 Sc 424.683
09-01-D04 8/23/01 16:04:49 1,0317032 2,20E-02 2,12899997 Sc 424.683
09-01-E04 8/23/01 16:07:00 0,98639387 2,03E-02 2,05897829 Sc 424.683
09-01-F04 8/23/01 16:09:11 1,01898491 2,22E-02 2,18209309 Sc 424.683
10-01-A04 8/23/01 16:13:04 1,00122 1,21E-02 1,20898275 Sc 424.683
10-01-B04 8/23/01 16:15:17 1,02395018 1,95E-02 1,90182903 Sc 424.683
10-01-C04 8/23/01 16:17:29 1,05141154 2,30E-02 2,19006453 Sc 424.683
10-01-D04 8/23/01 16:19:43 1,05834997 2,09E-02 1,97926353 Sc 424.683
10-01-E04 8/23/01 16:21:53 1,00329543 1,80E-02 1,79298593 Sc 424.683
10-01-F04 8/23/01 16:23:59 0,97276696 1,92E-02 1,97113548 Sc 424.683
11-01-A04 8/23/01 16:27:47 1,01487286 2,07E-02 2,04035112 Sc 424.683
11-01-B04 8/23/01 16:29:54 1,03586971 2,46E-02 2,3749023 Sc 424.683
11-01-C04 8/23/01 16:32:02 1,01800753 2,34E-02 2,30067958 Sc 424.683
11-01-D04 8/23/01 16:34:10 1,00738911 2,34E-02 2,31824265 Sc 424.683
11-01-E04 8/23/01 16:36:19 1,0000395 2,27E-02 2,27162813 Sc 424.683
11-01-F04 8/23/01 16:38:08 0,96750997 1,76E-02 1,82206148 Sc 424.683
12-01-A04 8/23/01 16:41:50 1,04838757 1,96E-02 1,86859665 Sc 424.683
12-01-B04 8/23/01 16:44:01 1,00658482 2,37E-02 2,35084974 Sc 424.683
12-01-C04 8/23/01 16:46:11 1,01275129 1,62E-02 1,60236066 Sc 424.683
12-01-D04 8/23/01 16:48:23 1,02159992 2,32E-02 2,27492162 Sc 424.683
12-01-E04 8/23/01 16:50:34 0,99700724 1,94E-02 1,94163266 Sc 424.683
12-01-F04 8/23/01 16:52:27 1,00326024 1,73E-02 1,72122105 Sc 424.683
BL1 8/23/01 14:20:08 1,01480552 1,82E-02 1,79628327 Sc 424.683
BL2 8/23/01 14:27:47 1,04230833 2,26E-02 2,1721845 Sc 424.683
BL3 8/23/01 15:46:54 0,97540599 2,03E-02 2,08354571 Sc 424.683
BL4 8/23/01 15:54:27 1,03856977 1,86E-02 1,79267504 Sc 424.683
BL5 8/23/01 16:56:11 1,00808055 1,86E-02 1,85000357 Sc 424.683
BL6 8/23/01 17:03:48 1,03772627 1,31E-02 1,25824911 Sc 424.683
C1 8/23/01 14:22:27 1,03843506 6,77E-03 0,65153763 Sc 424.683
C2 8/23/01 15:49:12 0,99610164 1,09E-02 1,09288116 Sc 424.683
C3 8/23/01 16:58:34 1,01174223 5,89E-03 0,5824479 Sc 424.683
C4 8/23/01 14:24:07 1,04543337 1,35E-02 1,29318584 Sc 424.683
C5 8/23/01 15:50:50 1,00807287 1,74E-02 1,72536391 Sc 424.683
C6 8/23/01 17:00:15 1,01613597 1,53E-02 1,50582551 Sc 424.683
C7 8/23/01 14:25:48 1,05147125 2,09E-02 1,98461501 Sc 424.683
C8 8/23/01 15:52:29 1,03733937 1,72E-02 1,66132578 Sc 424.683
C9 8/23/01 17:01:52 0,98764246 2,27E-02 2,3012252 Sc 424.683
std 5.0 µg/mL8/23/01 14:18:09 1,05258214 1,61E-02 1,53303947 Sc 424.683
std 5.0 µg/mL8/23/01 14:31:49 1,0593165 1,74E-02 1,64439398 Sc 424.683
std 5.0 µg/mL8/23/01 14:46:44 1,06221174 1,90E-02 1,78792999 Sc 424.683
std 5.0 µg/mL8/23/01 15:01:32 1,06143388 1,31E-02 1,23633684 Sc 424.683
std 5.0 µg/mL8/23/01 15:27:42 1,06117549 1,18E-02 1,11124642 Sc 424.683
std 5.0 µg/mL8/23/01 15:42:40 1,06228665 1,23E-02 1,1619939 Sc 424.683
std 5.0 µg/mL8/23/01 15:56:19 1,04755743 1,95E-02 1,86354936 Sc 424.683
std 5.0 µg/mL8/23/01 16:11:03 1,04996728 1,64E-02 1,56669446 Sc 424.683
std 5.0 µg/mL8/23/01 16:25:48 1,04387233 1,94E-02 1,86238985 Sc 424.683
std 5.0 µg/mL8/23/01 16:39:49 1,04382521 1,88E-02 1,79733868 Sc 424.683
std 5.0 µg/mL8/23/01 16:54:09 1,04516426 1,64E-02 1,56562865 Sc 424.683
std 5.0 µg/mL8/23/01 17:05:38 1,04160179 1,62E-02 1,55951992 Sc 424.683
05-01-C16 8/23/01 15:03:42 0,34600704 3,89E-02 11,2399762 Fe 259.939
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Defined values: Measured values:
Total volume (mL) 5,00             500-µL autodispenser this day (mL) 0,4966
Fe and K in std. 5 (µg/mL) 5,00             250-µL finnpipette this day (mL) 0,2505
Sc in stock solution (µg/mL) 10,00           weighed in FeSO4;7H2O (mg) 553,7
Fe in stock solution (µg/mL) 100,00         
Fe in std. bovine liver (µg/g) 184 Computed values:
K in std. bovine liver (wt.%) 0,994 Sc as int.std. in samples (µg/mL) 0,9932 (based on autodispenser performance this day)
FeSO4;7H2O - Mw (g/mol) 278,01 conc. of Fe in FeSO4-sol. (µg/mL) 111,23        
Fe - Mw (g/mol) 55,847 added Fe from FeSO4-sol. (µg) 27,86          (based on finnpipette performance this day)
added Fe from stock sol. (µg) 25,05 (based on finnpipette performance this day)
K in std. bovine liver (µg/g) 9940
Detection limits
Fe 259.939 K 766.490
Sample ID Conc (Calib) SD (Calib) RSD (Conc) Conc (Calib) SD (Calib) RSD (Conc)
BL1 -0,0752      0,0027        3,5527        0,0132        0,0198            150,3429    
BL2 -0,0717      0,0016        2,2410        0,1875        0,0342            18,2670      
BL3 -0,0768      0,0009        1,1922        0,0122        0,0110            90,3668      
BL4 -0,0738      0,0008        1,0914        0,1948        0,0405            20,7876      
BL5 -0,0756      0,0009        1,2394        0,0474        0,0311            65,6213      
BL6 -0,0733      0,0018        2,5067        0,1849        0,0421            22,7430      
Avg. -0,0744      0,1067        
SD 0,0018        DL: 0,0305        0,0912        DL: 1,5050        
%RSD 2,48 % QL: 0,0923        85,51 % QL: 4,5605        
DL = 3.3 * SD * total volume QL = 10 * SD * total volume
Controls Fe 259.939 K 766.490
Organ Analyte Analyte Total Analyte Analyte Total
dry weight measured from organ recovery measured from organ recovery
Sample ID g µg/mL µg/g % µg/mL µg/g %
std 5.0 µg/mL - 5,0060        - 100,12 % 4,9990        - 99,98 %
std 5.0 µg/mL - 4,9926        - 99,85 % 4,9707        - 99,41 %
std 5.0 µg/mL - 4,9942        - 99,88 % 4,9440        - 98,88 %
std 5.0 µg/mL - 4,9964        - 99,93 % 4,9278        - 98,56 %
std 5.0 µg/mL - 5,0000        - 100,00 % 4,9139        - 98,28 %
std 5.0 µg/mL - 5,0044        - 100,09 % 4,8986        - 97,97 %
std 5.0 µg/mL - 5,0130        - 100,26 % 4,9353        - 98,71 %
std 5.0 µg/mL - 5,0087        - 100,17 % 4,9070        - 98,14 %
std 5.0 µg/mL - 5,0091        - 100,18 % 4,9068        - 98,14 %
std 5.0 µg/mL - 5,0170        - 100,34 % 4,8969        - 97,94 %
std 5.0 µg/mL - 5,0101        - 100,20 % 4,8632        - 97,26 %
std 5.0 µg/mL - 5,0179        - 100,36 % 4,9109        - 98,22 %
Avg. - 5,0058        - 100,12 % 4,9228        - 98,46 %
SD - 0,0085        - 0,17 % 0,0360        - 0,72 %
%RSD - 0,17 % - 0,17 % 0,73 % - 0,73 %
C1 0,0443         1,5496        183,2975    99,62 % 85,1277      9 596,0544     96,54 %
C2 0,0501         1,7894        186,0064    101,09 % 94,3879      9 409,3009     94,66 %
C3 0,0537         1,9059        184,3878    100,21 % 102,0410    9 491,0914     95,48 %
C4 0,0514         7,4967        194,4143    101,43 % 101,9751    9 909,3823     99,69 %
C5 0,0533         7,7127        207,7453    103,36 % 101,9472    9 553,5250     96,11 %
C6 0,0501         7,5389        203,6659    102,66 % 96,4573      9 615,8314     96,74 %
C7 0,0519         7,0337        202,1249    102,72 % 102,3758    9 852,5180     99,12 %
C8 0,0494         6,8731        196,1064    101,75 % 94,6903      9 573,2447     96,31 %
C9 0,0531         7,1302        206,6523    103,45 % 102,8116    9 670,8973     97,29 %
Avg. 0,0508         5,4478        196,0445    101,81 % 97,9793      9 630,2050     96,88 %
SD 0,0029         2,7884        9,6584        1,35 % 5,9381        161,1161        1,62 %
%RSD 5,68 % 51,18 % 4,93 % 1,33 % 6,06 % 1,67 % 1,67 %
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NB!  Missing sample no. 03-01-B09;  All values FALSE
Samples Fe 259.939 K 766.490
Organ Analyte Analyte Relative to Analyte Analyte Relative to
wet weight measured from organ pre-inc. measured from organ pre-inc.
Sample ID g µg/mL µg/g % µg/mL µg/g %
03-01-A04 0,0225         0,3264        89,0583      100,00 % 5,0126        1 090,2091     100,00 % A: pre-incubated
03-01-B03 0,0215         0,3725        103,9318    116,70 % 9,5949        2 206,5612     202,40 % B: 3-h negative
03-01-B09 FALSE FALSE FALSE FALSE FALSE FALSE FALSE B: 6-h negative
03-01-B13 0,0161         0,4946        176,7090    198,42 % 8,9843        2 757,0426     252,89 % B: 24-h negative
03-01-C04 0,0204         0,5115        143,5977    161,24 % 8,9391        2 164,8068     198,57 % C: 3-h test 100
03-01-C11 0,0274         0,4522        96,0888      107,89 % 6,3525        1 139,7502     104,54 % C: 6-h test 100
03-01-C16 0,0211         0,3175        92,8693      104,28 % 4,4790        1 036,1042     95,04 % C: 24-h test 100
05-01-A04 0,0208         0,2241        71,7617      100,00 % 5,4797        1 291,5884     100,00 % A: pre-incubated
05-01-B03 0,0235         0,2942        78,4166      109,27 % 10,7593      2 266,5290     175,48 % B: 3-h negative
05-01-B09 0,0220         0,4316        114,9897    160,24 % 10,8105      2 432,6885     188,35 % B: 6-h negative
05-01-B13 0,0180         0,3081        106,2499    148,06 % 8,6648        2 377,2740     184,06 % B: 24-h negative
05-01-C04 0,0227         0,3341        89,9806      125,39 % 9,8261        2 140,8566     165,75 % C: 3-h test 100
05-01-C11 0,0272         0,4435        95,2050      132,67 % 9,2872        1 687,6010     130,66 % C: 6-h test 100
05-01-C16 0,0193         0,3661        114,1242    159,03 % 8,8574        2 267,0300     175,52 % C: 24-h test 100
06-01-A04 0,0171         0,3652        128,5490    100,00 % 4,5514        1 299,6241     100,00 % A: pre-incubated
06-01-B04 0,0187         0,3780        120,9688    94,10 % 9,8342        2 600,9465     200,13 % B: 24-h negative
06-01-C04 0,0203         0,2229        73,2280      56,97 % 3,7226        890,6354        68,53 % C: 24-h positive
06-01-D04 0,0133         0,2539        123,4144    96,01 % 5,3880        1 985,4554     152,77 % D: 24-h test 100
06-01-E04 0,0195         0,3511        109,1015    84,87 % 8,4469        2 138,5330     164,55 % E: 24-h test 200
06-01-F04 0,0156         0,3268        128,5963    100,04 % 8,2594        2 613,0415     201,06 % F: 24-h test 400
07-01-A04 0,0264         0,4757        104,1906    100,00 % 5,1729        959,5242        100,00 % A: pre-incubated
07-01-B04 0,0215         0,2925        85,3319      81,90 % 8,2485        1 893,4446     197,33 % B: 24-h negative
07-01-C04 0,0328         0,2532        49,9377      47,93 % 3,5905        531,0760        55,35 % C: 24-h positive
07-01-D04 0,0239         0,3345        85,5371      82,10 % 6,8900        1 419,1182     147,90 % D: 24-h test 100
07-01-E04 0,0162         0,2440        98,2677      94,32 % 5,5970        1 694,5644     176,60 % E: 24-h test 200
07-01-F04 0,0231         0,5231        129,3319    124,13 % 5,4608        1 158,9154     120,78 % F: 24-h test 400
09-01-A04 0,0334         0,5963        100,3979    100,00 % 4,1347        603,0014        100,00 % A: pre-incubated
09-01-B04 0,0243         0,1854        53,4592      53,25 % 3,7611        751,9399        124,70 % B: 24-h negative
09-01-C04 0,0288         0,1340        36,1896      36,05 % 1,8440        301,6221        50,02 % C: 24-h positive
09-01-D04 0,0248         0,2798        71,4026      71,12 % 3,9098        766,7621        127,16 % D: 24-h test 0.200
09-01-E04 0,0295         0,4192        83,6556      83,32 % 1,7764        283,0014        46,93 % E: 24-h test 1.00
09-01-F04 0,0259         0,7103        151,4914    150,89 % 2,5219        466,2641        77,32 % F: 24-h test 5.00
10-01-A04 0,0287         0,4891        98,1773      100,00 % 6,9698        1 195,6656     100,00 % A: pre-incubated
10-01-B04 0,0195         0,3383        105,8103    107,77 % 8,0904        2 047,1149     171,21 % B: 24-h negative
10-01-C04 0,0244         0,2162        59,5462      60,65 % 3,9517        787,9163        65,90 % C: 24-h positive
10-01-D04 0,0208         0,3107        92,5614      94,28 % 6,4477        1 524,2848     127,48 % D: 24-h test 0.200
10-01-E04 0,0182         0,3781        124,3035    126,61 % 6,1997        1 673,9101     140,00 % E: 24-h test 1.00
10-01-F04 0,0187         0,4581        142,3922    145,04 % 5,4069        1 417,1849     118,53 % F: 24-h test 5.00
11-01-A04 0,0263         0,3861        87,5529      100,00 % 4,2669        790,9141        100,00 % A: pre-incubated
11-01-B04 0,0222         0,3302        91,1204      104,07 % 6,1410        1 359,0801     171,84 % B: 24-h negative
11-01-C04 0,0216         0,2474        74,4931      85,08 % 4,0291        907,9776        114,80 % C: 24-h positive
11-01-D04 0,0203         0,3628        107,6770    122,99 % 6,5073        1 576,5228     199,33 % D: 24-h test 0.200
11-01-E04 0,0250         0,4387        102,6253    117,22 % 5,0257        983,8177        124,39 % E: 24-h test 1.00
11-01-F04 0,0235         1,2723        286,5300    327,26 % 5,1504        1 073,1416     135,68 % F: 24-h test 5.00
12-01-A04 0,0239         0,3781        94,6690      100,00 % 6,1959        1 273,8934     100,00 % A: pre-incubated
12-01-B04 0,0193         0,2484        83,6190      88,33 % 12,2415      3 143,7529     246,78 % B: 24-h negative
12-01-C04 0,0217         0,2122        66,0337      69,75 % 4,2087        945,1664        74,20 % C: 24-h positive
12-01-D04 0,0188         0,4496        139,3532    147,20 % 11,3221      2 982,8259     234,15 % D: 24-h test 0.200
12-01-E04 0,0178         0,4922        159,1519    168,11 % 7,6739        2 125,6180     166,86 % E: 24-h test 1.00
12-01-F04 0,0199         1,3678        362,3611    382,77 % 8,4169        2 087,9945     163,91 % F: 24-h test 5.00
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Analysed by: Eva Mokastet Sign:_____________________________Date:________________
and Edvard G. Nygaard
Controlled by: Eva Mokastet Sign:_____________________________Date:________________
Results:
µg/g is content of Fe or K per slice wet weight;  % is content relative to pre-incubated slices from the same experiments.
Identical experiments:  {03, 05 (3-6-24-h, 100)}, {06, 07 (24-h, 100/200/400)}, {09 to 12 (24-h, 200/1000/5000)}
Fe 259.939 K 766.490
Groups no. of slices (µg/g) SD (%) (µg/g) SD (%)
03, 05 4 82,60 9,95 100,00 % 948,46 302,24 100,00 %
06, 07 4 119,51 22,11 100,00 % 1167,65 260,13 100,00 %
09  to 12 8 100,42 12,39 100,00 % 1002,59 294,63 100,00 %
Pre-incubated total 16 100,74 100,00 % 1030,32 100,00 %
06, 07, 09  to 12 12 106,78 100,00 % 1057,61 100,00 %
03, 05, 06, 07 8 101,05 100,00 % 1058,05 100,00 %
3-h negative (03, 05) 4 87,76 11,19 106,25 % 2058,87 239,43 217,08 %
6-h negative (03, 05) 3 117,29 7,13 142,00 % 2264,41 514,37 238,75 %
03, 05 4 123,58 35,95 149,61 % 2271,82 374,92 239,53 %
06, 07 4 97,90 36,61 81,92 % 2024,08 995,74 173,35 %
09  to 12 8 85,25 25,52 84,89 % 1829,85 915,44 182,51 %
24-h negative total 16 97,99 97,28 % 1988,90 193,04 %
06, 07 4 58,81 13,87 49,21 % 679,95 263,28 58,23 %
09  to 12 8 69,32 17,24 69,03 % 879,61 333,78 87,73 %
24-h positive total 12 65,82 61,64 % 813,06 76,88 %
3-h test 100 (03, 05) 4 97,86 31,01 118,48 % 1664,92 623,97 175,54 %
6-h test 100 (03, 05) 4 102,88 13,74 124,55 % 1615,06 590,12 170,28 %
03, 05 4 114,23 15,14 138,29 % 1883,58 569,57 198,59 %
06, 07 4 112,81 31,19 94,40 % 1766,21 243,85 151,26 %
24-h test 100 total 8 113,52 112,34 % 1824,89 172,48 %
06, 07 4 108,76 8,87 91,01 % 1921,57 285,19 164,57 %
09  to 12 8 96,09 22,25 95,68 % 1640,54 742,13 163,63 %
24-h test 200 total 12 100,31 93,94 % 1734,21 163,98 %
24-h test 400 (06, 07) 4 125,29 4,28 104,84 % 1957,58 702,60 167,65 %
24-h test 1000 (09-12) 8 119,34 32,11 118,84 % 1374,24 796,43 137,07 %
24-h test 5000 (09-12) 8 215,76 86,20 214,86 % 1167,69 692,41 116,47 %
Fe og K analyse.xls / oppsummering
Slice weights (mg)
Single-concentration, 3-/6-/24-hour experiments





mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 0h A-03 21,0 FALSE A-02 23,6 21,5
A-04 21,7 29,4 A-03 45,6 24,8
A-05 24,2 27,9 A-04 22,5 20,8
A-06 26,1 26,5 A-05 23,3 25,6
A-07 19,2 26,1
mean 22,44 27,475 28,75 23,175
SD 2,72084546 1,49749791 11,2429237 2,3781996
mean-mean 24,9575 repl= 5 25,9625 repl= 4
SE 3,56028264 n= 2 3,94212031 n= 2
neg ctrl 3h B-01 22,2 23,7 B-01 46,2 24,2
B-02 22,0 22,7 B-02 21,4 24,4
B-03 19,0 23,1 B-03 21,5 23,5
B-04 19,4 23,8 B-04 44,4 26,1
B-05 26,1 25,7 B-05 42,3 23,0
B-06 20,9 22,8
mean 21,74 23,8 32,7833333 24,0
SD 2,8404225 1,15325626 12,6777627 1,2083046
mean-mean 22,77 repl= 5 28,3916667 repl= 6
SE 1,45663997 n= 2 6,21075456 n= 2
neg ctrl 6h B-06 18,1 17,8 B-07 31,0 26,8
B-07 22,8 23,1 B-08 27,9 21,1
B-08 23,3 21,2 B-09 FALSE 22,0
B-09 17,8 23,3 B-10 23,1 25,2
B-10 23,2 24,9
mean 21,04 22,06 27,3333333 23,775
SD 2,82895741 2,71900717 3,98036849 2,67628474
mean-mean 21,55 repl= 5 25,5541667 repl= 4
SE 0,72124892 n= 2 2,51612163 n= 2
neg ctrl 24h B-11 14,3 20,5 B-11 21,2 17,2
B-12 15,5 17,3 B-12 20,9 18,5
B-13 18,1 19,2 B-13 16,1 18,0
B-14 17,0 19,9 B-14 16,4 19,2
B-15 19,9 19,6 B-15 16,2 19,7
B-16 16,8 18,3
mean 16,96 19,3 17,9333333 18,4833333
SD 2,1881499 1,21449578 2,42789346 0,88411915
mean-mean 18,13 repl= 5 18,2083333 repl= 6




EGN-04-00 EGN-02-01 EGN-03-01 EGN-05-01
"menadione" "Fe-100"
test 3h C-01 22,0 25,9 C-01 22,0 26,4
C-02 25,8 24,1 C-02 20,7 19,4
C-03 19,9 29,8 C-03 39,0 26,0
C-04 21,0 30,1 C-04 20,4 22,7
C-05 22,7 31 C-05 44,3 23,0
C-06 20,1 24,9
C-07 17,5 20,9
mean 22,28 28,18 26,2857143 23,3285714
SD 2,2331592 3,00449663 10,6913405 2,61005382
mean-mean 25,23 repl= 5 24,8071429 repl= 7
SE 4,17193001 n= 2 2,09101577 n= 2
test 6h C-06 28,8 27,6 C-08 21,5 35,5
C-07 22,6 24,1 C-09 24,5 23,8
C-08 22,0 31,7 C-10 28,8 21,7
C-09 26,0 23,7 C-11 27,4 27,2
C-10 27,0 27,6 C-12 21,4 25,3
mean 25,28 26,94 24,72 26,7
SD 2,90723236 3,24391738 3,36407491 5,3164838
mean-mean 26,11 repl= 5 25,71 repl= 5
SE 1,17379726 n= 2 1,40007143 n= 2
test 24h C-11 21,4 23,8 C-13 22,9 17,4
C-12 21,1 20,8 C-14 23,2 16,0
C-13 22,6 27,2 C-15 19,1 18,7
C-14 22,6 23,3 C-16 21,1 19,3
C-15 23,4 28,3 C-17 18,7 16,7
C-18 19,0 18,5
C-19 19,9 21,4
mean 22,22 24,68 20,5571429 18,2857143
SD 0,94973681 3,04909823 1,87958962 1,80132227
mean-mean 23,45 repl= 5 19,4214286 repl= 7
SE 1,73948268 n= 2 1,60614255 n= 2
"menadione" Negative and positive control (200 µM menadione):
Mean ± SE from n=2 animals x 5 replicates
"Fe-100" Negative control and 100 µM FeSO4:
Mean ± SE from n=2 animals x 4-7 replicates
"Fe-3xLow" 100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=2 animals x 6-7 replicates
"Fe-3xHigh" 200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=4 animals x 6-7 replicates
Slice weights (mg)
Three-concentration, 24-hour experiments




mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 0h A-02 15,1 29,9 A-02 32,2 21,7 28,8 27,5
A-03 19,3 27,0 A-03 29,9 26,3 31,9 23,1
A-04 17,1 26,4 A-04 33,4 28,7 26,3 23,9
A-05 21,7 28,6 A-05 32,9 23,0 25,2 28,0
A-06 17,6 28,4 A-06 28,5 28,1 25,3 24,8
A-07 16,6 29,6 A-07 22,2 25,2 26,1 24,4
mean 17,9 28,3166667 29,85 25,5 27,2666667 25,2833333
SD 2,30911238 1,38912442 4,18986873 2,77200289 2,61737782 1,99941658
mean-mean 23,1083333 repl= 6 26,975 repl= 6
SE 7,36569564 n= 2 2,11250685 n= 4
neg ctrl 24h B-02 16,9 23,9 B-02 25,3 16,6 25,0 19,6
B-03 16,6 24,1 B-03 25,1 17,5 19,5 18,6
B-04 18,7 21,5 B-04 24,3 19,5 22,2 19,3
B-05 14,1 23,6 B-05 24,8 15,3 18,3 FALSE
B-06 15,7 23,1 B-06 21,7 16,6 16,8 19,3
B-07 14,9 18,8 B-07 23,9 20,6 17,0 18,7
mean 16,15 22,5 24,1833333 17,6833333 19,8 19,1
SD 1,62696036 2,03862699 1,32123679 1,9934058 3,22428287 0,43011626
mean-mean 19,325 repl= 6 20,1916667 repl= 6
SE 4,49012806 n= 2 2,80299113 n= 4
pos ctrl 24h C-02 20,0 26,2 C-02 26,5 20,3 26,2 26,4
C-03 20,1 33,6 C-03 24,7 22,2 25,6 25,4
C-04 20,3 32,8 C-04 28,8 24,4 21,6 21,7
C-05 22,9 29,4 C-05 28,9 20,3 25,1 22,1
C-06 20,3 29,7 C-06 27,3 20,5 24,5 23,4
C-07 17,9 24,7 C-07 23,2 24,4 20,3 23,7
mean 20,25 29,4 26,5666667 22,0166667 23,8833333 23,7833333
SD 1,58965405 3,51055551 2,27126984 1,97930964 2,37606117 1,8323937
mean-mean 24,825 repl= 6 24,0625 repl= 6
SE 6,47002705 n= 2 1,8767276 n= 4









mean-mean 19,7857143 repl= 7




EGN-06-01 EGN-07-01 EGN-09-01 EGN-10-01 EGN-11-01 EGN-12-01
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
Fe-200 24h E-01 17,9 26,5 D-01 23,0 17,5 25,6 20,2
E-02 19,5 23,1 D-02 25,5 17,2 21,3 17,5
E-03 16,4 20,7 D-03 20,4 19,3 22,6 19,7
E-04 19,5 16,2 D-04 24,8 20,8 20,3 18,8
E-05 16,3 28,6 D-05 24,4 21,2 21,2 18,4
E-06 16,2 23,5 D-06 17,9 20,1 18,4 19,4
E-07 15,7 23,7 D-07 29,1 14,3 16,1 19,6
mean 17,3571429 23,1857143 23,5857143 18,6285714 20,7857143 19,0857143
SD 1,61230388 3,99267186 3,62924628 2,44929533 3,02182537 0,91729416
mean-mean 20,2714286 repl= 7 20,5214286 repl= 7
SE 4,12142238 n= 2 2,24379719 n= 4









mean-mean 20,4357143 repl= 7
SE 4,87903679 n= 2
Fe-1000 24h E-01 33,6 19,2 23,4 20,3
E-02 25,0 17,4 FALSE 20,9
E-03 28,0 21,1 24,0 18,6
E-04 29,5 18,2 25,0 17,8
E-05 26,5 16,8 25,5 19,5
E-06 26,9 20,4 21,7 20,5
E-07 23,3 15,7 19,2 19,7
mean 27,5428571 18,4 23,1333333 19,6142857
SD 3,33409515 1,95021366 2,34236348 1,09913386
mean-mean 22,172619 repl= 7
SE 4,10447532 n= 4
Fe-5000 24h F-01 24,1 22,6 28,5 20,8
F-02 30,7 14,5 22,7 20,5
F-03 25,3 21,8 26,9 18,9
F-04 25,9 18,7 23,5 19,9
F-05 25,7 20,0 26,5 21,9
F-06 26,1 18,3 20,5 18,1
F-07 29,5 21,0 18,6 20,3
mean 26,7571429 19,5571429 23,8857143 20,0571429
SD 2,39920622 2,72204405 3,60944528 1,25147532
mean-mean 22,5642857 repl= 7
SE 3,39876929 n= 4
MTT test (% of 24h negative control; OD-570 / mg slice weight)
Single-concentration, 3-/6-/24-hour experiments





mean-mean repl= 0 repl= 0
SE n= 0 n= 0







mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 3h B-01 B-01
B-02 B-02
B-03 0,93713542 0,8729865 B-03
B-04 1,23849471 0,80146029 B-04
B-05 B-05 0,31268122 0,91059416
B-06 0,82283465 0,84105195
mean 1,08781507 0,83722339 0,56775794 0,87582306
SD 0,2130932 0,05057666 0,36073295 0,04917377
mean-mean 0,96251923 repl= 2 0,7217905 repl= 2
SE 0,17719507 n= 2 0,21783493 n= 2







mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 24h B-11 B-11
B-12 B-12
B-13 1,11895625 1,08577696 B-13
B-14 0,88104375 0,91422304 B-14
B-15 B-15 0,90203327 0,93175339
B-16 1,09796673 1,06824661
mean 1,00 1,00 1,00 1,00
SD 0,16822954 0,12130693 0,13854588 0,09651528
mean-mean 1 repl= 2 1 repl= 2
SE 0 n= 2 0 n= 2
"menadione" "Fe-100"
MTT test (% of 24h negative control; OD-570 / mg slice weight)
Single-concentration, 3-/6-/24-hour experiments
EGN-04-00 EGN-02-01 EGN-03-01 EGN-05-01
"menadione" "Fe-100"
test 3h C-01 C-01
C-02 C-02
C-03 0,59143821 0,52935792 C-03




mean 0,64629563 0,40896826 0,90767468 0,97621337
SD 0,07758012 0,17025669 0,23046877 0,10422244
mean-mean 0,52763195 repl= 2 0,94194402 repl= 2
SE 0,1678158 n= 2 0,04846417 n= 2







mean-mean repl= 0 #DIV/0! repl= 0
SE n= 0 #DIV/0! n= 0
test 24h C-11 C-13
C-12 C-14
C-13 0,14195237 0,35272506 C-15




mean 0,21853761 0,32679346 0,61612142 0,70537089
SD 0,10830789 0,03667281 0,18727562 0,00879223
mean-mean 0,27266554 repl= 2 0,66074615 repl= 2
SE 0,07654845 n= 2 0,0631089 n= 2
"menadione" Negative and positive control (200 µM menadione):
Mean ± SE from n=2 animals x 2 replicates
"Fe-100" Negative control and 100 µM FeSO4:
Mean ± SE from n=2 animals x 2 replicates
"Fe-3xLow" 100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=2 animals x 2 replicates
"Fe-3xHigh" 200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=4 animals x 2 replicates
MTT test (% of 24h negative control; OD-570 / mg slice weight)
Three-concentration, 24-hour experiments




mean-mean repl= 0 repl= 0
SE n= 0 n= 0




A-06 0,92239348 1,13145378 A-06 1,63607229 0,6535595 0,87696926 0,88295862
A-07 1,07350003 0,94076636 A-07 1,00784749 0,99639621 0,8095143 0,76294354
mean 0,99794675 1,03611007 1,32195989 0,82497786 0,84324178 0,82295108
SD 0,10684847 0,13483637 0,44422202 0,24242216 0,04769786 0,08486348
mean-mean 1,01702841 repl= 2 0,95328265 repl= 2
SE 0,02698554 n= 2 0,24595416 n= 4




B-06 FALSE 1,10004823 B-06 1,08729614 0,92155026 1,11977981 0,89762424
B-07 1,00 0,89995177 B-07 0,91270386 1,07844974 0,88022019 1,10237576
mean 1,00 1,00 1,00 1,00 1,00 1,00
SD #DIV/0! 0,14148957 0,12345538 0,11094468 0,16939424 0,14478119
mean-mean 1 repl= 2 1 repl= 2
SE 0 n= 2 0 n= 4




C-06 0,22834504 0,49148765 C-06 0,2868791 0,5668712 0,35071548 0,63032164
C-07 0,30991678 0,41085864 C-07 0,31767825 0,42193645 0,33293856 0,5637911
mean 0,26913091 0,45117315 0,30227868 0,49440383 0,34182702 0,59705637
SD 0,05767993 0,05701331 0,02177829 0,10248434 0,01257018 0,0470442
mean-mean 0,36015203 repl= 2 0,43389147 repl= 2










mean-mean 1,01881666 repl= 2
SE 0,10674328 n= 2
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
MTT test (% of 24h negative control; OD-570 / mg slice weight)
Three-concentration, 24-hour experiments
EGN-06-01 EGN-07-01 EGN-09-01 EGN-10-01 EGN-11-01 EGN-12-01
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"





E-06 0,88445877 1,26511454 D-06 1,37891252 0,75193486 0,87360874 1,0315581
E-07 1,26943926 0,70155379 D-07 0,26403462 0,94526943 0,68129316 0,96759814
mean 1,07694902 0,98333417 0,82147357 0,84860214 0,77745095 0,99957812
SD 0,27222232 0,39849763 0,78833772 0,13670819 0,13598765 0,04522652
mean-mean 1,03014159 repl= 2 0,86177619 repl= 2










mean-mean 1,01557345 repl= 2






E-06 0,54551371 0,82151021 0,59435039 0,94938501
E-07 0,98786464 1,2042597 0,68070825 1,05793617
mean 0,76668918 1,01288495 0,63752932 1,00366059
SD 0,31278934 0,27064476 0,06106423 0,07675726
mean-mean 0,85519101 repl= 2






F-06 0,4352579 0,89886212 0,62410178 1,00390709
F-07 0,4225399 0,78099032 0,67535609 0,78375802
mean 0,4288989 0,83992622 0,64972894 0,89383255
SD 0,00899298 0,08334794 0,03624227 0,15566889
mean-mean 0,70309665 repl= 2
SE 0,21066168 n= 4
Potassium content (% of 0h negative control; µg K / g slice weight)
Single-concentration, 3-/6-/24-hour experiments





mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 0h A-03 A-02
A-04 A-03 1,00 1,00





mean-mean repl= 0 1,00 repl= 2
SE n= 0 0 n= 2
neg ctrl 3h B-01 B-01
B-02 B-02 2,84369205 2,52850536






mean-mean repl= 0 2,28775393 repl= 2
SE n= 0 0,20659116 n= 2
neg ctrl 6h B-06 B-07
B-07 B-08 2,76814913 3,33111131





mean-mean repl= 0 2,68772387 repl= 2
SE n= 0 0,1137385 n= 2
neg ctrl 24h B-11 B-11
B-12 B-12 3,21315691 2,48538742






mean-mean repl= 0 2,51700946 repl= 2
SE n= 0 0,50066676 n= 2
"menadione" "Fe-100"
Potassium content (% of 0h negative control; µg K / g slice weight)
Single-concentration, 3-/6-/24-hour experiments
EGN-04-00 EGN-02-01 EGN-03-01 EGN-05-01
"menadione" "Fe-100"
test 3h C-01 C-01
C-02 C-02
C-03 C-03 1,3927406 1,87543623






mean-mean repl= 0 1,72784877 repl= 2
SE n= 0 0,05464276 n= 2
test 6h C-06 C-08
C-07 C-09
C-08 C-10 1,9875898 3,01717731




mean-mean repl= 0 1,83920448 repl= 2
SE n= 0 0,45635069 n= 2
test 24h C-11 C-13
C-12 C-14
C-13 C-15 3,45093696 2,6514811






mean-mean repl= 0 2,2020041 repl= 2
SE n= 0 0,00190868 n= 2
"menadione" -
"Fe-100" Negative control and 100 µM FeSO4:
Mean ± SE from n=2 animals x 2 replicates
"Fe-3xLow" 100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=2 animals x 2 replicates
"Fe-3xHigh" 200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=4 animals x 2 replicates
Potassium content (% of 0h negative control; µg K / g slice weight)
Three-concentration, 24-hour experiments




mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 0h A-02 A-02
A-03 1,00 1,00 A-03 1,00 1,00 1,00 1,00




mean 1,00 1,00 1,00 1,00 1,00 1,00
SD 0 0 0 0 0 0
mean-mean 1,00 repl= 2 1,00 repl= 2
SE 0 n= 2 0 n= 4
neg ctrl 24h B-02 B-02
B-03 1,98992457 0,71924511 B-03 1,07163721 1,99324502 1,56395593 2,04590872




mean 1,99561571 1,34628066 1,15931623 1,85267913 1,64116103 2,25686963
SD 0,0080485 0,88676218 0,12399687 0,19879018 0,1091845 0,29834378
mean-mean 1,67094819 repl= 2 1,72750651 repl= 2
SE 0,45914922 n= 2 0,4568695 n= 4
pos ctrl 24h C-02 C-02
C-03 0,6213064 0,40876518 C-03 0,94423213 0,90412127 0,98846267 1,08206679




mean 0,65330438 0,48112183 0,72221673 0,78154923 1,0682365 0,91200889
SD 0,04525198 0,10232775 0,31397719 0,17334304 0,11281723 0,24049818
mean-mean 0,56721311 repl= 2 0,87100284 repl= 2










mean-mean 1,54606098 repl= 2
SE 0,21175438 n= 2
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
Potassium content (% of 0h negative control; µg K / g slice weight)
Three-concentration, 24-hour experiments
EGN-06-01 EGN-07-01 EGN-09-01 EGN-10-01 EGN-11-01 EGN-12-01
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
Fe-200 24h E-01 D-01
E-02 D-02
E-03 1,49429169 1,7595139 D-03 1,54105486 1,08679635 1,51084761 1,89646243




mean 1,56989648 1,76278026 1,40631536 1,18081922 1,75206977 2,118983
SD 0,10692131 0,00461933 0,19055043 0,13296841 0,34113965 0,31469162
mean-mean 1,66633837 repl= 2 1,61454684 repl= 2










mean-mean 1,64563651 repl= 2
SE 0,28674325 n= 2
Fe-1000 24h E-01
E-02
E-03 0,46065523 1,53457285 1,51905013 1,78500528




mean 0,46498828 1,46727734 1,3814748 1,72680245
SD 0,00612785 0,09517022 0,1945609 0,08231123
mean-mean 1,26013572 repl= 2
SE 0,55005094 n= 4
Fe-5000 24h F-01
F-02
F-03 0,51478297 1,10868491 0,56582619 1,53437017




mean 0,64401085 1,14697679 0,96133159 1,58671779
SD 0,18275582 0,0541529 0,5593291 0,07403072
mean-mean 1,08475926 repl= 2
SE 0,39383877 n= 4
Iron content (% of 0h negative control; µg Fe / g slice weight)
Single-concentration, 3-/6-/24-hour experiments





mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 0h A-03 A-02
A-04 A-03 1,00 1,00





mean-mean repl= 0 1,00 repl= 2
SE n= 0 0 n= 2
neg ctrl 3h B-01 B-01
B-02 B-02 0,92380452 1,08059278






mean-mean repl= 0 1,06603583 repl= 2
SE n= 0 0,02917348 n= 2
neg ctrl 6h B-06 B-07
B-07 B-08 1,20262835 1,6316027





mean-mean repl= 0 1,40981049 repl= 2
SE n= 0 0,29299979 n= 2
neg ctrl 24h B-11 B-11
B-12 B-12 1,21974876 1,27828933






mean-mean repl= 0 1,49070672 repl= 2
SE n= 0 0,15735288 n= 2
"menadione" "Fe-100"
Iron content (% of 0h negative control; µg Fe / g slice weight)
Single-concentration, 3-/6-/24-hour experiments
EGN-04-00 EGN-02-01 EGN-03-01 EGN-05-01
"menadione" "Fe-100"
test 3h C-01 C-01
C-02 C-02
C-03 C-03 0,87908133 0,99361655






mean-mean repl= 0 1,18474517 repl= 2
SE n= 0 0,08626159 n= 2
test 6h C-06 C-08
C-07 C-09
C-08 C-10 1,04250417 1,60791422




mean-mean repl= 0 1,26401096 repl= 2
SE n= 0 0,28749174 n= 2
test 24h C-11 C-13
C-12 C-14
C-13 C-15 1,34058138 1,63467056






mean-mean repl= 0 1,4020918 repl= 2
SE n= 0 0,29755699 n= 2
"menadione" -
"Fe-100" Negative control and 100 µM FeSO4:
Mean ± SE from n=2 animals x 2 replicates
"Fe-3xLow" 100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=2 animals x 2 replicates
"Fe-3xHigh" 200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=4 animals x 2 replicates
Iron content (% of 0h negative control; µg Fe / g slice weight)
Three-concentration, 24-hour experiments




mean-mean repl= 0 #DIV/0! repl= 0
SE n= 0 #DIV/0! n= 0
neg ctrl 0h A-02 A-02
A-03 1,00 1,00 A-03 1,00 1,00 1,00 1,00




mean 1,00 1,00 1,00 1,00 1,00 1,00
SD 0 0 0 0 0 0
mean-mean 1,00 repl= 2 1 repl= 2
SE 0 n= 2 0 n= 4
neg ctrl 24h B-02 B-02
B-03 1,34649731 0,3563585 B-03 0,59657443 1,52145743 0,74830916 0,58128065




mean 1,14376476 0,58767829 0,56452367 1,29960212 0,89452782 0,73227936
SD 0,28670712 0,32713557 0,04532661 0,31375079 0,20678442 0,21354443
mean-mean 0,86572152 repl= 2 0,87273324 repl= 2
SE 0,39321251 n= 2 0,31486107 n= 4
pos ctrl 24h C-02 C-02
C-03 0,68545698 0,30265358 C-03 0,68195516 0,93962621 0,64271071 0,78361417




mean 0,62755371 0,39097242 0,5212085 0,77307136 0,74677263 0,7405681
SD 0,08188758 0,12490171 0,22733011 0,23554412 0,14716578 0,06087634
mean-mean 0,50926307 repl= 2 0,69540515 repl= 2










mean-mean 0,93296144 repl= 2
SE 0,00408471 n= 2
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
Iron content (% of 0h negative control; µg Fe / g slice weight)
Three-concentration, 24-hour experiments
EGN-06-01 EGN-07-01 EGN-09-01 EGN-10-01 EGN-11-01 EGN-12-01
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
Fe-200 24h E-01 D-01
E-02 D-02
E-03 1,08984821 0,81910846 D-03 0,71936942 1,18563111 0,86409901 0,69105345




mean 0,9692817 0,88113044 0,71528279 1,0642143 1,04697455 1,08152897
SD 0,1705068 0,08771233 0,00577936 0,1717093 0,25862506 0,55221578
mean-mean 0,92520607 repl= 2 0,97700015 repl= 2










mean-mean 1,07515245 repl= 2
SE 0,0529413 n= 2
Fe-1000 24h E-01
E-02
E-03 0,75664342 1,68851676 0,94710878 1,27002042




mean 0,79494211 1,47731447 1,05962997 1,4755805
SD 0,05416252 0,29868514 0,15912898 0,29070585
mean-mean 1,20186676 repl= 2
SE 0,33496748 n= 4
Fe-5000 24h F-01
F-02
F-03 1,48481385 1,97281934 1,44665347 2,45537411




mean 1,49686179 1,71158839 2,35965107 3,14151951
SD 0,01703837 0,36943636 1,29117358 0,97035613
mean-mean 2,17740519 repl= 2
SE 0,7400123 n= 4
ALAT leakage (% of total ALAT; U / litre)
Single-concentration, 3-/6-/24-hour experiments





mean-mean repl= 0 repl= 0
SE n= 0 n= 0







mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 3h B-01 0,03026706 0,03998236 B-01 0,1006239 0,02278351
B-02 0,06389713 0,03498457 B-02 0,02991521 0,02804124
B-03 0,0504451 0,03998236 B-03 0,03807391 0,02804124
B-04 0,04371909 0,03998236 B-04 0,11694129 0,03505155
B-05 0,0504451 0,04747905 B-05 0,08702608 0,02278351
B-06 0,03807391 0,04381443
mean 0,0477547 0,04048214 0,06844238 0,03008591
SD 0,01221841 0,00447016 0,03758185 0,00810113
mean-mean 0,04411842 repl= 5 0,04926415 repl= 6
SE 0,00514248 n= 2 0,02712212 n= 2
neg ctrl 6h B-06 0,0546136 0,06122449 B-07 0,14382403 0,03421122
B-07 0,06978404 0,06705539 B-08 0,13663283 0,03569866
B-08 0,06978404 0,06122449 B-09 FALSE 0,03718611
B-09 0,04854542 0,06997085 B-10 0,08629442 0,05503544
B-10 0,0546136 0,06997085
mean 0,05946814 0,06588921 0,12225042 0,04053286
SD 0,00973749 0,0044215 0,03134572 0,00974437
mean-mean 0,06267868 repl= 5 0,08139164 repl= 4
SE 0,00454038 n= 2 0,05778305 n= 2
neg ctrl 24h B-11 0,0874036 0,16227568 B-11 0,14641148 0,05470041
B-12 0,08116048 0,11683849 B-12 0,13556619 0,05322202
B-13 0,0874036 0,12982054 B-13 0,07591707 0,04730846
B-14 0,09988983 0,13631157 B-14 0,08133971 0,03991651
B-15 0,11861917 0,17525773 B-15 0,1030303 0,0413949
B-16 0,07049442 0,03104618
mean 0,09489534 0,1441008 0,10212653 0,04459808
SD 0,01490523 0,02402557 0,03224842 0,00893988
mean-mean 0,11949807 repl= 5 0,0733623 repl= 6
SE 0,03479352 n= 2 0,04067876 n= 2
"menadione" "Fe-100"
ALAT leakage (% of total ALAT; U / litre)
Single-concentration, 3-/6-/24-hour experiments
EGN-04-00 EGN-02-01 EGN-03-01 EGN-05-01
"menadione" "Fe-100"
test 3h C-01 0,08545099 0,05464388 C-01 0,03745083 0,02750531
C-02 0,09969282 0,0460159 C-02 0,04880383 0,0133055
C-03 0,05696733 0,05751988 C-03 0,21148325 0,0413949
C-04 0,07120916 0,06902385 C-04 0,02407553 0,02578623
C-05 0,0617146 0,06614786 C-05 0,09362707 0,02922439
C-06 0,02942565 0,02234806
C-07 0,01872541 0,02406715
mean 0,07500698 0,05867028 0,06622737 0,02623308
SD 0,01757134 0,0092301 0,06876199 0,0084415
mean-mean 0,06683863 repl= 5 0,04623022 repl= 7
SE 0,0115518 n= 2 0,02828023 n= 2
test 6h C-06 0,16714101 0,14250946 C-08 0,10687023 0,06857192
C-07 0,0923674 0,1563007 C-09 0,09541985 0,03501545
C-08 0,10116429 0,17468902 C-10 0,1259542 0,0379334
C-09 0,0923674 0,13791239 C-11 0,09923664 0,05252317
C-10 0,13635188 0,1563007 C-12 0,08396947 0,05252317
mean 0,1178784 0,15354246 0,10229008 0,04931342
SD 0,03297369 0,01439114 0,01559757 0,01346692
mean-mean 0,13571043 repl= 5 0,07580175 repl= 5
SE 0,0252183 n= 2 0,03746015 n= 2
test 24h C-11 0,39230769 0,10610789 C-13 0,1827302 0,06371611
C-12 0,44461538 0,09094962 C-14 0,12472089 0,04435168
C-13 0,39230769 0,12126616 C-15 0,13556619 0,05174363
C-14 0,23538462 0,10610789 C-16 0,13400215 0,03660287
C-15 0,26153846 0,14400357 C-17 0,14009316 0,08133971
C-18 0,15836618 0,10167464
C-19 0,13400215 0,05964912
mean 0,34523077 0,11368703 0,14421156 0,0627254
SD 0,09135146 0,02005251 0,01984982 0,02241488
mean-mean 0,2294589 repl= 5 0,10346848 repl= 7
SE 0,16372615 n= 2 0,05761942 n= 2
"menadione" Negative and positive control (200 µM menadione):
Mean ± SE from n=2 animals x 5 replicates
"Fe-100" Negative control and 100 µM FeSO4:
Mean ± SE from n=2 animals x 4-7 replicates
"Fe-3xLow" 100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=2 animals x 6-7 replicates
"Fe-3xHigh" 200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=4 animals x 6-7 replicates
ALAT leakage (% of total ALAT; U / litre)
Three-concentration, 24-hour experiments




mean-mean repl= 0 repl= 0
SE n= 0 n= 0








mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 24h B-02 0,07247535 0,10351508 B-02 0,34860384 0,10016069 0,15632184 0,05352032
B-03 0,06341593 0,13174647 B-03 0,30410122 0,12747724 0,14850575 0,04865484
B-04 0,09965361 0,03764185 B-04 0,31893543 0,13658275 0,13287356 0,03892387
B-05 0,04076739 0,1364517 B-05 0,26701571 0,10016069 0,11724138 0,10704064
B-06 0,05435651 0,08939939 B-06 0,22251309 0,11837172 0,0937931 0,07298226
B-07 0,06341593 0,06587324 B-07 0,21509599 0,12747724 0,1016092 0,04865484
mean 0,06568079 0,09410462 0,27937755 0,11837172 0,12505747 0,06162946
SD 0,01979644 0,03822548 0,05382725 0,01523644 0,02520614 0,0249361
mean-mean 0,07989271 repl= 6 0,14610905 repl= 6
SE 0,02009869 n= 2 0,09329134 n= 4
pos ctrl 24h C-02 0,07689145 0,13934426 C-02 0,27419355 0,10559006 0,1162546 0,09451008
C-03 0,11883224 0,12192623 C-03 0,19707661 0,09503106 0,12519726 0,07088256
C-04 0,11883224 0,13934426 C-04 0,19707661 0,10559006 0,10731194 0,07088256
C-05 0,11184211 0,13934426 C-05 0,27419355 0,10559006 0,1162546 0,08269632
C-06 0,06990132 0,18288934 C-06 0,05997984 0,09503106 0,08942662 0,0886032
C-07 0,08388158 0,09579918 C-07 0,17993952 0,11614907 0,06259863 0,08269632
mean 0,09669682 0,13644126 0,19707661 0,10383023 0,10284061 0,08171184
SD 0,02228818 0,02844353 0,0787188 0,00794853 0,02314751 0,00946331
mean-mean 0,11656904 repl= 6 0,12136482 repl= 6
SE 0,02810356 n= 2 0,05149512 n= 4









mean-mean 0,11867674 repl= 7
SE 0,04206581 n= 2
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
ALAT leakage (% of total ALAT; U / litre)
Three-concentration, 24-hour experiments
EGN-06-01 EGN-07-01 EGN-09-01 EGN-10-01 EGN-11-01 EGN-12-01
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
Fe-200 24h E-01 0,06726014 0,30167015 D-01 0,28909166 0,1045082 0,1515827 0,05315268
E-02 0,08407517 0,33716075 D-02 0,27498963 0,16547131 0,15916184 0,07972903
E-03 0,10089021 0,23956159 D-03 0,21153049 0,1567623 0,14400357 0,05315268
E-04 0,10509397 0,17745303 D-04 0,31024471 0,13934426 0,09852876 0,04872329
E-05 0,0504451 0,24843424 D-05 0,3031937 0,13934426 0,14400357 0,06201146
E-06 0,0714639 0,24843424 D-06 0,21153049 0,11321721 0,12126616 0,06201146
E-07 0,0504451 0,22181628 D-07 0,28909166 0,09579918 0,10610789 0,07529964
mean 0,07566766 0,25350432 0,26995319 0,13063525 0,1320935 0,06201146
SD 0,0221114 0,05220486 0,04145819 0,02660648 0,02350638 0,01171907
mean-mean 0,16458599 repl= 7 0,14867335 repl= 7
SE 0,12574951 n= 2 0,08721496 n= 4









mean-mean 0,1429666 repl= 7
SE 0,04774721 n= 2
Fe-1000 24h E-01 0,34913112 0,16047198 0,17346939 0,12118126
E-02 0,28199052 0,15044248 0,1971243 0,10386965
E-03 0,28199052 0,19056047 0,18923933 0,09809912
E-04 0,28870458 0,17050147 0,22077922 0,10386965
E-05 0,24170616 0,15044248 0,22077922 0,10386965
E-06 0,22827804 0,18053097 0,18135436 0,08655804
E-07 0,18799368 0,11032448 0,13404453 0,09232858
mean 0,26568495 0,15903919 0,18811291 0,10139657
SD 0,05169639 0,02617204 0,03000042 0,01097775
mean-mean 0,1785584 repl= 7
SE 0,06835513 n= 4
Fe-5000 24h F-01 0,27811861 0,21881188 0,27025641 0,10284061
F-02 0,3406953 0,11782178 0,34 0,09389795
F-03 0,25725971 0,21881188 0,30512821 0,08942662
F-04 0,28507157 0,19356436 0,25282051 0,09389795
F-05 0,31288344 0,16831683 0,26153846 0,1162546
F-06 0,25030675 0,14306931 0,18307692 0,06706996
F-07 0,23640082 0,15990099 0,19179487 0,10284061
mean 0,28010517 0,17432815 0,2578022 0,09517547
SD 0,03672901 0,03817067 0,05646673 0,01521004
mean-mean 0,20185275 repl= 7
SE 0,08444215 n= 4
ASAT leakage (% of total ASAT; U / litre)
Single-concentration, 3-/6-/24-hour experiments





mean-mean repl= 0 repl= 0
SE n= 0 n= 0







mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 3h B-01 0,01063164 0,01838928 B-01 0,02210118 0,02466151
B-02 0,01771941 0,01660967 B-02 0,00724004 0,02671663
B-03 0,01366926 0,01660967 B-03 0,00990743 0,03082689
B-04 0,01366926 0,01779608 B-04 0,02629278 0,03288201
B-05 0,01366926 0,02016889 B-05 0,02019591 0,01712605
B-06 0,01028848 0,02397647
mean 0,01387177 0,01791472 0,0160043 0,02603159
SD 0,0025212 0,00147706 0,00783899 0,00558215
mean-mean 0,01589324 repl= 5 0,02101795 repl= 6
SE 0,0028588 n= 2 0,00709036 n= 2
neg ctrl 6h B-06 0,01468297 0,02442728 B-07 0,06675799 0,02890424
B-07 0,02029705 0,03690078 B-08 0,07452055 0,02890424
B-08 0,02418371 0,03274295 B-09 FALSE 0,02951923
B-09 0,01295556 0,03742051 B-10 0,04657534 0,03628405
B-10 0,01813779 0,04625591
mean 0,01805142 0,03554949 0,06261796 0,03090294
SD 0,00447129 0,00792992 0,01442527 0,0035991
mean-mean 0,02680045 repl= 5 0,04676045 repl= 4
SE 0,012373 n= 2 0,02242591 n= 2
neg ctrl 24h B-11 0,02331816 0,07792293 B-11 0,07649749 0,05338546
B-12 0,03020762 0,04898013 B-12 0,07148126 0,05393021
B-13 0,02702787 0,0578856 B-13 0,03699469 0,04739321
B-14 0,03815699 0,06623449 B-14 0,0351136 0,03867722
B-15 0,04981607 0,08849818 B-15 0,0526704 0,04412472
B-16 0,03762172 0,03268497
mean 0,03370534 0,06790427 0,05172986 0,04503263
SD 0,01053671 0,01569847 0,0184212 0,00834493
mean-mean 0,0508048 repl= 5 0,04838125 repl= 6
SE 0,02418229 n= 2 0,00473566 n= 2
"menadione" "Fe-100"
ASAT leakage (% of total ASAT; U / litre)
Single-concentration, 3-/6-/24-hour experiments
EGN-04-00 EGN-02-01 EGN-03-01 EGN-05-01
"menadione" "Fe-100"
test 3h C-01 0,02113573 0,01750006 C-01 0,00859767 0,02451573
C-02 0,02536288 0,01531256 C-02 0,01065949 0,01307399
C-03 0,0158518 0,01881257 C-03 0,03887577 0,02178998
C-04 0,01743698 0,01618756 C-04 0,00722204 0,02319055
C-05 0,01532341 0,01793757 C-05 0,01925878 0,02716608
C-06 0,00722204 0,02451573
C-07 0,0051586 0,02385314
mean 0,01902216 0,01715006 0,01385634 0,02258646
SD 0,0042106 0,00139727 0,01194927 0,00450015
mean-mean 0,01808611 repl= 5 0,0182214 repl= 7
SE 0,00132377 n= 2 0,00617312 n= 2
test 6h C-06 0,05832089 0,04561955 C-08 0,05306512 0,05413582
C-07 0,03186049 0,05092414 C-09 0,04643198 0,03180479
C-08 0,04158064 0,06259426 C-10 0,05159109 0,03654168
C-09 0,03186049 0,04508909 C-11 0,05011706 0,04060186
C-10 0,04482069 0,06153334 C-12 0,0427469 0,04466205
mean 0,04168864 0,05315208 0,04879043 0,04154924
SD 0,01095032 0,00845747 0,0041822 0,00850057
mean-mean 0,04742036 repl= 5 0,04516983 repl= 5
SE 0,00810587 n= 2 0,00512029 n= 2
test 24h C-11 0,07572164 0,06237474 C-13 0,11921178 0,05113363
C-12 0,09833979 0,06132643 C-14 0,08652995 0,04249047
C-13 0,07670504 0,06866463 C-15 0,06709206 0,05011696
C-14 0,0481865 0,07233373 C-16 0,09190629 0,02921922
C-15 0,06982125 0,06761632 C-17 0,07858654 0,05972752
C-18 0,09989814 0,08164194
C-19 0,06859672 0,05242272
mean 0,07375484 0,06646317 0,08740307 0,05239321
SD 0,01793185 0,00457551 0,01840702 0,0160787
mean-mean 0,07010901 repl= 5 0,06989814 repl= 7
SE 0,00515599 n= 2 0,02475571 n= 2
"menadione" Negative and positive control (200 µM menadione):
Mean ± SE from n=2 animals x 5 replicates
"Fe-100" Negative control and 100 µM FeSO4:
Mean ± SE from n=2 animals x 4-7 replicates
"Fe-3xLow" 100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=2 animals x 6-7 replicates
"Fe-3xHigh" 200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=4 animals x 6-7 replicates
ASAT leakage (% of total ASAT; U / litre)
Three-concentration, 24-hour experiments




mean-mean repl= 0 repl= 0
SE n= 0 n= 0








mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 24h B-02 0,04223443 0,07628845 B-02 0,10398703 0,07965451 0,07747721 0,04071682
B-03 0,03711511 0,07687528 B-03 0,08582062 0,09021113 0,08622464 0,04507934
B-04 0,06911089 0,05340191 B-04 0,10523989 0,09788868 0,06810497 0,03926265
B-05 0,0243168 0,08039629 B-05 0,07141278 0,07869482 0,06498089 0,09670245
B-06 0,0447941 0,05692292 B-06 0,06326922 0,13339731 0,04811085 0,05816689
B-07 0,0447941 0,03697055 B-07 0,08143563 0,12667946 0,05935754 0,04435225
mean 0,04372757 0,0634759 0,08519419 0,10108765 0,06737602 0,05404673
SD 0,01462409 0,017187 0,01697146 0,02361443 0,01340907 0,02194146
mean-mean 0,05360174 repl= 6 0,07692615 repl= 6
SE 0,01396418 n= 2 0,02054922 n= 4
pos ctrl 24h C-02 0,0755913 0,06783507 C-02 0,07415644 0,08536526 0,07915473 0,0454237
C-03 0,08524125 0,07382051 C-03 0,06325108 0,08536526 0,09209348 0,04686572
C-04 0,0948912 0,08446131 C-04 0,08578882 0,0952151 0,06164936 0,07714819
C-05 0,08041627 0,07049527 C-05 0,08651584 0,08454444 0,0974212 0,05335482
C-06 0,0755913 0,07049527 C-06 0,01672155 0,07633625 0,08828797 0,06200696
C-07 0,08122044 0,06517487 C-07 0,07924561 0,09849838 0,06697708 0,06272797
mean 0,08215863 0,07204705 0,06761322 0,08755412 0,08093064 0,05792123
SD 0,00723598 0,00673859 0,02636201 0,00803677 0,01428497 0,01190578
mean-mean 0,07710284 repl= 6 0,0735048 repl= 6
SE 0,00714996 n= 2 0,01329266 n= 4









mean-mean 0,06735734 repl= 7
SE 0,00203543 n= 2
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
ASAT leakage (% of total ASAT; U / litre)
Three-concentration, 24-hour experiments
EGN-06-01 EGN-07-01 EGN-09-01 EGN-10-01 EGN-11-01 EGN-12-01
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
Fe-200 24h E-01 0,062256 0,09449732 D-01 0,09591062 0,06996886 0,06699727 0,04337912
E-02 0,06636725 0,10401504 D-02 0,07647775 0,09673956 0,07146376 0,09506488
E-03 0,07458974 0,06662401 D-03 0,07961208 0,13263663 0,06755558 0,0830664
E-04 0,0734151 0,0645845 D-04 0,08964195 0,09004688 0,04019836 0,04522504
E-05 0,03817585 0,10741422 D-05 0,07961208 0,08092051 0,05415613 0,06183832
E-06 0,06166868 0,10537471 D-06 0,05829861 0,06327619 0,05638937 0,06737608
E-07 0,03876317 0,08905863 D-07 0,11158229 0,04745714 0,05136458 0,07568272
mean 0,0593194 0,09022406 0,08444791 0,08300654 0,05830358 0,06737608
SD 0,01508473 0,01802407 0,0167766 0,02747328 0,01103921 0,01905713
mean-mean 0,07477173 repl= 7 0,07328353 repl= 7
SE 0,0218529 n= 2 0,01262903 n= 4









mean-mean 0,08015093 repl= 7
SE 0,0131877 n= 2
Fe-1000 24h E-01 0,10370265 0,0935032 0,08833645 0,09584337
E-02 0,1049085 0,09190485 0,12837383 0,08713034
E-03 0,09345297 0,13506017 0,08198131 0,07928861
E-04 0,10068804 0,10149492 0,13028037 0,09148685
E-05 0,08923252 0,10868748 0,12074766 0,08974425
E-06 0,08199745 0,11747838 0,08325234 0,09148685
E-07 0,08018868 0,06313464 0,0591028 0,08974425
mean 0,09345297 0,10160909 0,09886782 0,08924636
SD 0,01011281 0,02258719 0,02755977 0,00512657
mean-mean 0,09579406 repl= 7
SE 0,00552617 n= 4
Fe-5000 24h F-01 0,15882428 0,16499288 0,18632689 0,13847252
F-02 0,15012158 0,08217792 0,2026305 0,12205567
F-03 0,13924321 0,15671138 0,24998858 0,12205567
F-04 0,14141888 0,14715581 0,1451797 0,12276945
F-05 0,13996843 0,10065203 0,15604877 0,14346895
F-06 0,13996843 0,15225212 0,11179614 0,11777302
F-07 0,15664861 0,12294836 0,12577065 0,14132762
mean 0,14659906 0,13241293 0,16824875 0,12970327
SD 0,00848264 0,03131747 0,04806702 0,01086968
mean-mean 0,144241 repl= 7
SE 0,0176369 n= 4
GLDH leakage (% of total GLDH; U / litre)
Single-concentration, 3-/6-/24-hour experiments





mean-mean repl= 0 repl= 0
SE n= 0 n= 0







mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 3h B-01 0,00109373 0,00170968 B-01 0,00156641 0,00252911
B-02 0,00084133 0,00170968 B-02 0,00113921 0,00234177
B-03 0,0010096 0,00132111 B-03 0,00142401 0,00206075
B-04 0,00067306 0,00202053 B-04 0,00185122 0,00290379
B-05 0,00109373 0,00271994 B-05 0,00170881 0,00177974
B-06 0,00113921 0,00168607
mean 0,00094229 0,00189619 0,00147148 0,00221687
SD 0,0001824 0,00052305 0,00029414 0,00046522
mean-mean 0,00141924 repl= 5 0,00184418 repl= 6
SE 0,00067451 n= 2 0,00052707 n= 2
neg ctrl 6h B-06 0,0017866 0,00573471 B-07 0,01010856 0,00455833
B-07 0,00240802 0,01065018 B-08 0,0140036 0,00546999
B-08 0,0031848 0,00856483 B-09 FALSE 0,00647282
B-09 0,00147588 0,01057571 B-10 0,0102013 0,00510532
B-10 0,00372855 0,01370373
mean 0,00251677 0,00984583 0,01143782 0,00540162
SD 0,00094116 0,00294132 0,00222252 0,00080645
mean-mean 0,0061813 repl= 5 0,00841972 repl= 4
SE 0,00518243 n= 2 0,00426824 n= 2
neg ctrl 24h B-11 0,00958074 0,0297144 B-11 0,03609736 0,01912649
B-12 0,01471328 0,02253569 B-12 0,03844616 0,02332499
B-13 0,01631007 0,02826049 B-13 0,01792506 0,02117909
B-14 0,02326752 0,03643876 B-14 0,01743057 0,01343519
B-15 0,03387477 0,04298138 B-15 0,02324076 0,01520789
B-16 0,01854316 0,0132486
mean 0,01954928 0,03198615 0,02528051 0,01758704
SD 0,00938477 0,00789103 0,00954584 0,00424069
mean-mean 0,02576771 repl= 5 0,02143378 repl= 6
SE 0,00879419 n= 2 0,0054401 n= 2
"menadione" "Fe-100"
GLDH leakage (% of total GLDH; U / litre)
Single-concentration, 3-/6-/24-hour experiments
EGN-04-00 EGN-02-01 EGN-03-01 EGN-05-01
"menadione" "Fe-100"
test 3h C-01 0,00173538 0,00185333 C-01 0,0015484 0,00275652
C-02 0,00163897 0,00163093 C-02 0,00210156 0,0014928
C-03 0,00134974 0,0024464 C-03 0,00519209 0,001866
C-04 0,00125333 0,00192746 C-04 0,00098534 0,00176417
C-05 0,0009641 0,0015568 C-05 0,00140763 0,00220521
C-06 0,00098534 0,00231548
C-07 0,0007742 0,00231548
mean 0,00138831 0,00188298 0,00185637 0,00210224
SD 0,00030941 0,00035008 0,00153687 0,00042252
mean-mean 0,00163564 repl= 5 0,0019793 repl= 7
SE 0,00034979 n= 2 0,00017386 n= 2
test 6h C-06 0,00337946 0,00675208 C-08 0,01199527 0,01256104
C-07 0,00231226 0,0089162 C-09 0,01141485 0,00679996
C-08 0,00435772 0,01038781 C-10 0,00938339 0,00821662
C-09 0,00222333 0,00605956 C-11 0,01141485 0,00604441
C-10 0,00275693 0,0126385 C-12 0,00851277 0,01067216
mean 0,00300594 0,00895083 0,01054423 0,00885884
SD 0,00088353 0,00268603 0,00150797 0,00271877
mean-mean 0,00597838 repl= 5 0,00970153 repl= 5
SE 0,00420367 n= 2 0,00119175 n= 2
test 24h C-11 0,0295475 0,01715439 C-13 0,04286748 0,02157478
C-12 0,04992508 0,01882799 C-14 0,03807529 0,01828679
C-13 0,04924583 0,01840959 C-15 0,02979268 0,02043269
C-14 0,03498152 0,02635918 C-16 0,0456877 0,01267623
C-15 0,04584957 0,01799119 C-17 0,03169937 0,02224636
C-18 0,04523647 0,03156465
C-19 0,03090971 0,01830078
mean 0,0419099 0,01974847 0,03775267 0,02072604
SD 0,00914346 0,00374696 0,00697695 0,0057333
mean-mean 0,03082918 repl= 5 0,02923936 repl= 7
SE 0,0156705 n= 2 0,01203965 n= 2
"menadione" Negative and positive control (200 µM menadione):
Mean ± SE from n=2 animals x 5 replicates
"Fe-100" Negative control and 100 µM FeSO4:
Mean ± SE from n=2 animals x 4-7 replicates
"Fe-3xLow" 100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=2 animals x 6-7 replicates
"Fe-3xHigh" 200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=4 animals x 6-7 replicates
GLDH leakage (% of total GLDH; U / litre)
Three-concentration, 24-hour experiments




mean-mean repl= 0 repl= 0
SE n= 0 n= 0








mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 24h B-02 0,02376665 0,04075961 B-02 0,05634085 0,22340812 0,05055339 0,01682605
B-03 0,02396806 0,02854254 B-03 0,04107849 0,26413998 0,06532779 0,0175223
B-04 0,0525686 0,02119067 B-04 0,06332257 0,19872214 0,04111913 0,01415709
B-05 0,01047344 0,03535382 B-05 0,04643655 0,23328251 0,04254317 0,04490816
B-06 0,03081608 0,02324487 B-06 0,02955053 0,50235969 0,03097285 0,02645752
B-07 0,03464291 0,01351446 B-07 0,03555806 0,29376316 0,03684701 0,01821855
mean 0,02937262 0,02710099 0,04538118 FALSE 0,04456055 0,02301495
SD 0,01404086 0,00991101 0,012718 0,11105308 0,0120601 0,01149872
mean-mean 0,02823681 repl= 6 0,03765223 repl= 6
SE 0,00160628 n= 2 0,01268289 n= 3
pos ctrl 24h C-02 0,02636732 0,02055146 C-02 0,01116931 0,02896979 0,02400195 0,00957682
C-03 0,02131826 0,02926527 C-03 0,01613345 0,03064573 0,03000244 0,00976835
C-04 0,02393629 0,03797909 C-04 0,02047707 0,03806774 0,01615516 0,03294425
C-05 0,02318828 0,02745675 C-05 0,02761302 0,02992747 0,03123331 0,01302447
C-06 0,01570819 0,02235998 C-06 0,01023853 0,0229843 0,02661755 0,02624048
C-07 0,01870022 0,02318204 C-07 0,01861552 0,02920921 0,01877076 0,01819595
mean 0,02153643 0,0267991 0,01737448 0,02996737 0,02446353 0,01829172
SD 0,0038441 0,00637697 0,00643366 0,00482516 0,00604647 0,00953132
mean-mean 0,02416776 repl= 6 0,02252428 repl= 6
SE 0,00372127 n= 2 0,00587637 n= 4









mean-mean 0,04446925 repl= 7
SE 0,01348973 n= 2
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
GLDH leakage (% of total GLDH; U / litre)
Three-concentration, 24-hour experiments
EGN-06-01 EGN-07-01 EGN-09-01 EGN-10-01 EGN-11-01 EGN-12-01
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
Fe-200 24h E-01 0,03293415 0,0501071 D-01 0,06633427 0,03492285 0,03767819 0,0340982
E-02 0,03964296 0,05461985 D-02 0,04984768 0,05309537 0,04110348 0,09581595
E-03 0,03695944 0,03501272 D-03 0,04325305 0,0993958 0,03753547 0,08047176
E-04 0,03293415 0,02941069 D-04 0,06167924 0,04835471 0,02012358 0,04500963
E-05 0,01671103 0,06193362 D-05 0,05256312 0,04740658 0,02882952 0,07092426
E-06 0,03256822 0,06193362 D-06 0,03219734 0,03587098 0,03753547 0,04876043
E-07 0,01646708 0,04777292 D-07 0,07292891 0,02291318 0,02997129 0,07637997
mean 0,02974529 0,04868436 0,0541148 0,04885135 0,03325386 0,06449432
SD 0,00934984 0,01256688 0,01402067 0,02453015 0,00730992 0,02224885
mean-mean 0,03921482 repl= 7 0,05017858 repl= 7
SE 0,01339194 n= 2 0,01302103 n= 4









mean-mean 0,07064428 repl= 7
SE 0,03602519 n= 2
Fe-1000 24h E-01 0,07988264 0,05317751 0,05198403 0,24712759
E-02 0,07623318 0,05487919 0,08806706 0,18853032
E-03 0,07420571 0,08274421 0,0420459 0,17918873
E-04 0,08353211 0,06126049 0,07614131 0,21570586
E-05 0,06974525 0,07508665 0,07400079 0,23269058
E-06 0,05190344 0,06913077 0,04556247 0,22504746
E-07 0,04257704 0,03722426 0,03042595 0,23523829
mean 0,06829705 0,06192901 0,05831822 0,21764697
SD 0,01525666 0,01524971 0,0211904 0,02513371
mean-mean 0,10154781 repl= 7
SE 0,0775093 n= 4
Fe-5000 24h F-01 0,17387843 0,15629057 0,13121486 0,18969932
F-02 0,15175318 0,07179111 0,13121486 0,16029305
F-03 0,14420456 0,12864431 0,16228245 0,18047382
F-04 0,13821773 0,14068381 0,08662374 0,17960893
F-05 0,13275149 0,08405356 0,10215753 0,18191531
F-06 0,12181902 0,14937901 0,06432818 0,17038343
F-07 0,14524575 0,1103621 0,07967922 0,17730256
mean 0,14398145 0,12017207 0,1082144 0,17709663
SD 0,01636247 0,03263843 0,03469989 0,00937403
mean-mean 0,13736614 repl= 7
SE 0,03037397 n= 4
LDH leakage (% of total LDH; U / litre)
Single-concentration, 3-/6-/24-hour experiments





mean-mean repl= 0 repl= 0
SE n= 0 n= 0







mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 3h B-01 0,06748772 0,07060782 B-01 0,13621795 0,07405707
B-02 0,09711104 0,06096535 B-02 0,05128958 0,08377209
B-03 0,07550606 0,06843049 B-03 0,05653365 0,09014259
B-04 0,06704225 0,06267611 B-04 0,16576381 0,10288359
B-05 0,07238782 0,06905259 B-05 0,12662514 0,0641828
B-06 0,06164981 0,07644601
mean 0,07590698 0,06634647 0,09967999 0,08191402
SD 0,01236552 0,0042501 0,04914808 0,01354187
mean-mean 0,07112672 repl= 5 0,09079701 repl= 6
SE 0,0067603 n= 2 0,01256243 n= 2
neg ctrl 6h B-06 0,08193406 0,09379873 B-07 0,20435061 0,12331547
B-07 0,12369108 0,10297469 B-08 0,20625235 0,10883019
B-08 0,13181677 0,09379873 B-09 FALSE 0,10902079
B-09 0,08509405 0,11384991 B-10 0,14574244 0,16048165
B-10 0,09683116 0,12472512
mean 0,10387342 0,10582944 0,18544847 0,12541202
SD 0,02267799 0,01340709 0,03439957 0,02434409
mean-mean 0,10485143 repl= 5 0,15543025 repl= 4
SE 0,00138311 n= 2 0,04245218 n= 2
neg ctrl 24h B-11 0,10902486 0,29413165 B-11 0,28918237 0,16673057
B-12 0,13832922 0,17917745 B-12 0,25793905 0,17261765
B-13 0,12414969 0,21047953 B-13 0,13369235 0,14213098
B-14 0,18181313 0,24474992 B-14 0,13151259 0,11248531
B-15 0,22151582 0,32570358 B-15 0,18092063 0,1406592
B-16 0,130786 0,10260343
mean 0,15496654 0,25084843 0,18733883 0,13953786
SD 0,04606154 0,05975011 0,07012906 0,02806311
mean-mean 0,20290748 repl= 5 0,16343834 repl= 6
SE 0,06779873 n= 2 0,03380039 n= 2
"menadione" "Fe-100"
LDH leakage (% of total LDH; U / litre)
Single-concentration, 3-/6-/24-hour experiments
EGN-04-00 EGN-02-01 EGN-03-01 EGN-05-01
"menadione" "Fe-100"
test 3h C-01 0,14334666 0,08358602 C-01 0,05366472 0,09375101
C-02 0,178755 0,07945655 C-02 0,0784716 0,06643992
C-03 0,11279269 0,09583201 C-03 0,28288527 0,11458784
C-04 0,11050828 0,08743069 C-04 0,05101927 0,09356826
C-05 0,10908053 0,09939189 C-05 0,13567348 0,10215753
C-06 0,05593224 0,09576126
C-07 0,03250117 0,08479623
mean 0,13089663 0,08913943 0,09859254 0,09300887
SD 0,03026882 0,00832799 0,08776232 0,01489489
mean-mean 0,11001803 repl= 5 0,0958007 repl= 7
SE 0,0295268 n= 2 0,00394825 n= 2
test 6h C-06 0,4001109 0,26013081 C-08 0,18001263 0,18080039
C-07 0,21720306 0,29811963 C-09 0,15325646 0,10478421
C-08 0,25751498 0,35255484 C-10 0,20276448 0,10630835
C-09 0,21269053 0,27101785 C-11 0,17819249 0,14993668
C-10 0,28308598 0,28676931 C-12 0,14688594 0,13393327
mean 0,27412109 0,29371849 0,1722224 0,13515258
SD 0,07622818 0,03596119 0,02253215 0,03185124
mean-mean 0,28391979 repl= 5 0,15368749 repl= 5
SE 0,01385746 n= 2 0,02621232 n= 2
test 24h C-11 0,60076839 0,49600685 C-13 0,49269763 0,20072516
C-12 0,73927732 0,42042213 C-14 0,37661524 0,12720302
C-13 0,65819892 0,51083856 C-15 0,25043097 0,16504854
C-14 0,69198159 0,48716486 C-16 0,36572433 0,11687287
C-15 0,65819892 0,52082145 C-17 0,29824561 0,23434612
C-18 0,34228706 0,33801076
C-19 0,27042996 0,21193215
mean 0,66968503 0,48705077 0,34234726 0,19916266
SD 0,05087629 0,03945224 0,08153903 0,07505081
mean-mean 0,5783679 repl= 5 0,27075496 repl= 7
SE 0,12914192 n= 2 0,1012468 n= 2
"menadione" Negative and positive control (200 µM menadione):
Mean ± SE from n=2 animals x 5 replicates
"Fe-100" Negative control and 100 µM FeSO4:
Mean ± SE from n=2 animals x 4-7 replicates
"Fe-3xLow" 100-200-400 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=2 animals x 6-7 replicates
"Fe-3xHigh" 200-1000-5000 µM FeSO4 and pos.ctrl. (200 µM menadione):
Mean ± SE from n=4 animals x 6-7 replicates
LDH leakage (% of total LDH; U / litre)
Three-concentration, 24-hour experiments




mean-mean repl= 0 repl= 0
SE n= 0 n= 0








mean-mean repl= 0 repl= 0
SE n= 0 n= 0
neg ctrl 24h B-02 0,20370457 0,27652465 B-02 0,29852428 0,23956736 0,3156464 0,09431633
B-03 0,16201065 0,31048382 B-03 0,24915954 0,27098603 0,30024265 0,10400163
B-04 0,26525273 0,20456356 B-04 0,26504347 0,38380762 0,30207022 0,08370863
B-05 0,12547884 0,22093673 B-05 0,24152903 0,23385488 0,24071628 0,2121541
B-06 0,18385032 0,20759563 B-06 0,1934101 0,33346634 0,17152993 0,11806837
B-07 0,20529291 0,11117585 B-07 0,24090613 0,40879975 0,2190466 0,08486164
mean 0,19093167 0,22188004 0,24809543 0,311747 0,25820868 0,11618511
SD 0,04703968 0,06869771 0,03439979 0,07486286 0,05717104 0,04873634
mean-mean 0,20640586 repl= 6 0,23355905 repl= 6
SE 0,0218838 n= 2 0,08308411 n= 4
pos ctrl 24h C-02 0,44400741 0,46941058 C-02 0,57637888 0,46836805 0,48540107 0,24310706
C-03 0,47726374 0,57732413 C-03 0,49196433 0,49080278 0,45464479 0,2826195
C-04 0,45745146 0,55456321 C-04 0,57577376 0,560523 0,39617741 0,34867464
C-05 0,51052007 0,59928173 C-05 0,63265524 0,44938482 0,49270949 0,29739896
C-06 0,46134316 0,46619727 C-06 0,49620019 0,4735453 0,42297496 0,19394273
C-07 0,41499657 0,45628958 C-07 0,52222044 0,54257522 0,37151148 0,28442923
mean 0,4609304 0,52051108 0,54919881 0,4975332 0,43723653 0,27502868
SD 0,03204525 0,06368318 0,05517686 0,04424046 0,04880399 0,05227632
mean-mean 0,49072074 repl= 6 0,4397493 repl= 6
SE 0,04212991 n= 2 0,1189641 n= 4









mean-mean 0,2657914 repl= 7
SE 0,03541926 n= 2
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
LDH leakage (% of total LDH; U / litre)
Three-concentration, 24-hour experiments
EGN-06-01 EGN-07-01 EGN-09-01 EGN-10-01 EGN-11-01 EGN-12-01
"Fe-3xHigh""Fe-3xLow" "Fe-3xHigh"
Fe-200 24h E-01 0,13408381 0,42579748 D-01 0,39603408 0,22347601 0,36167959 0,15593892
E-02 0,15976469 0,38563865 D-02 0,4007785 0,30600146 0,35638414 0,2782092
E-03 0,1716174 0,30389693 D-03 0,32187133 0,327424 0,340233 0,23966748
E-04 0,20100225 0,25918107 D-04 0,3847973 0,327424 0,20466935 0,13334549
E-05 0,09013 0,55367913 D-05 0,37955347 0,27484141 0,27483413 0,1869495
E-06 0,15531992 0,3964616 D-06 0,25320212 0,23540446 0,22770458 0,25561578
E-07 0,0767957 0,42693674 D-07 0,51689189 0,16602466 0,20625798 0,24764163
mean 0,14124483 0,39308452 0,37901838 0,26579943 0,28168039 0,21390972
SD 0,04444516 0,09483156 0,08052054 0,06050243 0,07069704 0,05515612
mean-mean 0,26716467 repl= 7 0,28510198 repl= 7
SE 0,17807755 n= 2 0,06897566 n= 4









mean-mean 0,2889592 repl= 7
SE 0,13003116 n= 2
Fe-1000 24h E-01 0,7254983 0,27554075 0,38925246 0,32879121
E-02 0,52612687 0,29666234 0,46141725 0,22417582
E-03 0,52753288 0,36674761 0,30615362 0,20293811
E-04 0,60317592 0,34498598 0,44528951 0,21748988
E-05 0,48788355 0,31778393 0,43271534 0,26153846
E-06 0,44654702 0,3465861 0,34715634 0,25052632
E-07 0,42517575 0,19905499 0,26515091 0,21277039
mean 0,5345629 0,30676595 0,37816221 0,24260431
SD 0,10261251 0,05692738 0,07467113 0,04336522
mean-mean 0,36552384 repl= 7
SE 0,12555959 n= 4
Fe-5000 24h F-01 0,50982099 0,39414939 0,45235033 0,18408858
F-02 0,57763648 0,21499058 0,24398177 0,13820464
F-03 0,49673983 0,38356274 0,42454702 0,12106727
F-04 0,49329742 0,34040175 0,32582969 0,12714827
F-05 0,54803175 0,28719701 0,43548091 0,17662553
F-06 0,53804876 0,31868553 0,24648094 0,14539128
F-07 0,58624251 0,29099735 0,25803962 0,1727558
mean 0,53568825 0,31856919 0,34095861 0,15218305
SD 0,03754197 0,06176049 0,09466131 0,02541355
mean-mean 0,33684978 repl= 7
SE 0,15704522 n= 4
